PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	An, JB; Nagaki, Y; Motoyama, S; Kuze, Y; Hoshizaki, M; Kemuriyama, K; Yamaguchi, T; Ebihara, T; Minamiya, Y; Suzuki, Y; Imai, Y; Kuba, K				An, Jianbo; Nagaki, Yushi; Motoyama, Satoru; Kuze, Yuta; Hoshizaki, Midori; Kemuriyama, Kohei; Yamaguchi, Tomokazu; Ebihara, Takashi; Minamiya, Yoshihiro; Suzuki, Yutaka; Imai, Yumiko; Kuba, Keiji			Identification of Galectin-7 as a crucial metastatic enhancer of squamous cell carcinoma associated with immunosuppression	ONCOGENE			English	Article; Early Access							TUMOR PROGRESSION; CANCER; PATTERNS; MARKER; CHEMORADIOTHERAPY; LYMPHANGIOGENESIS; EXPRESSION; ESOPHAGEAL; PROMOTES; SURVIVAL	Metastasis predicts poor prognosis in cancer patients. It has been recognized that specific tumor microenvironment defines cancer cell metastasis, whereas the underlying mechanisms remain elusive. Here we show that Galectin-7 is a crucial mediator of metastasis associated with immunosuppression. In a syngeneic mouse squamous cell carcinoma (SCC) model of NR-S1M cells, we isolated metastasized NR-S1M cells from lymph nodes in tumor-bearing mice and established metastatic NR-S1M cells in in vitro culture. RNA-seq analysis revealed that interferon gene signature was markedly downregulated in metastatic NR-S1M cells compared with parental cells, and in vivo NR-S1M tumors heterogeneously developed focal immunosuppressive areas featured by deficiency of anti-tumor immune cells. Spatial transcriptome analysis (Visium) for the NR-S1M tumors revealed that various pro-metastatic genes were significantly upregulated in immunosuppressive areas when compared to immunocompetent areas. Notably, Galectin-7 was identified as a novel metastasis-driving factor. Galectin-7 expression was induced during tumorigenesis particularly in the microenvironment of immunosuppression, and extracellularly released at later stage of tumor progression. Deletion of Galectin-7 in NR-S1M cells significantly suppressed lymph node and lung metastasis without affecting primary tumor growth. Therefore, Galectin-7 is a crucial mediator of tumor metastasis of SCC, which is educated in the immune-suppressed tumor areas, and may be a potential target of cancer immunotherapy.	[An, Jianbo; Nagaki, Yushi; Hoshizaki, Midori; Kemuriyama, Kohei; Yamaguchi, Tomokazu; Kuba, Keiji] Akita Univ, Dept Biochem & Metab Sci, Grad Sch Med, 1-1-1 Hondo, Akita 0108543, Japan; [Nagaki, Yushi; Motoyama, Satoru; Kemuriyama, Kohei; Minamiya, Yoshihiro] Akita Univ, Dept Surg, Grad Sch Med, Akita, Japan; [Kuze, Yuta; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Hoshizaki, Midori; Ebihara, Takashi] Akita Univ, Dept Med Biol, Grad Sch Med, Akita, Japan; [Imai, Yumiko] Natl Inst Biomed Innovat Hlth & Nutr, Lab Regulat Intractable Infect Dis, Osaka 5670085, Japan; [Kuba, Keiji] Kyushu Univ, Dept Pharmacol, Grad Sch Med Sci, Fukuoka 8128582, Japan	Akita University; Akita University; University of Tokyo; Akita University; Kyushu University	Kuba, K (corresponding author), Akita Univ, Dept Biochem & Metab Sci, Grad Sch Med, 1-1-1 Hondo, Akita 0108543, Japan.; Kuba, K (corresponding author), Kyushu Univ, Dept Pharmacol, Grad Sch Med Sci, Fukuoka 8128582, Japan.	kuba.keiji.815@m.kyushu-u.ac.jp		Ebihara, Takashi/0000-0002-6056-3230	Kaken from Japanese Ministry of Science [20H03426, 20K21566, 22K19551, 20K07285, 20K09048, 17H06179]; Naito Foundation; AMED [JP 21lm0203079]	Kaken from Japanese Ministry of Science; Naito Foundation(Naito Memorial Foundation); AMED	KKuba is supported by the Kaken [20H03426, 20K21566, 22K19551] from Japanese Ministry of Science and the Naito Foundation. JA is supported by the Kaken [20K16153, 22K06907], SM is supported by the Kaken [20K09048], YI is supported by the Kaken [17H06179], and TY is supported by the Kaken [20K07285] from Japanese Ministry of Science. This research was also supported by AMED under Grant Number JP 21lm0203079.	Advedissian T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122760; Albini A, 2008, CANCER METAST REV, V27, P75, DOI 10.1007/s10555-007-9111-x; Alves PM, 2011, PATHOL RES PRACT, V207, P236, DOI 10.1016/j.prp.2011.02.004; Arnold M, 2020, GUT, V69, P1564, DOI 10.1136/gutjnl-2020-321600; Bogucka K, 2020, ELIFE, V9, DOI 10.7554/eLife.52511; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen YS, 2018, THERANOSTICS, V8, P3841, DOI 10.7150/thno.25784; Cramer JD, 2019, NAT REV CLIN ONCOL, V16, P669, DOI 10.1038/s41571-019-0227-z; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Gonzalez H, 2018, GENE DEV, V32, P1267, DOI 10.1101/gad.314617.118; Gozgit JM, 2021, CANCER CELL, V39, P1214, DOI 10.1016/j.ccell.2021.06.018; Guo JP, 2017, ONCOL LETT, V13, P1919, DOI 10.3892/ol.2017.5649; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Huang WC, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1091-5; Janssen LME, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0283-9; Johannes L, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208884; Kaur Manpreet, 2016, Asian Pac J Cancer Prev, V17, P455; Labrie M, 2014, ONCOTARGET, V5, P7705, DOI 10.18632/oncotarget.2299; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lawson DA, 2018, NAT CELL BIOL, V20, P1349, DOI 10.1038/s41556-018-0236-7; Li HJ, 2021, CANCER RES, V81, P4094, DOI 10.1158/0008-5472.CAN-20-3543; Liu XL, 2018, ONCOL RES, V26, P1123, DOI 10.3727/096504018X15166223632406; Liu Y, 2016, J MOL MED, V94, P509, DOI 10.1007/s00109-015-1376-x; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; MAGNALDO T, 1995, DEV BIOL, V168, P259, DOI 10.1006/dbio.1995.1078; Matsumoto G, 2010, CLIN EXP METASTAS, V27, P539, DOI 10.1007/s10585-010-9343-y; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mesquita JA, 2016, EUR ARCH OTO-RHINO-L, V273, P237, DOI 10.1007/s00405-014-3439-y; Mody MD, 2021, LANCET, V398, P2289, DOI 10.1016/S0140-6736(21)01550-6; Nagasawa S, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01959-9; Nguyen B, 2022, CELL, V185, P563, DOI 10.1016/j.cell.2022.01.003; Owen KL, 2020, EMBO REP, V21, DOI 10.15252/embr.202050162; Pape M, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.3_suppl.186; Pham NTH, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101308; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rahma OE, 2019, CLIN CANCER RES, V25, P5449, DOI 10.1158/1078-0432.CCR-18-1543; Richardson AM, 2018, CLIN CANCER RES, V24, P420, DOI 10.1158/1078-0432.CCR-17-1776; Saussez S, 2006, CELL MOL LIFE SCI, V63, P686, DOI 10.1007/s00018-005-5458-8; Saussez S, 2008, ORAL ONCOL, V44, P86, DOI 10.1016/j.oraloncology.2006.12.014; Saussez S, 2006, ANN SURG ONCOL, V13, P999, DOI 10.1245/ASO.2006.08.033; Saussez S, 2009, INT J ONCOL, V34, P433, DOI 10.3892/ijo_00000167; Sewgobind NV, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11111720; Si YL, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129755; St-Pierre Y, 2012, FRONT BIOSCI-LANDMRK, V17, P438, DOI 10.2741/3937; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Terry S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01625; Tsai CJ, 2013, GYNECOL ONCOL, V131, P645, DOI 10.1016/j.ygyno.2013.04.056; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Wang JW, 2018, CANCER LETT, V418, P176, DOI 10.1016/j.canlet.2018.01.040; Wenig BM, 2017, MODERN PATHOL, V30, pS112, DOI 10.1038/modpathol.2016.207; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhu H, 2013, INT J CANCER, V132, P1051, DOI 10.1002/ijc.27764; Zhu H, 2009, J PROTEOME RES, V8, P3969, DOI 10.1021/pr900287a; Zhu X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-290	57	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene												10.1038/s41388-022-02525-1	http://dx.doi.org/10.1038/s41388-022-02525-1		NOV 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5Y2QR	36335283	Bronze			2022-12-26	WOS:000879132500001
J	Gedfie, S; Getawa, S; Kassahun, W; Gashaye, KT; Melku, M				Gedfie, Solomon; Getawa, Solomon; Kassahun, Woldeteklehaymanot; Gashaye, Kiros Terefe; Melku, Mulugeta			Hematological parameters of reproductive-age women using hormonal contraceptives at University of Gondar Comprehensive Specialized Referral Hospital, Northwest Ethiopia: A comparative cross-sectional study	PLOS ONE			English	Article							ORAL-CONTRACEPTIVES; FOLATE STATUS; DESOGESTREL	Background More than one-third of reproductive aged women in Ethiopia use hormonal contraceptives to prevent conception. The present study aimed to compare the hematological parameters of reproductive-age women taking hormonal contraceptives at the University of Gondar Comprehensive Specialized Referral Hospital, Northwest Ethiopia in 2021. Methods A comparative cross-sectional study was conducted from April to June 2021. A total of 240 study participants were recruited by using a consecutive sampling technique. Data on socio-demographic variables and clinical data were collected through face-to-face interviews using a structured questionnaire and medical record reviews, respectively. Three milliliter venous blood was collected for complete blood count analysis using Unicel DxH 800 coulter hematology analyzer. Data was entered into Epi-data 4.4.3.1 version then exported to IBM SPSS v25 for analysis. Kruskal-Wallis H, Dunn-Bonferroni pairwise comparison test, and Spearman's correlation analysis were used for inferential statistics. P<0.05 were considered statistically significant. Result The median and interquartile range of platelet count among combined oral contraceptive users was 285(238-332) which is significantly higher than that of depot medroxyprogesterone acetate users 246(220-226) (p = 0.010), implant user 247(221-297) (p = 0.034), and controls 256(224-278) (p = 0.015). The result also showed long-term use of implant negatively correlated with red blood cell count (p = 0.033). Conclusion This finding concludes that combined oral contraceptive users had a higher platelet counts than controls while long-term use of implants can result in low red blood cells count. Therefore, a baseline evaluation of complete blood count in women desiring contraceptive methods would also be recommended.	[Gedfie, Solomon; Kassahun, Woldeteklehaymanot] Woldia Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Woldia, Ethiopia; [Getawa, Solomon; Melku, Mulugeta] Univ Gondar, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia; [Gashaye, Kiros Terefe] Univ Gondar, Sch Med, Dept Obstet & Gynecol, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar	Kassahun, W (corresponding author), Woldia Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Woldia, Ethiopia.	teklu1142@gmail.com		Kassahun, Woldeteklehaymanot/0000-0001-5769-0944; Gedfie, Solomon/0000-0001-9964-1964; Getawa, Solomon/0000-0003-2670-9547				Abdalla T., 2012, KHARTOUM MED J, V1; Adejumo EN., 2016, J BIOSCIENCES MED, V4, P107; Afsar Nasir Ali, 2005, J Ayub Med Coll Abbottabad, V17, P21; Ahmed YMAA, 2018, EFFECT ORAL CONTRACE; Aitazaz F., 2016, PJP, V12, P10; Akinloye O, 2011, W INDIAN MED J, V60, P308; Al-Chalaby SS., 2006, MEDICAL J TIKRIT U, V1, P56; Al-Zayadi T., 2018, J CHEM BIOPHY SCI SE, P8; Andres E, 2004, EUR J OBSTET GYN R B, V115, P241, DOI 10.1016/S0301-2115(03)00197-0; Balogun OR, 2016, INT J HEALTH SCI-IJH, V10, P499; Bellizzi S, 2018, CONTRACEPTION, V97, P236, DOI 10.1016/j.contraception.2017.11.001; Blumenthal PD, 2008, OBSTET GYNECOL, V112, P670, DOI 10.1097/AOG.0b013e31818425b7; Carr J, 2012, LABMEDICINE, V43, P157, DOI 10.1309/LMEJRJLI8L5ZCDWP; Coffie S., 2020, ASIAN HEMATOLOGY RES, V3, P1; Egbunah M., 2018, JMSCR, V6, P73; Haider S, 2007, CLIN OBSTET GYNECOL, V50, P898, DOI 10.1097/GRF.0b013e318159c20a; Jamil S., 2014, AM J PHYTOMEDICINE C, V2, P580; Klinger G, 2000, GYNECOL ENDOCRINOL, V14, P15, DOI 10.3109/09513590009167655; Klipping C, 2005, CONTRACEPTION, V71, P409, DOI 10.1016/j.contraception.2004.12.005; McArthur JO, 2013, NUTRIENTS, V5, P3634, DOI 10.3390/nu5093634; Merera AM, 2022, J RACIAL ETHN HEALTH, V9, P2340, DOI 10.1007/s40615-021-01171-9; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Oumer M, 2020, OPEN ACCESS J CONTR, V11, P53, DOI 10.2147/OAJC.S252970; Palmery M, 2013, EUR REV MED PHARMACO, V17, P1804; Rachmilewitz B., 2019, VITAMIN B12, P765; Rakhi J, 2011, J OBSTET GYN INDIA, V61, P626, DOI 10.1007/s13224-011-0107-7; Samsunnahar AkhteQS., 2014, BANGLADESH SOC PHYSL, V9; Schrager S, 2002, AM FAM PHYSICIAN, V65, P2073; Shere M, 2015, J OBSTET GYNAECOL CA, V37, P430, DOI 10.1016/S1701-2163(15)30258-9; Sutterlin MW, 2003, EUR J OBSTET GYN R B, V107, P57, DOI 10.1016/S0301-2115(02)00371-8; Teferra AS., 2015, SCI J PUBLIC HLTH, V3, P143, DOI DOI 10.11648/J.SJPH; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Wakeman MP., 2019, J ADV MED MED RES, P1	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0277254	10.1371/journal.pone.0277254	http://dx.doi.org/10.1371/journal.pone.0277254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346804	Green Published, gold			2022-12-26	WOS:000894053200018
J	Spina, R; Mills, I; Ahmad, F; Chen, CX; Ames, HM; Winkles, JA; Woodworth, GF; Bar, EE				Spina, Raffaella; Mills, Ian; Ahmad, Fahim; Chen, Chixiang; Ames, Heather M.; Winkles, Jeffrey A.; Woodworth, Graeme F.; Bar, Eli E.			DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts	ONCOGENE			English	Article; Early Access							CENTRAL-NERVOUS-SYSTEM; PROMOTES RADIORESISTANCE; HYPOXIC MICROENVIRONMENT; THERAPEUTIC RESISTANCE; URIDINE LEVELS; CDP-CHOLINE; TUMORS; GROWTH; CLASSIFICATION; ACTIVATION	Glioma stem cells (GSCs) promote tumor progression and therapeutic resistance and exhibit remarkable bioenergetic and metabolic plasticity, a phenomenon that has been linked to their ability to escape standard and targeted therapies. However, specific mechanisms that promote therapeutic resistance have been somewhat elusive. We hypothesized that because GSCs proliferate continuously, they may require the salvage and de novo nucleotide synthesis pathways to satisfy their bioenergetic needs. Here, we demonstrate that GSCs lacking EGFR (or EGFRvIII) amplification are exquisitely sensitive to de novo pyrimidine synthesis perturbations, while GSCs that amplify EGFR are utterly resistant. Furthermore, we show that EGFRvIII promotes BAY2402234 resistance in otherwise BAY2402234 responsive GSCs. Remarkably, a novel, orally bioavailable, blood-brain-barrier penetrating, dihydroorotate dehydrogenase (DHODH) inhibitor BAY2402234 was found to abrogate GSC proliferation, block cell-cycle progression, and induce DNA damage and apoptosis. When dosed daily by oral gavage, BAY2402234 significantly impaired the growth of two different intracranial human glioblastoma xenograft models in mice. Given this observed efficacy and the previously established safety profiles in preclinical animal models and human clinical trials, the clinical testing of BAY2402234 in patients with primary glioblastoma that lacks EGFR amplification is warranted.	[Spina, Raffaella; Mills, Ian; Ahmad, Fahim; Ames, Heather M.; Bar, Eli E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Chen, Chixiang; Winkles, Jeffrey A.; Woodworth, Graeme F.; Bar, Eli E.] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Chen, Chixiang] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Ames, Heather M.; Winkles, Jeffrey A.; Woodworth, Graeme F.; Bar, Eli E.] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bar, EE (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Bar, EE (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Bar, EE (corresponding author), Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.	ebar@som.umaryland.edu		Mills, Ian/0000-0003-1334-2686; Winkles, Jeffrey/0000-0002-3305-1424; Ahmad, Fahim/0000-0002-7216-5539; Chen, Chixiang/0000-0001-5474-2833	National Institutes of Health [R21NS106553, R01CA187780]; National Cancer Institute Cancer Center Support Grant (CCSG) [P30CA134274]; Maryland Department of Health's Cigarette Restitution Fund Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center Support Grant (CCSG); Maryland Department of Health's Cigarette Restitution Fund Program	This study is funded by National Institutes of Health grant R01CA187780 (EEB), National Institutes of Health grant R21NS106553 (EEB), National Cancer Institute Cancer Center Support Grant (CCSG) - P30CA134274, and Maryland Department of Health's Cigarette Restitution Fund Program.	Ashour OM, 2000, CANCER CHEMOTH PHARM, V45, P351, DOI 10.1007/s002800051002; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Cansev M, 2005, BRAIN RES, V1058, P101, DOI 10.1016/j.brainres.2005.07.054; Carruthers RD, 2018, CANCER RES, V78, P5060, DOI 10.1158/0008-5472.CAN-18-0569; Christian S, 2019, LEUKEMIA, V33, P2403, DOI 10.1038/s41375-019-0461-5; Chu Q, 2013, CLIN CANCER RES, V19, P3224, DOI 10.1158/1078-0432.CCR-12-2119; Dahan P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.509; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Fuller GN, 2008, ARCH PATHOL LAB MED, V132, P906, DOI 10.1043/1543-2165(2008)132[906:TWCOTO]2.0.CO;2; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Grant GD, 2018, CELL CYCLE, V17, P2496, DOI 10.1080/15384101.2018.1547001; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Henricks LM, 2018, BRIT J CLIN PHARMACO, V84, P2761, DOI 10.1111/bcp.13719; Hess KR, 2004, CANCER, V101, P2293, DOI 10.1002/cncr.20621; Honoki K, 2010, ONCOL REP, V24, P501, DOI 10.3892/or_00000885; Jialiang W, 2009, NOTCH PROMOTES RADIO, V28, P17; Kahlert UD, 2015, BRAIN PATHOL, V25, P724, DOI 10.1111/bpa.12240; Kahlert UD, 2012, FOLIA NEUROPATHOL, V50, P357, DOI 10.5114/fn.2012.32365; Kim Y, 2012, LAB INVEST, V92, P466, DOI 10.1038/labinvest.2011.161; Lal B, 2009, MOL CANCER THER, V8, P1751, DOI 10.1158/1535-7163.MCT-09-0188; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li YQ, 2011, P NATL ACAD SCI USA, V108, P9951, DOI 10.1073/pnas.1016912108; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lim KS, 2014, ONCOGENE, V33, P4433, DOI 10.1038/onc.2013.390; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Louis DN, 2021, NEURO-ONCOLOGY, V23, P1231, DOI 10.1093/neuonc/noab106; Mashimo M, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.014479; Nakano RMAI, 2011, J CARCINOGENE MUTAGE, P1; Osuka S, 2017, J CLIN INVEST, V127, P415, DOI 10.1172/JCI89587; Pistollato F, 2009, STEM CELLS, V27, P7, DOI 10.1634/stemcells.2008-0402; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Robinson AD, 2020, CANCER LETT, V470, P134, DOI 10.1016/j.canlet.2019.11.013; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Singh SK, 2003, CANCER RES, V63, P5821; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Spina R., 2020, NEUROONCOL ADV, V2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-401; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Szeto MD, 2009, CANCER RES, V69, P4502, DOI 10.1158/0008-5472.CAN-08-3884; Tilghman J, 2014, CANCER RES, V74, P3168, DOI 10.1158/0008-5472.CAN-13-2103; Uribe D, 2017, MOL ASPECTS MED, V55, P140, DOI 10.1016/j.mam.2017.01.009; van Wijk Nick, 2017, Alzheimers Dement (Amst), V8, P139, DOI 10.1016/j.dadm.2017.04.005; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang MX, 2013, INT J ONCOL, V43, P131, DOI 10.3892/ijo.2013.1929; Wang SD, 2012, ONCOGENE, V31, P5132, DOI 10.1038/onc.2012.16; Wang XX, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau4972; Williams MG, 2003, BIOMED CHROMATOGR, V17, P215, DOI 10.1002/bmc.210; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Wu YJ, 2012, CANCER SCI, V103, P1028, DOI 10.1111/j.1349-7006.2012.02260.x; Wurtman RJ, 2000, BIOCHEM PHARMACOL, V60, P989, DOI 10.1016/S0006-2952(00)00436-6; Ying M, 2011, ONCOGENE, V30, P3454, DOI 10.1038/onc.2011.58; Ying MY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588988; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561	65	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene												10.1038/s41388-022-02517-1	http://dx.doi.org/10.1038/s41388-022-02517-1		NOV 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5Z0JJ	36344676				2022-12-26	WOS:000879664600003
J	Pavey, H; Kulkarni, S; Wood, A; Ben-Shlomo, Y; Sever, P; McEniery, C; Wilkinson, I				Pavey, Holly; Kulkarni, Spoorthy; Wood, Angela; Ben-Shlomo, Yoav; Sever, Peter; McEniery, Carmel; Wilkinson, Ian			Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank	JOURNAL OF HUMAN HYPERTENSION			English	Meeting Abstract									[Pavey, Holly; Wood, Angela; McEniery, Carmel; Wilkinson, Ian] Univ Cambridge, Cambridge, England; [Kulkarni, Spoorthy] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Ben-Shlomo, Yoav] Univ Bristol, Bristol, Avon, England; [Sever, Peter] Imperial Coll London, London, England	University of Cambridge; University of Cambridge; University of Bristol; Imperial College London			Wood, Angela/GZA-5762-2022	Wood, Angela/0000-0002-7937-304X; Kulkarni (Burli), Spoorthy/0000-0003-2827-214X					0	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9240	1476-5527		J HUM HYPERTENS	J. Hum. Hypertens.	SEP	2022	36	SUPPL 1		1	SI	O-6	3	3						1	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	4H7NI	36350810	gold, Green Published			2022-12-26	WOS:000850063200007
J	Stubbs, FE; Flynn, BP; Rivers, CA; Birnie, MT; Herman, A; Swinstead, EE; Baek, S; Fang, H; Temple, J; Carroll, JS; Hager, GL; Lightman, SL; Conway-Campbell, BL				Stubbs, Felicity E.; Flynn, Benjamin P.; Rivers, Caroline A.; Birnie, Matthew T.; Herman, Andrew; Swinstead, Erin E.; Baek, Songjoon; Fang, Hai; Temple, Jillian; Carroll, Jason S.; Hager, Gordon L.; Lightman, Stafford L.; Conway-Campbell, Becky L.			Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation	ONCOGENE			English	Article; Early Access							CHROMATIN-REMODELING COMPLEX; GLUCOCORTICOID-RECEPTOR; TUMOR-SUPPRESSOR; POLY(ADP-RIBOSE) POLYMERASE; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; SOLID TUMORS; 53BP1; BINDING; ARREST	ARID1a (BAF250), a component of human SWI/SNF chromatin remodeling complexes, is frequently mutated across numerous cancers, and its loss of function has been putatively linked to glucocorticoid resistance. Here, we interrogate the impact of siRNA knockdown of ARID1a compared to a functional interference approach in the HeLa human cervical cancer cell line. We report that ARID1a knockdown resulted in a significant global decrease in chromatin accessibility in ATAC-Seq analysis, as well as affecting a subset of genome-wide GR binding sites determined by analyzing GR ChIP-Seq data. Interestingly, the specific effects on gene expression were limited to a relatively small subset of glucocorticoid-regulated genes, notably those involved in cell cycle regulation and DNA repair. The vast majority of glucocorticoid-regulated genes were largely unaffected by ARID1a knockdown or functional interference, consistent with a more specific role for ARID1a in glucocorticoid function than previously speculated. Using liquid chromatography-mass spectrometry, we have identified a chromatin-associated protein complex comprising GR, ARID1a, and several DNA damage repair proteins including P53 binding protein 1 (P53BP1), Poly(ADP-Ribose) Polymerase 1 (PARP1), DNA damage-binding protein 1 (DDB1), DNA mismatch repair protein MSH6 and splicing factor proline and glutamine-rich protein (SFPQ), as well as the histone acetyltransferase KAT7, an epigenetic regulator of steroid-dependent transcription, DNA damage repair and cell cycle regulation. Not only was this protein complex ablated with both ARID1a knockdown and functional interference, but spontaneously arising DNA damage was also found to accumulate in a manner consistent with impaired DNA damage repair mechanisms. Recovery from dexamethasone-dependent cell cycle arrest was also significantly impaired. Taken together, our data demonstrate that although glucocorticoids can still promote cell cycle arrest in the absence of ARID1a, the purpose of this arrest to allow time for DNA damage repair is hindered.	[Stubbs, Felicity E.; Flynn, Benjamin P.; Rivers, Caroline A.; Birnie, Matthew T.; Lightman, Stafford L.; Conway-Campbell, Becky L.] Univ Bristol, Fac Hlth Sci, Henry Wellcome Labs Integrat Neurosci & Endocrino, Translat Hlth Sci, Dorothy Hodgkin Bldg,Whitson St, Bristol BS1 3NY, Avon, England; [Stubbs, Felicity E.; Swinstead, Erin E.; Baek, Songjoon; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, US Natl Inst Hlth, 41 Medlars Dr, Bethesda, MD 20892 USA; [Herman, Andrew] Univ Bristol, Fac Life Sci, Sch Cellular & Mol Med, Flow Cytometry Facil, Biomed Sci Bldg, Bristol, Avon, England; [Fang, Hai] Shanghai Jiao Tong Univ, Ruijin Hosp, Natl Res Ctr Translat Med Shanghai,Sch Med, Thanghai Inst Hematol,State Key Lab Med Genom, Shanghai 200025, Peoples R China; [Temple, Jillian; Carroll, Jason S.] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bristol; Chinese Academy of Sciences; Shanghai Jiao Tong University; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Conway-Campbell, BL (corresponding author), Univ Bristol, Fac Hlth Sci, Henry Wellcome Labs Integrat Neurosci & Endocrino, Translat Hlth Sci, Dorothy Hodgkin Bldg,Whitson St, Bristol BS1 3NY, Avon, England.	b.conway-campbell@bristol.ac.uk		Flynn, Benjamin/0000-0002-1871-3039; Rivers, Caroline/0000-0002-2993-3723	Wellcome Trust [089647/Z/09/Z]; MRC [MR/R010919/1]; Needham Cooper Charitable Trust; Neuroendocrinology Charitable Trust; Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program [W81XWH-17-1-0067]	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Needham Cooper Charitable Trust; Neuroendocrinology Charitable Trust; Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program	Majority of materials and consumables were provided by funding from Wellcome Trust Grant 089647/Z/09/Z and MRC Grant MR/R010919/1 to BLC-C and SLL FES was awarded an early career grant by The Society for Endocrinology for the costs of the proteomics and FACS studies. FES was supported by a Ph.D. scholarship provided by the Needham Cooper Charitable Trust and a research fellowship awarded by the Neuroendocrinology Charitable Trust. BLC-C was supported by Wellcome Trust Grant 089647/Z/09/Z and MRC Grant MR/R010919/1. EES was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Programunder Award No. W81XWH-17-1-0067. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. Finally, we would like to thank The University of Bristol Genomics Facility (Dr. Christy Waterfall and Ms. Jane Coghill), Proteomics Facility (Dr. Kate Heesom), and FACS facility (Helen Rice and Lorena Sueiro Ballesteros) for their excellent technical support and invaluable advice throughout the course of the project.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ARCHER TK, 1994, MOL ENDOCRINOL, V8, P1154, DOI 10.1210/me.8.9.1154; Baell JB, 2018, NATURE, V560, P253, DOI 10.1038/s41586-018-0387-5; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Conway-Campbell BL, 2011, MOL ENDOCRINOL, V25, P944, DOI 10.1210/me.2010-0073; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; Cortes U, 2000, MOL CARCINOGEN, V27, P57, DOI 10.1002/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.3.CO;2-9; Cuella-Martin R, 2016, MOL CELL, V64, P51, DOI 10.1016/j.molcel.2016.08.002; de Silva HC, 2019, CELL MOL LIFE SCI, V76, P2015, DOI 10.1007/s00018-019-03033-4; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Drane P, 2017, NATURE, V543, P211, DOI 10.1038/nature21358; Du F, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0315-y; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fang H, 2014, BIOCHEM BIOPH RES CO, V443, P285, DOI 10.1016/j.bbrc.2013.11.103; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; George CL, 2017, MOL CELL ENDOCRINOL, V439, P46, DOI 10.1016/j.mce.2016.10.019; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; GOYA L, 1993, MOL ENDOCRINOL, V7, P1121, DOI 10.1210/me.7.9.1121; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Han N, 2019, ONCOTARGETS THER, V12, P7591, DOI 10.2147/OTT.S222223; HARMON JM, 1979, J CELL PHYSIOL, V98, P267, DOI 10.1002/jcp.1040980203; He B, 2016, J CELL PHYSIOL, V231, P233, DOI 10.1002/jcp.25076; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Herr I, 2006, LANCET ONCOL, V7, P425, DOI 10.1016/S1470-2045(06)70694-5; Hoffmann JA, 2018, ELIFE, V7, DOI 10.7554/eLife.35073; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hu ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134299; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Jaafar L, 2017, NUCLEIC ACIDS RES, V45, P1848, DOI 10.1093/nar/gkw1209; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson TA, 2018, NUCLEIC ACIDS RES, V46, P203, DOI 10.1093/nar/gkx1044; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kang Y, 2011, BIOCHEM BIOPH RES CO, V404, P476, DOI 10.1016/j.bbrc.2010.12.005; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037030; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; MacPherson L, 2020, NATURE, V577, P266, DOI 10.1038/s41586-019-1835-6; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; Mattern J, 2007, CANCER BIOL THER, V6, P1345, DOI 10.4161/cbt.6.9.4765; Mirza-Aghazadeh-Attari M, 2019, DNA REPAIR, V73, P110, DOI 10.1016/j.dnarep.2018.11.008; Mittica G, 2018, RECENT PAT ANTI-CANC, V13, P392, DOI 10.2174/1574892813666180305165256; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Niida H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16102; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pardo M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08456-2; Petrucco S, 2003, NUCLEIC ACIDS RES, V31, P6689, DOI 10.1093/nar/gkg890; Planey SL, 2000, BIOCHEM BIOPH RES CO, V279, P307, DOI 10.1006/bbrc.2000.3922; Pommier Y, 2022, NAT REV MOL CELL BIO, V23, P407, DOI 10.1038/s41580-022-00452-3; Pooley JR, 2017, ENDOCRINOLOGY, V158, P1486, DOI 10.1210/en.2016-1929; Pottier N, 2008, JNCI-J NATL CANCER I, V100, P1792, DOI 10.1093/jnci/djn416; Prekovic S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24537-3; Rajesh C, 2011, NUCLEIC ACIDS RES, V39, P132, DOI 10.1093/nar/gkq738; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Rutz HP, 2002, LANCET, V360, P1969, DOI 10.1016/S0140-6736(02)11922-2; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Sharma A, 2012, HISTONE H2AX PHOSPHO, V920; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Shen PL, 2021, BIOCHEM BIOPHYS REP, V28, DOI 10.1016/j.bbrep.2021.101151; Sossey-Alaoui K, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1774-z; Soussi T, 2017, TRENDS CELL BIOL, V27, P311, DOI 10.1016/j.tcb.2016.10.004; Stubbs FE, 2018, MOL CELL ENDOCRINOL, V461, P226, DOI 10.1016/j.mce.2017.09.018; Sun JB, 2014, CANCER LETT, V355, P25, DOI 10.1016/j.canlet.2014.09.022; Swinstead EE, 2016, CELL, V165, P593, DOI 10.1016/j.cell.2016.02.067; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trizzino M, 2018, CELL REP, V23, P3933, DOI 10.1016/j.celrep.2018.05.097; Trotter KW, 2008, MOL CELL BIOL, V28, P1413, DOI 10.1128/MCB.01301-07; Trotter KW, 2015, MOL CELL BIOL, V35, P2799, DOI 10.1128/MCB.00230-15; Visconti R, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0433-9; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Yoon CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042006; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang XM, 2019, J RADIAT RES, V60, P318, DOI 10.1093/jrr/rrz003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	99	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene												10.1038/s41388-022-02516-2	http://dx.doi.org/10.1038/s41388-022-02516-2		NOV 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5Z0JJ	36344675	Green Published, hybrid			2022-12-26	WOS:000879664600001
J	Shiraishi, Y; Adachi, T; Cacicedo, JM; Ido, Y				Shiraishi, Yasunaga; Adachi, Takeshi; Cacicedo, Jose M.; Ido, Yasuo			Development of a high-yield, high-quality purification process for adeno-associated virus vectors that can be used in vivo without ultracentrifugation: Application to a lung endothelial cell-targeted adeno-associated virus	FASEB JOURNAL			English	Article						adeno-associated virus; capsid modification; inflammation; purification method	HIGH-EFFICIENCY TRANSDUCTION; GENE-TRANSFER; NEXT-GENERATION; VIRAL VECTORS; AAV VECTORS; EFFICACY; SEROTYPE; SAFETY; TITER	Recombinant adeno-associated viruses (rAAVs) are useful vectors for expressing genes of interest in vivo because of their low immunogenicity and long-term gene expression. Various mutations have been introduced in recent years and have enabled high-efficacy, stabilized, and organ-oriented transduction. Our purpose for using rAAV is to express our target gene in the mouse lung to investigate pulmonary artery hypertension. We constructed a self-complementary AAV having mutant capsids with the ESGHGYF insert, which directs the vectors to lung endothelial cells. However, when this mutant virus was purified from the producing cells by the conventional method using an ultracentrifuge, it resulted in a low yield. In addition, the purification method using an ultracentrifuge is tedious and labor-intensive. Therefore, we aimed to develop a simple, high-quality method for obtaining enough lung-targeted rAAV. First, we modified amino acids (T491V and Y730F) of the capsid to stabilize the rAAV from degradation, and we optimized culture conditions. Next, we noticed that many rAAVs were released from the cells into the culture medium. We, therefore, improved our purification method by purifying from the culture medium without the ultracentrifugation step. Purification without ultracentrifugation had the problem that impurities were mixed in, causing inflammation. However, by performing PEG precipitation and chloroform extraction twice, we were able to purify rAAV that caused only as little inflammation as that obtained by the ultracentrifuge method. Sufficient rAAV was obtained and can now be administered to a rat as well as mice from a single dish: 1.50 x 10(13) +/- 3.58 x 10(12) vector genome from one phi 150 mm dish (mean +/- SEM).	[Shiraishi, Yasunaga] Natl Def Med Coll, Res Inst, Div Environm Med, Saitama, Japan; [Shiraishi, Yasunaga; Adachi, Takeshi; Ido, Yasuo] Natl Def Med Coll, Dept Internal Med, Div Cardiovasc Med, Saitama, Japan; [Cacicedo, Jose M.] ALPCO Diagnost, Dept Res & Dev, Salem, NH USA; [Ido, Yasuo] Boston Univ, Sch Med, Dept Med, Boston, MA USA	National Defense Medical College - Japan; National Defense Medical College - Japan; Boston University	Shiraishi, Y; Ido, Y (corresponding author), Natl Def Med Coll, Dept Internal Med, Div Cardiovasc Med, Tokorozawa, Saitama 3598513, Japan.	sirayasu10@hotmail.com; yido@bu.edu		Shiraishi, Yasunaga/0000-0001-5901-4026	MEXT | Japan Society for the Promotion of Science (JSPS) [JP18K08120, JP20K17204]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18K08120 and JP20K17204	Aslanidi GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059142; Atkinson EM., 2003, METHODS GENERATING H; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Benskey MJ, 2016, HUM GENE THER METHOD, V27, P32, DOI 10.1089/hgtb.2015.117; Breous E, 2011, GASTROENTEROLOGY, V141, P348, DOI 10.1053/j.gastro.2011.04.002; Bryant LM, 2013, HUM GENE THER CL DEV, V24, P55, DOI 10.1089/humc.2013.087; Buning H, 2019, MOL THER-METH CLIN D, V12, P248, DOI 10.1016/j.omtm.2019.01.008; Cacicedo JM, 2011, INVEST OPHTH VIS SCI, V52, P3630, DOI 10.1167/iovs.10-5784; Clark K Reed, 2002, Kidney Int, V61, pS9; Davidoff AM, 2004, J VIROL METHODS, V121, P209, DOI 10.1016/j.jviromet.2004.07.001; Ding W, 2006, MOL THER, V13, P671, DOI 10.1016/j.ymthe.2005.12.002; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Gama-Norton L, 2011, HUM GENE THER, V22, P1269, DOI 10.1089/hum.2010.143; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Guo P, 2013, BIOENGINEERED, V4, P103, DOI 10.4161/bioe.22293; Guo P, 2012, J VIROL METHODS, V183, P139, DOI 10.1016/j.jviromet.2012.04.004; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Itagaki K, 2021, ANTIOXID REDOX SIGN, V35, P1273, DOI 10.1089/ars.2021.0052; Kimura T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49624-w; Korbelin J, 2016, MOL THER, V24, P1050, DOI 10.1038/mt.2016.62; Markusic DM, 2010, MOL THER, V18, P2048, DOI 10.1038/mt.2010.172; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Michailidis E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16882-5; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Piras BA, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.15; Rego M., 2018, BIORXIV, DOI [10.1101/488585, DOI 10.1101/488585]; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sakamoto S., 2018, METHOD MANUFACTURING; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Shiraishi Y, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030471; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x; Verdera HC, 2020, MOL THER, V28, P723, DOI 10.1016/j.ymthe.2019.12.010; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	42	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22653	10.1096/fj.202200840RR	http://dx.doi.org/10.1096/fj.202200840RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6D9SV	36374251				2022-12-26	WOS:000883025800001
J	Villani, R; Sangineto, M; Pontrelli, P; Bellanti, F; Bukke, VN; Moola, A; Gesualdo, L; Vendemiale, G; Grandaliano, G; Stallone, G; Serviddio, G				Villani, Rosanna; Sangineto, Moris; Pontrelli, Paola; Bellanti, Francesco; Bukke, Vidyasagar N.; Moola, Archana; Gesualdo, Loreto; Vendemiale, Gianluigi; Grandaliano, Giuseppe; Stallone, Giovanni; Serviddio, Gaetano			Eradication of HCV by direct antiviral agents restores mitochondrial function and energy homeostasis in peripheral blood mononuclear cells	FASEB JOURNAL			English	Article						direct antiviral agents; HCV; hepatitis; metabolism; mitochondria	DNA; SIGNATURE	Hepatitis C virus (HCV) adopts several immune evasion mechanisms such as interfering with innate immunity or promoting T-cell exhaustion. However, the recent direct-antiviral agents (DAAs) rapidly eliminate the virus, and the repercussions in terms of immune system balance are unknown. Here we compared the PBMCs transcriptomic profile of patients with HCV chronic infection at baseline (T0) and 12 weeks after the end of the therapy (SVR12) with DAAs. 3862 genes were differently modulated, identifying oxidative phosphorylation as the top canonical pathway differentially activated. Therefore, we dissected PBMCs bioenergetic profile by analyzing mitochondrial respiration and glycolysis at 4 timepoints: T0, 4 weeks of therapy, end of therapy (EoT), and SVR12. Maximal and reserve respiratory capacity considerably increased at EoT, persisting until SVR12. Notably, over time a significant increase was observed in respiratory chain (RC) complexes protein levels and the enzymatic activity of complexes I, II, and IV. Mitochondrial-DNA integrity improved over time, and the expression of mitochondrial biogenesis key regulators such as TFAM, Nrf-1, and PPARGC1A significantly increased at SVR12; hence, RC complexes synthesis and mitochondrial respiration were supported after treatment. HCV clearance with DAAS profoundly changed PBMCs bioenergetic profile, suggesting the immunometabolism study as a new approach to the understanding of viral immune evasion mechanisms and host adaptations during infections and therapies.	[Villani, Rosanna; Sangineto, Moris; Bukke, Vidyasagar N.; Moola, Archana; Serviddio, Gaetano] Univ Foggia, Dept Med & Surg Sci, Liver Unit, CURE Univ Ctr Liver Dis Res & Treatment, Foggia, Italy; [Pontrelli, Paola] Univ Bari Aldo Moro, Fac Med, Dept Emergency & Organ Transplantat, Expt Biol, Bari, Italy; [Bellanti, Francesco; Vendemiale, Gianluigi] Univ Foggia, Dept Med & Surg Sci, Internal Med, Foggia, Italy; [Gesualdo, Loreto; Grandaliano, Giuseppe] Aldo Moro Univ Bari, Dept Emergency & Organ Transplantat, Nephrol Dialysis & Transplantat Unit, Bari, Italy; [Stallone, Giovanni] Univ Foggia, Dept Med & Surg Sci, Nephrol Dialysis & Transplantat Unit, Foggia, Italy; [Stallone, Giovanni] Univ Foggia, Dept Med & Surg Sci, Nephrol Dialysis & Transplantat Unit, Viale Luigi Pinto,1, I-71100 Foggia, Italy	University of Foggia; Universita degli Studi di Bari Aldo Moro; University of Foggia; Universita degli Studi di Bari Aldo Moro; University of Foggia; University of Foggia	Stallone, G (corresponding author), Univ Foggia, Dept Med & Surg Sci, Nephrol Dialysis & Transplantat Unit, Viale Luigi Pinto,1, I-71100 Foggia, Italy.	trial.epatologia@unifg.it						Aregay A, 2019, J HEPATOL, V71, P889, DOI 10.1016/j.jhep.2019.06.025; Gokhale NS, 2014, FUTURE VIROL, V9, P1061, DOI 10.2217/FVL.14.89; Gureev AP, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00435; H-gM B., 2022, FASEB J, V36, P3217; Huang MH, 2014, ACTA PHARM SIN B, V4, P241, DOI 10.1016/j.apsb.2014.06.010; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jones N, 2015, CLIN EXP IMMUNOL, V182, P69, DOI 10.1111/cei.12662; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Liu HM, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/548390; Medeiros TC, 2019, AUTOPHAGY, V15, P178, DOI 10.1080/15548627.2018.1532263; Pawar T, 2018, MITOCHONDRION, V40, P16, DOI 10.1016/j.mito.2017.09.002; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pontrelli P, 2019, NEPHROL DIAL TRANSPL, V34, P157, DOI 10.1093/ndt/gfy206; Rascio F, 2015, J PATHOL, V237, P72, DOI 10.1002/path.4553; Saeidi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02569; Sangineto M, 2021, MED CLIN-BARCELONA, V156, P317, DOI 10.1016/j.medcli.2020.04.050; Sangineto M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020652; Schooley Robert T, 2014, Top Antivir Med, V21, P148; Schurich A, 2016, CELL REP, V16, P1243, DOI 10.1016/j.celrep.2016.06.078; Urbanowicz A, 2019, ARCH IMMUNOL THER EX, V67, P79, DOI 10.1007/s00005-018-0532-8; Villani R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93251-3; Villani R, 2021, INTERN EMERG MED, V16, P1239, DOI 10.1007/s11739-020-02628-1; Wang W, 2016, METHODS MOL BIOL, V1351, P27, DOI 10.1007/978-1-4939-3040-1_3; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	25	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22650	10.1096/fj.202200629R	http://dx.doi.org/10.1096/fj.202200629R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1KV	36394523				2022-12-26	WOS:000887950200001
J	Huang, HC; Shi, MX; Qi, CY; Tian, Q; Li, HD; Liu, MM; Li, MS; Liu, Q				Huang, Huachen; Shi, Mengxuan; Qi, Caiyun; Tian, Qi; Li, Handong; Liu, Mingming; Li, Minshu; Liu, Qiang			Sphingosine-1-phosphate receptor modulation improves neurogenesis and functional recovery after stroke	FASEB JOURNAL			English	Article						immune modulation; inflammation; ischemic stroke; neurogenesis; S1PR	NEURAL STEM-CELLS; SPHINGOSINE 1-PHOSPHATE; SUBVENTRICULAR ZONE; ISCHEMIC-STROKE; FINGOLIMOD; NEURONS; BRAIN; MICE; PROLIFERATION; GENERATION	Cerebral ischemia activates neural progenitors that participate in brain remodeling following acute injury. Sphingosine-1-phosphate receptor (S1PR) signaling governs cell proliferation and mobilization, yet its potential impact on neural progenitors and stroke recovery remains poorly understood. The goal of this study was to investigate the impact of S1PR modulation on post-stroke neurogenesis and functional recovery, using a S1PR modulator BAF312. Mice were subjected to 60 min middle cerebral artery occlusion (MCAO) and received BAF312 starting from day 3 after MCAO until the end of experiment. BAF312 facilitated motor function recovery in MCAO mice until day 14 after surgery. Flow cytometry analysis revealed that BAF312 treatment led to an increase of type A cells in subventricular zone (SVZ), but not other progenitor cell subsets in MCAO mice. We found an increase of BrdU incorporation in SVZ DCX+ cells from MCAO mice receiving BAF312 and augmented proliferation of DCX+ cells in cultured neurospheres isolated from SVZ tissues. Notably, a S1PR1 antagonist W146 abolished BAF312-induced increase of SVZ type A cells from MCAO mice and proliferation of DCX+ cells in cultured neurospheres. Additionally, the benefit of BAF312 to improve neurogenesis and stroke recovery remains in Rag2(-/-) mice lacking of T and B cells. Our results demonstrate that S1PR modulation improves neurogenesis and functional recovery following brain ischemia.	[Huang, Huachen; Shi, Mengxuan; Qi, Caiyun; Tian, Qi; Li, Handong; Liu, Mingming; Li, Minshu; Liu, Qiang] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University	Liu, Q (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China.	qliu@tmu.edu.cn	Liu, Qiang/HHZ-3181-2022					Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Behrangi N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010024; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; Bobinger T, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/3214350; Bobinger T, 2019, STROKE, V50, P3246, DOI 10.1161/STROKEAHA.119.027134; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Ceanga M, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.700297; Chatzikonstantinou S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10113217; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Dillen Y, 2020, TRANSL STROKE RES, V11, P60, DOI 10.1007/s12975-019-00717-8; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Faiz M, 2008, MOL CELL NEUROSCI, V38, P170, DOI 10.1016/j.mcn.2008.02.002; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gentile A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0686-4; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Healy LM, 2016, CURR DRUG TARGETS, V17, P1841, DOI 10.2174/1389450116666151001112710; Huang HC, 2019, STROKE, V50, P1021, DOI 10.1161/STROKEAHA.118.024287; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Huttner HB, 2014, NAT NEUROSCI, V17, P801, DOI 10.1038/nn.3706; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Jin WN, 2018, STROKE, V49, P1471, DOI 10.1161/STROKEAHA.118.020203; Kestner RI, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00280; Kimura A, 2007, STEM CELLS, V25, P115, DOI 10.1634/stemcells.2006-0223; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Li ZG, 2020, J EXP MED, V217, DOI 10.1084/jem.20200213; Liang HX, 2019, P NATL ACAD SCI USA, V116, P13621, DOI 10.1073/pnas.1811825116; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Lourbopoulos A, 2017, J CEREBR BLOOD F MET, V37, P2084, DOI 10.1177/0271678X16660986; Lucaciu A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176242; Lucaciu A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061515; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Palma-Tortosa S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16109-7; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Scott LJ, 2020, CNS DRUGS, V34, P1191, DOI 10.1007/s40263-020-00771-z; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Thompson A, 2020, NAT REV NEUROL, V16, P589, DOI 10.1038/s41582-020-00421-4; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; Zhang RL, 2016, J CEREBR BLOOD F MET, V36, P2034, DOI 10.1177/0271678X16674487	53	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22616	10.1096/fj.202200533RR	http://dx.doi.org/10.1096/fj.202200533RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1OR	36394527				2022-12-26	WOS:000887960200001
J	Lee, YJ; Jeon, HY; Lee, AJ; Kim, M; Ha, KS				Lee, Yeon-Ju; Jeon, Hye-Yoon; Lee, Ah-Jun; Kim, Minsoo; Ha, Kwon-Soo			Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy	FASEB JOURNAL			English	Article						diabetic retinopathy; dopamine; hyperglycemic memory; microvascular dysfunction; mitochondrial dysfunction	MITOCHONDRIAL FISSION; TRANSGLUTAMINASE 2; OXIDATIVE STRESS; METABOLIC MEMORY; VASCULAR LEAKAGE; C-PEPTIDE; PERMEABILITY; P66(SHC)	Dopamine is a neurotransmitter that mediates visual function in the retina and diabetic retinopathy (DR) is the most common microvascular complication of diabetes and the leading cause of blindness; however, the role of dopamine in retinal vascular dysfunction in DR remains unclear. Here, we report a mechanism of hyperglycemic memory (HGM)-induced retinal microvascular dysfunction and the protective effect of dopamine against the HGM-induced retinal microvascular leakage and abnormalities. We found that HGM induced persistent oxidative stress, mitochondrial membrane potential collapse and fission, and adherens junction disassembly and subsequent vascular leakage after blood glucose normalization in the mouse retinas. These persistent hyperglycemic stresses were inhibited by dopamine treatment in human retinal endothelial cells and by intravitreal injection of levodopa in the retinas of HGM mice. Moreover, levodopa supplementation ameliorated HGM-induced pericyte degeneration, acellular capillary and pericyte ghost generation, and endothelial apoptosis in the mouse retinas. Our findings suggest that dopamine alleviates HGM-induced retinal microvascular leakage and abnormalities by inhibiting persistent oxidative stress and mitochondrial dysfunction.	[Lee, Yeon-Ju; Jeon, Hye-Yoon; Lee, Ah-Jun; Ha, Kwon-Soo] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon, South Korea; [Kim, Minsoo] Kangwon Natl Univ, Dept Anesthesiol & Pain Med, Sch Med, Chunchon, South Korea	Kangwon National University; Kangwon National University	Ha, KS (corresponding author), Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 24341, Kangwon Do, South Korea.	ksha@kangwon.ac.kr		Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF) [2020R1A5A8019180, 2021R1A2C2091794]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2020R1A5A8019180 and 2021R1A2C2091794	Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Chesler K, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.4.8; Chou JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50489; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Devi SM, 2020, ACTA NEUROL BELG, V120, P257, DOI 10.1007/s13760-020-01274-w; Di Lisa F, 2017, BRIT J PHARMACOL, V174, P1690, DOI 10.1111/bph.13478; ENGERMAN RL, 1987, DIABETES, V36, P808, DOI 10.2337/diabetes.36.7.808; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ihnat MA, 2007, DIABETOLOGIA, V50, P1523, DOI 10.1007/s00125-007-0684-2; Jeon HY, 2022, BIOCHIP J, V16, P111, DOI 10.1007/s13206-022-00057-0; Jeon HY, 2019, FASEB J, V33, P750, DOI 10.1096/fj.201800723R; Kim D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071662; Kim MK, 2018, INVEST OPHTH VIS SCI, V59, P572, DOI 10.1167/iovs.17-22692; Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818; Kowluru RA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63527-1; Kowluru RA, 2019, DIABETES, V68, P241, DOI 10.2337/dbi18-0016; Kowluru RA, 2017, VISION RES, V139, P30, DOI 10.1016/j.visres.2017.02.011; Lahouaoui H, 2016, MOL VIS, V22, P959; Lee JY, 2019, FASEB J, V33, P12655, DOI 10.1096/fj.201901358RR; Lee YJ, 2018, FASEB J, V32, P6089, DOI 10.1096/fj.201800014RR; Lee YJ, 2017, J ENDOCRINOL, V235, P39, DOI 10.1530/JOE-17-0109; Lee YJ, 2016, DIABETES, V65, P2414, DOI 10.2337/db15-1594; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Motz CT, 2020, DIABETES, V69, P1518, DOI 10.2337/db19-0869; Okabe J, 2012, CIRC RES, V110, P1067, DOI 10.1161/CIRCRESAHA.112.266171; Paneni F, 2013, DIABETES, V62, P1800, DOI 10.2337/db12-1648; Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Popova E, 2014, J COMP PHYSIOL A, V200, P333, DOI 10.1007/s00359-014-0906-2; Semeraro F, 2019, DIABETES METAB, V45, P517, DOI 10.1016/j.diabet.2019.04.002; Seo JA, 2020, BIOCHEM PHARMACOL, V178, DOI 10.1016/j.bcp.2020.114052; Simo R, 2018, DIABETOLOGIA, V61, P1902, DOI 10.1007/s00125-018-4692-1; Simo-Servat O, 2019, OPHTHALMIC RES, V62, P211, DOI 10.1159/000499541; Sinha S, 2009, J CELL SCI, V122, P3385, DOI 10.1242/jcs.053124; Wang W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061816; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006	39	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22643	10.1096/fj.202200865R	http://dx.doi.org/10.1096/fj.202200865R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5X6UC	36331561				2022-12-26	WOS:000878733500001
J	Romero, JR; Inostroza-Nieves, Y; Pulido-Perez, P; Lopez, P; Wohlgemuth, JG; Dlott, JS; Snyder, LM; Alper, SL; Rivera, A				Romero, Jose R.; Inostroza-Nieves, Yaritza; Pulido-Perez, Patricia; Lopez, Pablo; Wohlgemuth, Jay G.; Dlott, Jeffrey S.; Snyder, L. Michael; Alper, Seth L.; Rivera, Alicia			Magnesium homeostasis in deoxygenated sickle erythrocytes is modulated by endothelin-1 via Na+/Mg2+ exchange	FASEB JOURNAL			English	Article							GARDOS CHANNEL ACTIVITY; TRANSGENIC MOUSE MODEL; PROTEIN-KINASE-C; CELL-DISEASE; MG2+ EFFLUX; RED-CELLS; PLASMA; RECEPTOR; DEFICIENCY; ACTIVATION	Painful crises in sickle cell disease (SCD) are associated with increased plasma cytokines levels, including endothelin-1 (ET-1). Reduced red cell magnesium content, mediated in part by increased Na+/Mg2+ exchanger (NME) activity, contributes to erythrocyte K+ loss, dehydration and sickling in SCD. However, the relationship between ET-1 and the NME in SCD has remained unexamined. We observed increased NME activity in sickle red cells incubated in the presence of 500 nM ET-1. Deoxygenation of sickle red cells, in contrast, led to decreased red cell NME activity and cellular dehydration that was reversed by the NME inhibitor, imipramine. Increased NME activity in sickle red cells was significantly blocked by pre-incubation with 100 nM BQ788, a selective blocker of ET-1 type B receptors. These results suggest an important role for ET-1 and for cellular magnesium homeostasis in SCD. Consistent with these results, we observed increased NME activity in sickle red cells of three mouse models of sickle cell disease greater than that in red cells of C57BL/J6 mice. In vivo treatment of BERK sickle transgenic mice with ET-1 receptor antagonists reduced red cell NME activity. Our results suggest that ET-1 receptor blockade may be a promising therapeutic approach to control erythrocyte volume and magnesium homeostasis in SCD and may thus attenuate or retard the associated chronic inflammatory and vascular complications of SCD.	[Romero, Jose R.; Inostroza-Nieves, Yaritza; Pulido-Perez, Patricia; Lopez, Pablo] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA; [Romero, Jose R.; Inostroza-Nieves, Yaritza; Pulido-Perez, Patricia; Lopez, Pablo; Alper, Seth L.; Rivera, Alicia] Harvard Med Sch, Dept Med, Boston, MA USA; [Inostroza-Nieves, Yaritza] San Juan Bautista Sch Med, Dept Biochem & Pharmacol, Caguas, PR USA; [Wohlgemuth, Jay G.; Dlott, Jeffrey S.; Snyder, L. Michael] Quest Diagnost, Secaucus, NJ USA; [Alper, Seth L.; Rivera, Alicia] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA USA; [Alper, Seth L.; Rivera, Alicia] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA USA; [Rivera, Alicia] Boston Childrens Hosp, Div Lab Med, Boston, MA USA; [Rivera, Alicia] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Rivera, A (corresponding author), Beth Israel Deaconess Med Ctr, 99 Brookline Ave Bldg RN 380A, Boston, MA 02215 USA.	arivera3@bidmc.harvard.edu		Romero, Jose Ricardo/0000-0001-8225-0772	National Heart, Lung, and Blood Institute [HL67699, HL090632, HL096518]; National Institute of Diabetes and Digestive and Kidney Diseases [DK064841]; Quest Diagnostics	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Quest Diagnostics	National Heart, Lung, and Blood Institute, Grant/Award Number: HL67699, HL090632 and HL096518; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: DK064841; Quest Diagnostics	Ahmed S, 2021, DEV COMP IMMUNOL, V125, DOI 10.1016/j.dci.2021.104230; Altura BM, 2014, INT J CLIN EXP MED, V7, P1; Altura RA, 2002, J PEDIATR-US, V140, P565, DOI 10.1067/mpd.2002.122644; Angerio Allan D, 2003, Crit Care Nurs Q, V26, P225; Arjona FJ, 2019, PFLUG ARCH EUR J PHY, V471, P845, DOI 10.1007/s00424-018-2234-9; Aromataris EC, 2006, J PHYSIOL-LONDON, V573, P611, DOI 10.1113/jphysiol.2006.109819; Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Bourantas KL, 1998, EUR J HAEMATOL, V61, P49; Brailoiu E, 2018, NEUROSCIENCE, V377, P105, DOI 10.1016/j.neuroscience.2018.02.039; Brugnara C, 1995, Ann N Y Acad Sci, V763, P262, DOI 10.1111/j.1749-6632.1995.tb32411.x; Chadebech P, 2020, CYTOKINE, V136, DOI 10.1016/j.cyto.2020.155259; Croizat H, 1999, AM J HEMATOL, V60, P105, DOI 10.1002/(SICI)1096-8652(199902)60:2<105::AID-AJH4>3.0.CO;2-Z; De Franceschi L, 2000, BRIT J HAEMATOL, V108, P284; DeFranceschi L, 1996, BLOOD, V88, P2738, DOI 10.1182/blood.V88.7.2738.bloodjournal8872738; Durpes MC, 2010, BLOOD CELL MOL DIS, V44, P219, DOI 10.1016/j.bcmd.2010.02.001; Ebel H, 2004, BBA-BIOMEMBRANES, V1667, P132, DOI 10.1016/j.bbamem.2004.09.008; Ebel H, 2004, BBA-BIOMEMBRANES, V1664, P150, DOI 10.1016/j.bbamem.2004.05.004; Ergul S, 2004, AM J HEMATOL, V76, P245, DOI 10.1002/ajh.20107; Feillet-Coudray C, 2006, EUR J NUTR, V45, P171, DOI 10.1007/s00394-005-0579-2; Feillet-Coudray C, 2004, METABOLISM, V53, P660, DOI 10.1016/j.metabol.2003.12.014; FERAY JC, 1988, N-S ARCH PHARMACOL, V338, P332; FERAY JC, 1986, BIOCHIM BIOPHYS ACTA, V856, P76, DOI 10.1016/0005-2736(86)90012-X; Ferre S, 2010, BBA-MOL BASIS DIS, V1802, P952, DOI 10.1016/j.bbadis.2010.06.016; Ferreira A, 2004, J CELL PHYSIOL, V199, P434, DOI 10.1002/jcp.10463; Ferreira A, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.861644; Ferri C, 1997, CLIN SCI, V93, P35, DOI 10.1042/cs0930035; Gao F, 2013, J SURG RES, V184, P944, DOI 10.1016/j.jss.2013.03.034; Geisness AC, 2022, HAEMATOLOGICA, V107, P1438, DOI 10.3324/haematol.2021.278666; Ginzburg YZ, 2007, AM J HEMATOL, V82, P911, DOI 10.1002/ajh.20941; Graido-Gonzalez E, 1998, BLOOD, V92, P2551, DOI 10.1182/blood.V92.7.2551.2551_2551_2555; GUNTHER T, 1985, BIOCHEM BIOPH RES CO, V130, P540, DOI 10.1016/0006-291X(85)90450-4; GUNTHER T, 1993, MINER ELECTROL METAB, V19, P259; Hankins JS, 2008, BRIT J HAEMATOL, V140, P80, DOI 10.1111/j.1365-2141.2007.06884.x; JIMENEZ JS, 1995, MOL CELL BIOCHEM, V152, P1; Kalish BT, 2015, HAEMATOLOGICA, V100, P870, DOI 10.3324/haematol.2015.124586; Kaul DK, 2006, AM J PHYSIOL-HEART C, V291, pH167, DOI 10.1152/ajpheart.01096.2005; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Kolisek M, 2012, AM J PHYSIOL-CELL PH, V302, pC318, DOI 10.1152/ajpcell.00289.2011; KURANTSINMILLS J, 1987, J LAB CLIN MED, V109, P486; LEHMANN H, 1963, BRIT MED J, P1158; Libien J, 2005, MOL BRAIN RES, V136, P104, DOI 10.1016/j.molbrainres.2005.01.005; LUDI H, 1987, J PHYSIOL-LONDON, V390, P367; Maier JA, 2021, SEMIN CELL DEV BIOL, V115, P37, DOI 10.1016/j.semcdb.2020.11.002; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Moslehi N, 2012, J RES MED SCI, V17, P607; Musa BOP, 2010, CLIN VACCINE IMMUNOL, V17, P602, DOI 10.1128/CVI.00145-09; Nielsen FH, 2018, J INFLAMM RES, V11, P25, DOI 10.2147/JIR.S136742; Oh SO, 1997, J LAB CLIN MED, V130, P191, DOI 10.1016/S0022-2143(97)90095-0; ORTIZ OE, 1990, J PHYSIOL-LONDON, V427, P211, DOI 10.1113/jphysiol.1990.sp018168; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pedrosa AM, 2020, BRIT J HAEMATOL, V190, pE39, DOI 10.1111/bjh.16693; PHELAN M, 1995, J CLIN INVEST, V96, P1145, DOI 10.1172/JCI118102; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Prado GN, 2013, FASEB J, V27, P4619, DOI 10.1096/fj.13-228577; Rab MAE, 2019, JOVE-J VIS EXP, DOI 10.3791/60213; Rivera A, 2005, BLOOD, V105, P382, DOI 10.1182/blood-2003-11-3755; Rivera A, 2002, BLOOD, V99, P357, DOI 10.1182/blood.V99.1.357; Rivera A, 2007, AM J PHYSIOL-CELL PH, V293, pC960, DOI 10.1152/ajpcell.00530.2006; Romero JR, 2004, BLOOD, V103, P2384, DOI 10.1182/blood-2003-01-0237; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; SALTER KJ, 1995, EXP PHYSIOL, V80, P815, DOI 10.1113/expphysiol.1995.sp003889; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Shmukler BE, 2019, BLOOD CELL MOL DIS, V79, DOI 10.1016/j.bcmd.2019.102346; Sponder G, 2013, MAGNESIUM RES, V26, P176, DOI 10.1684/mrh.2014.0351; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Touyz RM, 2003, J HYPERTENS, V21, P337, DOI 10.1097/00004872-200302000-00025; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; XU W, 1994, J MEMBRANE BIOL, V141, P277; Yousif OO, 2018, BIOL TRACE ELEM RES, V186, P295, DOI 10.1007/s12011-018-1307-0	74	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22638	10.1096/fj.202201339R	http://dx.doi.org/10.1096/fj.202201339R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5X6TX	36331552				2022-12-26	WOS:000878733000001
J	Yoshida, M; Ishihara, T; Isobe, Y; Arita, M				Yoshida, Mio; Ishihara, Tomoaki; Isobe, Yosuke; Arita, Makoto			Genetic deletion of Cyp4f18 disrupts the omega-3 epoxidation pathway and results in psoriasis-like dermatitis	FASEB JOURNAL			English	Article						dendritic cell; fatty acid metabolism; lipid mediator; n-3 polyunsaturated fatty acids; psoriasis	EICOSAPENTAENOIC ACID; LANGERHANS CELLS; INDUCED LIPOKINE; PIVOTAL ROLE; RESOLVIN E1; T-CELLS; INFLAMMATION; SKIN; MICE; N-3	Cyp4f18 catalyzes the conversion of n-3 polyunsaturated fatty acids (PUFAs) into omega-3 epoxides, such as 17,18-epoxyeicosatetraenoic acid (17,18-EpETE) and 19,20-epoxydocosapentaenoic acid (19,20-EpDPE) from eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), respectively. Cyp4f18-deficient mice spontaneously develop psoriasis-like dermatitis. A significant increase in the number of IL-17A-positive gamma delta (gamma delta) T cells in the skin and enlargement of draining lymph nodes was observed. These symptoms were drastically suppressed by antibiotic treatment. Cyp4f18 is highly expressed in dendritic cells (DCs), and Cyp4f18-deficient bone marrow-derived dendritic cells (BMDCs) show markedly increased expression levels of cytokines such as IL-23 and IL-1 beta in response to lipopolysaccharide (LPS) stimulation. Lipidomic analysis of lymph nodes and BMDCs revealed a significant decrease in a series of omega-3 epoxidized metabolites. Among them, 17,18-dihydroxyeicosatetraenoic acid (17,18-diHETE), a vicinal diol derived from EPA omega-3 epoxidation suppressed IL-23 production in LPS-stimulated BMDCs in Cyp4f18-deficient mice. These results demonstrate that Cyp4f18 endogenously produces omega-3-epoxidized metabolites in the draining lymph nodes, and these metabolites contribute to skin homeostasis by suppressing the excessive activation of the IL-23/IL-17 axis initiated by DCs.	[Yoshida, Mio; Isobe, Yosuke; Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan; [Yoshida, Mio; Ishihara, Tomoaki; Isobe, Yosuke; Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa, Japan; [Isobe, Yosuke; Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epignt Lab, Yokohama, Kanagawa, Japan; [Ishihara, Tomoaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	Keio University; RIKEN; Yokohama City University; Nagasaki International University	Arita, M (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Minato Ku, Tokyo 1058512, Japan.	arita-mk@pha.keio.ac.jp			Japan Society for the Promotion of Science [15H05897, 15H05898, 20H00495]; Exploratory Research for Advanced Technology [JPMJER2101]; RIKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Exploratory Research for Advanced Technology; RIKEN	Japan Society for the Promotion of Science, Grant/Award Number: 15H05897, 15H05898 and 20H00495; Exploratory Research for Advanced Technology, Grant/Award Number: JPMJER2101; RIKEN, Grant/Award Number: Glyco-Lipidologue Initiative and Junior Research Associate Program	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; DYERBERG J, 1975, AM J CLIN NUTR, V28, P958, DOI 10.1093/ajcn/28.9.958; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Glitzner E, 2014, EMBO MOL MED, V6, P1312, DOI 10.15252/emmm.201404114; Goto Haruka, 2021, JAAD Int, V2, P51, DOI 10.1016/j.jdin.2020.10.011; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hecker M, 2018, BBA-MOL CELL BIOL L, V1863, P1016, DOI 10.1016/j.bbalip.2018.06.011; Isobe Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26325-4; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Ito Y, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109052; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kubota T, 2014, FASEB J, V28, P586, DOI 10.1096/fj.13-236224; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Levan SR, 2019, NAT MICROBIOL, V4, P1851, DOI 10.1038/s41564-019-0498-2; Li JP, 2018, CARCINOGENESIS, V39, P1380, DOI 10.1093/carcin/bgy117; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lynes MD, 2017, NAT MED, V23, P631, DOI 10.1038/nm.4297; Mochimaru T, 2018, ALLERGY, V73, P369, DOI 10.1111/all.13297; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Nagatake T, 2018, J ALLERGY CLIN IMMUN, V142, P470, DOI 10.1016/j.jaci.2017.09.053; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Nakamizo S, 2015, SEMIN IMMUNOPATHOL, V37, P73, DOI 10.1007/s00281-014-0452-6; Naldi Luigi, 2004, Current Drug Targets - Inflammation and Allergy, V3, P121, DOI 10.2174/1568010043343958; Ninomiya T, 2013, ATHEROSCLEROSIS, V231, P261, DOI 10.1016/j.atherosclerosis.2013.09.023; Qin S, 2014, MOL MED REP, V9, P2097, DOI 10.3892/mmr.2014.2136; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Saito-Sasaki N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23623-9; Sawada Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30373-1; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Singh TP, 2010, J IMMUNOL, V184, P7257, DOI 10.4049/jimmunol.0903719; Stanford KI, 2018, CELL METAB, V27, P1111, DOI 10.1016/j.cmet.2018.03.020; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Xiao CY, 2017, J DERMATOL SCI, V85, P170, DOI 10.1016/j.jdermsci.2016.12.003; Xu JT, 2018, J DERMATOL SCI, V89, P127, DOI 10.1016/j.jdermsci.2017.10.016; Yan D, 2017, CURR DERMATOL REP, V6, P94, DOI 10.1007/s13671-017-0178-5; Yokomizo T, 2018, J CLIN INVEST, V128, P2691, DOI 10.1172/JCI97946; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zeng JR, 2017, J DERMATOL, V44, P863, DOI 10.1111/1346-8138.13806; Zhang GD, 2014, PROG LIPID RES, V53, P108, DOI 10.1016/j.plipres.2013.11.003	48	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22648	10.1096/fj.202200982R	http://dx.doi.org/10.1096/fj.202200982R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6D9SH	36374250				2022-12-26	WOS:000883024300001
J	Chen, N; Li, Z; Tang, B				Chen, Ni; Li, Zhi; Tang, Bo			Can digital skill protect against job displacement risk caused by artificial intelligence? Empirical evidence from 701 detailed occupations	PLOS ONE			English	Article							TECHNOLOGICAL-CHANGE; LABOR; AUTOMATION; EMPLOYMENT; FUTURE; GROWTH; SHARE	To identify the role of digital skill in the skill-biased technological changes caused by artificial intelligence, this study estimates the impacts of displacement risk on occupational wage and employment and examines the moderation effects of digital skill through the occupational data from the U.S. Bureau of Labor Statistics through the methods of fixed-effects modeling, heterogeneity analyzing and moderation effect testing. The results highlight three main points that (1) the displacement risk by artificial intelligence has significantly negative effects on occupational wage and employment, (2) the heterogeneous effects across occupational characteristics are significant, and (3) the digital skill exerts a significant moderation effect to protect against displacement risk. The core policy implication is suggested to emphasize digital skill in education and training across occupations to accommodate job requirements in the future.	[Chen, Ni; Li, Zhi; Tang, Bo] Chongqing Univ, Sch Publ Policy & Adm, Chongqing, Peoples R China	Chongqing University	Tang, B (corresponding author), Chongqing Univ, Sch Publ Policy & Adm, Chongqing, Peoples R China.	hipytea@gmail.com		Tang, Bo/0000-0001-7971-2745				Acemoglu D, 2020, J POLIT ECON, V128, P2188, DOI 10.1086/705716; Acemoglu D, 2019, J ECON PERSPECT, V33, P3, DOI 10.1257/jep.33.2.3; Acemoglu D, 2018, J HUM CAPITAL, V12, P204, DOI 10.1086/697242; Zuniga-Gonzalez CA, 2021, REV ELECTRON CALID E, V12, P279, DOI 10.22458/caes.v12i2.3730; Arntz M., 2016, OECD SOCIAL EMPLOYME, DOI [10.1787/5jlz9h56dvq7-en, DOI 10.1787/5JLZ9H56DVQ7-EN]; Autor D, 2018, BROOKINGS PAP ECO AC, P1; Autor DH, 2008, REV ECON STAT, V90, P300, DOI 10.1162/rest.90.2.300; Autor DH, 2015, ECON J, V125, P621, DOI 10.1111/ecoj.12245; Autor DH, 2003, Q J ECON, V118, P1279, DOI 10.1162/003355303322552801; Berg A, 2018, J MONETARY ECON, V97, P117, DOI 10.1016/j.jmoneco.2018.05.014; Bessen J, 2019, ECON POLICY, V34, P589; Bonoli G, 2010, POLIT SOC, V38, P435, DOI 10.1177/0032329210381235; Borenstein J, 2011, AI SOC, V26, P87, DOI 10.1007/s00146-009-0227-0; Burda MC, 2001, LABOUR ECON, V8, P15, DOI 10.1016/S0927-5371(00)00022-1; Calmfors L., 1994, OECD EC STUDIES, V22, P7; Dao MC, 2019, ECON POLICY, V34, P723; Dauth W., 2017, CEPR DISCUSSION PAPE; DeCanio SJ, 2016, J MACROECON, V49, P280, DOI 10.1016/j.jmacro.2016.08.003; Feijao C., 2021, GLOBAL DIGITAL SKILL; Felten EW., 2019, SSRN ELECT, DOI [10.5465/AMBPP.2019.140, DOI 10.5465/AMBPP.2019.140]; Fossen FM., 2019, SSRN ELECT J, DOI [10.2139/ssrn.3390231, DOI 10.2139/SSRN.3390231]; Frey CB, 2017, TECHNOL FORECAST SOC, V114, P254, DOI 10.1016/j.techfore.2016.08.019; Furman J, 2019, INNOV POLICY EC, V19, P161, DOI 10.1086/699936; Gilster P., 1998, DIGITAL LITERACY, V1st; Goldin C, 2008, AM ECON REV, V98, P363, DOI 10.1257/aer.98.2.363; Goos M, 2014, AM ECON REV, V104, P2509, DOI 10.1257/aer.104.8.2509; Harrigan J, 2021, RES POLICY, V50, DOI 10.1016/j.respol.2020.104008; Jimenez G, 2020, INT J MED INFORM, V143, DOI 10.1016/j.ijmedinf.2020.104260; Kambourov G, 2009, REV ECON STUD, V76, P731, DOI 10.1111/j.1467-937X.2009.00535.x; Karabarbounis L, 2014, Q J ECON, V129, P61, DOI 10.1093/qje/qjt032; KATZ LF, 1992, Q J ECON, V107, P35, DOI 10.2307/2118323; Korinek A, 2017, ARTIF INTELL; Law N., 2018, GLOBAL FRAMEWORK REF; Manyika J., 2017, FUTURE WORKS AI AUTO; Mitrovic Z, 2010, S AFR J INFORM MANAG, V12, DOI 10.4102/sajim.v12i1.427; Mokyr J, 2015, J ECON PERSPECT, V29, P31, DOI 10.1257/jep.29.3.31; Organisation for Economic Co-operation and Development, 2021, DES ACT LAB MARK POL; Pichler D., 2021, BREAKING DIGITAL CEI; Pirosca GI, 2021, J THEOR APPL EL COMM, V16, P2843, DOI 10.3390/jtaer16070156; Richardson L, 2019, GEOFORUM, V99, P278, DOI 10.1016/j.geoforum.2017.09.014; Sharma R, 2016, TELECOMMUN POLICY, V40, P628, DOI 10.1016/j.telpol.2016.05.003; Stephany F., 2022, CLOSING DIGITAL SKIL; Stephany F, 2021, BIG DATA SOC, V8, DOI 10.1177/20539517211043240; Stevenson B., 2019, EC ARTIFICIAL INTELL; van Deursen AJAM, 2010, INT J HUM-COMPUT INT, V26, P891, DOI 10.1080/10447318.2010.496338; van Deursen AJAM, 2022, INFORM COMMUN SOC, V25, P1883, DOI 10.1080/1369118X.2021.1900320; van Laar E, 2017, COMPUT HUM BEHAV, V72, P577, DOI 10.1016/j.chb.2017.03.010	47	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0277280	10.1371/journal.pone.0277280	http://dx.doi.org/10.1371/journal.pone.0277280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346798	Green Published, gold			2022-12-26	WOS:000894053200019
J	Klouch, KZ; Stern, MH; Trabelsi-Grati, O; Kiavue, N; Cabel, L; Silveira, AB; Hego, C; Rampanou, A; Popova, T; Bataillon, G; Nasr, S; Proudhon, C; Michel, M; Renault, V; Planchon, JM; Vincent-Salomon, A; Pierga, JY; Bieche, I; Renault, S; Bidard, FC				Klouch, Khadidja Zeyneb; Stern, Marc-Henri; Trabelsi-Grati, Olfa; Kiavue, Nicolas; Cabel, Luc; Silveira, Amanda Bortolini; Hego, Caroline; Rampanou, Aurore; Popova, Tatiana; Bataillon, Guillaume; Nasr, Sarah; Proudhon, Charlotte; Michel, Marc; Renault, Victor; Planchon, Julien Masliah; Vincent-Salomon, Anne; Pierga, Jean-Yves; Bieche, Ivan; Renault, Shufang; Bidard, Francois-Clement			Microsatellite instability detection in breast cancer using drop-off droplet digital PCR	ONCOGENE			English	Article							COLORECTAL-CANCER; MARKERS; TUMORS	The use of conventional methods (immunohistochemistry, pentaplex PCR) for detecting microsatellite instability (MSI), a predictive biomarker of immunotherapy efficacy, is debated for cancers with low MSI prevalence, such as breast cancer (BC). We developed two multiplex drop-off droplet digital PCR (ddPCR) assays targeting four microsatellites, initially identified from public BC whole-genome sequencing dataset. Performances of the assays were investigated and 352 tumor DNA and 28 circulating cell-free DNA from BC patients, with unknown MSI status were blindly screened. Cross-validation of ddPCR MSI status with other MSI detection methods was performed. We then monitored circulating tumor DNA (ctDNA) dynamics before and during pembrolizumab immunotherapy in one patient with MSI-high (MSI-H) metastatic BC. The assays showed high analytical specificity and sensitivity (limit of detection = 0.16%). Among N = 380 samples, seven (1.8%) were found as MSI-H by ddPCR with six of them confirmed by next-generation sequencing (NGS). Specificity was 100% in N = 133 microsatellite stable BC submitted to NGS. In the patient with MSI-H metastatic BC, ctDNA monitoring revealed an early decrease of microsatellite mutant allelic frequencies during immunotherapy. These results demonstrated MSI detection by ddPCR, a non-invasive, fast and cost-effective approach, allowing for large pre-screening of BC patients who may benefit from immunotherapy.	[Klouch, Khadidja Zeyneb; Cabel, Luc; Silveira, Amanda Bortolini; Hego, Caroline; Rampanou, Aurore; Proudhon, Charlotte; Michel, Marc; Pierga, Jean-Yves; Renault, Shufang; Bidard, Francois-Clement] Inst Curie, Dept Translat Res, Circulating Tumor Biomarkers Lab, Inserm CIC BT 1428, Paris, France; [Stern, Marc-Henri; Popova, Tatiana] PSL Res Univ, Inst Curie, DNA Repair & Uveal Melanoma DRUM Team, Inserm U830, Paris, France; [Trabelsi-Grati, Olfa; Bataillon, Guillaume; Nasr, Sarah; Renault, Victor; Planchon, Julien Masliah; Vincent-Salomon, Anne; Bieche, Ivan] PSL Res Univ, Inst Curie, Dept Diagnost & Theranost Med, Paris, France; [Kiavue, Nicolas; Cabel, Luc; Pierga, Jean-Yves; Bidard, Francois-Clement] Inst Curie, Dept Med Oncol, Paris, France; [Kiavue, Nicolas; Cabel, Luc; Pierga, Jean-Yves; Bidard, Francois-Clement] Inst Curie, Dept Med Oncol, St Cloud, France; [Cabel, Luc; Pierga, Jean-Yves] Univ Paris, Paris, France; [Proudhon, Charlotte; Michel, Marc] CNRS, Inserm U934, UMR3215, Paris, France; [Bidard, Francois-Clement] Paris Saclay Univ, UVSQ, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Renault, S; Bidard, FC (corresponding author), Inst Curie, Dept Translat Res, Circulating Tumor Biomarkers Lab, Inserm CIC BT 1428, Paris, France.; Bidard, FC (corresponding author), Inst Curie, Dept Med Oncol, Paris, France.; Bidard, FC (corresponding author), Inst Curie, Dept Med Oncol, St Cloud, France.; Bidard, FC (corresponding author), Paris Saclay Univ, UVSQ, Paris, France.	shufang.renault@curie.fr; francois-clement.bidard@curie.fr	Stern, Marc-Henri/A-2728-2011	Stern, Marc-Henri/0000-0002-8100-2272; Michel, Marc/0000-0001-6613-8027				Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bonneville R, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00073; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Cicek MS, 2011, J MOL DIAGN, V13, P271, DOI 10.1016/j.jmoldx.2010.12.004; Cortes-Ciriano I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15180; Davies H, 2017, CANCER RES, V77, P4755, DOI 10.1158/0008-5472.CAN-17-1083; Fusco N, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky056; Gallon R, 2020, HUM MUTAT, V41, P332, DOI 10.1002/humu.23906; Georgiadis A, 2019, CLIN CANCER RES, V25, P7024, DOI 10.1158/1078-0432.CCR-19-1372; Gilson P, 2021, CANCERS, V13, DOI 10.3390/cancers13071491; Guardant Health, 2020, GUARDANT360 CDX 1 FD; Hanse RJ, 2016, NAT MED, V22, P1342, DOI 10.1038/nm.4191; Hechtman JF, 2020, MODERN PATHOL, V33, P871, DOI 10.1038/s41379-019-0414-6; Hempelmann JA, 2015, J MOL DIAGN, V17, P705, DOI 10.1016/j.jmoldx.2015.05.008; Horimoto Y, 2020, CANCER SCI, V111, P2647, DOI 10.1111/cas.14500; Huggett JF, 2020, CLIN CHEM, V66, P1012, DOI 10.1093/clinchem/hvaa125; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lee SC, 2001, AM J CLIN PATHOL, V115, P823; Long DR, 2020, CLIN CHEM, V66, P1310, DOI 10.1093/clinchem/hvaa177; Lorenzi M, 2020, J ONCOL, V2020, DOI 10.1155/2020/1807929; McConechy MK, 2015, GYNECOL ONCOL, V137, P306, DOI 10.1016/j.ygyno.2015.01.541; Middha S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00084; Mosele F, 2020, ANN ONCOL, V31, P1491, DOI 10.1016/j.annonc.2020.07.014; Schmitt FC, 1999, INT J CANCER, V82, P644, DOI 10.1002/(SICI)1097-0215(19990827)82:5<644::AID-IJC5>3.0.CO;2-S; Silveira AB, 2020, CLIN CHEM, V66, P606, DOI 10.1093/clinchem/hvaa013; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Willis J, 2019, CLIN CANCER RES, V25, P7035, DOI 10.1158/1078-0432.CCR-19-1324; Woodhouse R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237802; Yu FY, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1175; Zhu LZ, 2018, J MOL DIAGN, V20, P225, DOI 10.1016/j.jmoldx.2017.11.007	31	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 2	2022	41	49					5289	5297		10.1038/s41388-022-02504-6	http://dx.doi.org/10.1038/s41388-022-02504-6		NOV 2022	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	6R9BX	36329125				2022-12-26	WOS:000878459600001
J	Belter, L; Mazzella, A; O'Brien, S; Jarecki, J				Belter, Lisa; Mazzella, Allison; O'Brien, Shannon; Jarecki, Jill			Knowledge of genetic test results among caregivers and individuals with spinal muscular atrophy	PLOS ONE			English	Article							SMN2 COPY NUMBER; SMA; NUSINERSEN	Spinal muscular atrophy (SMA) is a progressive recessive genetic disease. Early identification is critical for achieving maximal treatment benefit. Survival motor neuron (SMN) 2 copy number may be a needed descriptor of disease severity than SMA type. Therefore, we assessed knowledge of SMN2 copy number among those with SMA and their caregivers via a phone survey. Only patients with SMA (or their caregivers) registered in the Cure SMA database with no SMN2 copy number on file were eligible. Descriptive results are reported. Backward stepwise multinomial logistic regressions determined if specific factors predicted knowledge of SMN2 copy number. Engagement with the SMA community (odds ratio [OR] 1.82; p<0.0001), ability to walk (OR 1.74; p = 0.006), and current age at time of survey (OR = 0.98; p<0.0001) each positively predicted knowledge of SMN2 copy number. Of 806 completed surveys, the majority (n = 452; 56.3%) did not know SMN2 copy numbers for themselves (n = 190; 62.5%) or their loved ones (n = 261; 52.4%). Of these, 66 respondents (8.2%) said genetic testing had not been done. Motor function increased linearly with increasing SMN2 copy number. SMN2 copy number is emerging as a critical descriptor of severity for SMA as type becomes more obsolete with early drug treatment. Communication of SMN2 copy numbers is recommended as a standard part of the treatment plan.	[Belter, Lisa; Mazzella, Allison; Jarecki, Jill] Cure SMA, Res Dept, Elk Grove Village, IL 60007 USA; [Mazzella, Allison] Perleman Ctr Adv Med, Div Penn Translat Med & Human Genet, Philadelphia, PA USA; [O'Brien, Shannon] Cure SMA, Community Support Dept, Elk Grove Village, IL USA; [Jarecki, Jill] BioMarin Pharmaceut Inc, Dept Strateg Risk Management, San Rafael, CA USA	BioMarin Pharmaceutical Inc.	Belter, L (corresponding author), Cure SMA, Res Dept, Elk Grove Village, IL 60007 USA.	lisa.belter@curesma.org			2020 SMA-IC; Genentech/Roche; Novartis Gene Therapies; Biogen; Cytokinetics; Scholar Rock	2020 SMA-IC; Genentech/Roche(Roche HoldingGenentech); Novartis Gene Therapies; Biogen(Biogen); Cytokinetics; Scholar Rock	Funding for this research was provided by members of the 2020 SMA-IC which included, Genentech/Roche, Novartis Gene Therapies, Biogen, Cytokinetics, and Scholar Rock. These funders (the Cure SMA Industry Collaboration) had a role in the study design, analysis, preparation of manuscript, and decision to publish.	Belter L, 2021, J NEUROMUSCULAR DIS, V8, P109, DOI 10.3233/JND-200563; Belter Lisa, 2018, J Neuromuscul Dis, V5, P167, DOI 10.3233/JND-170292; Calucho M, 2018, NEUROMUSCULAR DISORD, V28, P208, DOI 10.1016/j.nmd.2018.01.003; Chiriboga CA, 2017, EXPERT REV NEUROTHER, V17, P955, DOI 10.1080/14737175.2017.1364159; Cure SMA, 2022, ANN MAJ NEWB SCREEN; Curry M, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-02692-2; Cusco I, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000530; Dangouloff T, 2019, THER CLIN RISK MANAG, V15, P1153, DOI 10.2147/TCRM.S172291; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Glascock Jacqueline, 2018, J Neuromuscul Dis, V5, P145, DOI 10.3233/JND-180304; Harada Y, 2002, J NEUROL, V249, P1211, DOI 10.1007/s00415-002-0811-4; Kolb SJ, 2015, NEUROL CLIN, V33, P831, DOI 10.1016/j.ncl.2015.07.004; Leeper TJ, 2019, PUBLIC OPIN QUART, V83, P280, DOI 10.1093/poq/nfz010; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Menduti G, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.592234; Messina S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072222; Neil Erin E, 2019, J Pediatr Pharmacol Ther, V24, P194, DOI 10.5863/1551-6776-24.3.194; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Servais L, 2020, NEUROLOGY, V94; Strauss KA, 2022, NAT MED, V28, P1390, DOI 10.1038/s41591-022-01867-3; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Thematic, CONNECT UNDERSTAND A; Wadman RI, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa075; Watibayati MS, 2009, BRAIN DEV-JPN, V31, P42, DOI 10.1016/j.braindev.2008.08.012; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0276756	10.1371/journal.pone.0276756	http://dx.doi.org/10.1371/journal.pone.0276756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346824	gold, Green Published			2022-12-26	WOS:000894053200009
J	Rietdyk, S; Ambike, S; Amireault, S; Haddad, JM; Lin, G; Newton, D; Richards, EA				Rietdyk, Shirley; Ambike, Satyajit; Amireault, Steve; Haddad, Jeffrey M.; Lin, Guang; Newton, David; Richards, Elizabeth A.			Co-occurrences of fall-related factors in adults aged 60 to 85 years in the United States National Health and Nutrition Examination Survey	PLOS ONE			English	Article							RISK-FACTORS; OLDER-ADULTS; INJURIOUS FALLS; GAIT SPEED; GREATER-THAN-OR-EQUAL-TO-65 YEARS; PEOPLE; TESTS; PREVALENCE; PREVENTION; DISEASES	A broad set of factors are associated with falling (e.g., age, sex, physical activity, vision, health), but their co-occurrence is understudied. Our objectives were to quantify the number and pattern of co-occurring fall-related factors. Data were obtained from the U.S. National Health and Nutrition Examination Survey (N = 1,957, 60-85 years). Twenty fall-related factors were included (based on previous research), covering a wide range including cognitive, motor, sensory, health, and physical activity measures. The number and pattern of co-occurring fall-related factors were quantified with logistic regression and cluster analyses, respectively. Most participants (59%) had >= 4 fall-risk factors, and each additional risk factor increased the odds of reporting difficulty with falling by 1.28. The identified clusters included: (1) healthy, (2) cognitive and sensory impaired, and (3) health impaired. The mean number of co-occurring fall-related factors was 3.7, 3.8, and 7.2, for clusters 1, 2, and 3, respectively (p<0.001). These observations indicate that co-occurrence of multiple fall-risk factors was common in this national sample of U.S. older adults and the factors tended to aggregate into distinct clusters. The findings support the protective effect of physical activity on fall-risk, the association between gait speed and falls, and the detrimental effect of health-related factors on difficulty with falls (e.g., arthritis, prescription medications). Cluster analyses revealed a complex interplay between sex and BMI that may alter the role of BMI in the etiology of falls. Cluster analyses also revealed a large detrimental effect of health-related factors in cluster 3; it is important to extend current fall interventions (typically focused on balance, flexibility, strength, cognitive, fear factors) to include health-related interventions that target factors such as BMI and arthritis.	[Rietdyk, Shirley; Ambike, Satyajit; Amireault, Steve; Haddad, Jeffrey M.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47906 USA; [Rietdyk, Shirley; Ambike, Satyajit; Amireault, Steve; Haddad, Jeffrey M.; Richards, Elizabeth A.] Purdue Univ, Ctr Aging & Life Course, W Lafayette, IN 47907 USA; [Lin, Guang; Newton, David] Purdue Univ, Data Sci Consulting Serv, W Lafayette, IN USA; [Lin, Guang] Purdue Univ, Dept Math, W Lafayette, IN USA; [Lin, Guang; Newton, David] Purdue Univ, Dept Stat, W Lafayette, IN USA; [Lin, Guang] Purdue Univ, Dept Mech Engn, W Lafayette, IN USA; [Richards, Elizabeth A.] Purdue Univ, Sch Nursing, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rietdyk, S (corresponding author), Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47906 USA.; Rietdyk, S (corresponding author), Purdue Univ, Ctr Aging & Life Course, W Lafayette, IN 47907 USA.	srietdyk@purdue.edu		Rietdyk, Shirley/0000-0002-4990-3943; Ambike, Satyajit/0000-0003-0521-860X				Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Bloch F, 2013, GERIATR GERONTOL INT, V13, P250, DOI 10.1111/j.1447-0594.2012.00965.x; Brodie MA, 2015, MED HYPOTHESES, V84, P356, DOI 10.1016/j.mehy.2015.01.017; Chang VC, 2015, AM J EPIDEMIOL, V181, P521, DOI 10.1093/aje/kwu268; Cho BY, 2018, AM J PREV MED, V54, pE59, DOI 10.1016/j.amepre.2017.12.020; Cumming R.G., 2000, NURSING BRUX, V55, P299; Curtin Lester R, 2012, Vital Health Stat 2, P1; Gomes GADO, 2013, SAO PAULO MED J, V131, P13, DOI 10.1590/S1516-31802013000100003; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Dipietro L, 2019, MED SCI SPORT EXER, V51, P1303, DOI 10.1249/MSS.0000000000001942; Ek S, 2018, J GERONTOL A-BIOL, V73, P233, DOI 10.1093/gerona/glx115; Finch CF, 2015, INJURY PREV, V21, P254, DOI 10.1136/injuryprev-2014-041351; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Franchignoni F, 1998, AGING-CLIN EXP RES, V10, P26, DOI 10.1007/BF03339630; G R Neri S, 2020, J GERONTOL A-BIOL, V75, P952, DOI 10.1093/gerona/glz272; Helgadottir B, 2015, AGE AGEING, V44, P604, DOI 10.1093/ageing/afv051; Huang ZX, 1998, DATA MIN KNOWL DISC, V2, P283, DOI 10.1023/A:1009769707641; Hughes SL, 2004, GERONTOLOGIST, V44, P217, DOI 10.1093/geront/44.2.217; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Jaeger J, 2018, J CLIN PSYCHOPHARM, V38, P513, DOI 10.1097/JCP.0000000000000941; James SL, 2020, INJURY PREV, V26, P3, DOI 10.1136/injuryprev-2019-043286; Jung D, 2008, ASIAN NURS RES, V2, P214, DOI 10.1016/S1976-1317(09)60003-7; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kozinc Z, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10090667; Laflamme L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123390; Lyons JG, 2015, J AGING HEALTH, V27, P594, DOI 10.1177/0898264314556987; Machon M, 2020, EUR GERIATR MED, V11, P321, DOI 10.1007/s41999-020-00291-5; Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001; Montgomery JR, 2019, JAMA-J AM MED ASSOC, V321, P2129, DOI 10.1001/jama.2019.1146; Moreland B, 2020, MMWR-MORBID MORTAL W, V69, P875, DOI 10.15585/mmwr.mm6927a5externalicon; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Paul DR, 2018, J PHYS ACT HEALTH, V15, P543, DOI 10.1123/jpah.2017-0089; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Sherrington C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012424.pub2; Sibley K.M., 2014, CHRONIC DIS FALLS CO; Smith ML, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122798; Stenhagen M, 2014, ARCH GERONTOL GERIAT, V58, P95, DOI 10.1016/j.archger.2013.07.006; Stevens J.A., 2015, CDC COMPENDIUM EFFEC; Studenski S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13112; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Szepannek G, 2018, R J, V10, P200; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Timsina LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176561; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Vu T, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-45; Tricco AC, 2017, JAMA-J AM MED ASSOC, V318, P1687, DOI 10.1001/jama.2017.15006; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Viccaro LJ, 2011, J AM GERIATR SOC, V59, P887, DOI 10.1111/j.1532-5415.2011.03336.x; WEBER PC, 1993, AM J OTOL, V14, P566; Wechsler D., 2008, WECHSLER ADULT INTEL; Willis JR, 2013, JAMA OPHTHALMOL, V131, P1049, DOI 10.1001/jamaophthalmol.2013.316; Yardley L, 2002, GERONTOLOGIST, V42, P17, DOI 10.1093/geront/42.1.17; Ylitalo KR, 2016, PREV MED, V91, P217, DOI 10.1016/j.ypmed.2016.08.044	57	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0277406	10.1371/journal.pone.0277406	http://dx.doi.org/10.1371/journal.pone.0277406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346815	gold, Green Published			2022-12-26	WOS:000894053200024
J	Tsang, SV; Rainusso, N; Liu, M; Nomura, M; Patel, TD; Nakahata, K; Kim, H; Huang, SX; Rajapakshe, K; Coarfa, C; Man, TK; Rao, PH; Yustein, JT				Tsang, Susan, V; Rainusso, Nino; Liu, Meng; Nomura, Motonari; Patel, Tajhal D.; Nakahata, Kengo; Kim, Ha Ram; Huang, Shixia; Rajapakshe, Kimal; Coarfa, Cristian; Man, Tsz-Kwong; Rao, Pulivarthi H.; Yustein, Jason T.			LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination	ONCOGENE			English	Article; Early Access							LONG NONCODING RNA; CELLS; IDENTIFICATION; RESISTANCE; DISCOVERY; ONCOGENE	Osteosarcoma, the most common pediatric bone tumor, is an aggressive heterogeneous malignancy defined by complex chromosomal aberrations. Overall survival rates remain at similar to 70%, but patients with chemoresistant or metastatic disease have extremely poor outcomes of <30%. A subgroup of tumors harbor amplification of chromosome 8q24.2 and increased expression of the oncogenic long noncoding RNA (IncRNA) Plasmacytoma Variant Translocation-1 (PVT-1), which is associated with an extremely poor clinical prognosis. This study demonstrates that PVT-7 is critical for osteosarcoma tumor-initiation potential. Chromatin Hybridization by RNA Purification analysis identified Tripartite-Motif Containing Family 28 (TRIM28) as a novel PVT-1 binding partner. Mechanistically, co-immunoprecipitation studies showed the PVT-1/TRIM28 complex binds and increases SUMOylation of phosphatidylinositol 3-kinase catalytic subunit type 3 (Vps34), which leads to enhanced ubiquitination and degradation of tumor suppressor complex 2 (TSC2), thus contributing to increased self-renewal and stem cell phenotypes. Furthermore, we identified that osteosarcoma cells with increased PVT-1 have enhanced sensitivity to the SUMOylation inhibitor, TAK-981. Altogether, this study elucidated a role for PVT-1 in the enhancement of cancer stem-like behaviors, including migration and invasion, in osteosarcoma, and identified the novel PVT-1/TRIM28 axis signaling cascade as a potential therapeutic target for osteosarcoma treatment.	[Tsang, Susan, V; Rainusso, Nino; Liu, Meng; Patel, Tajhal D.; Nakahata, Kengo; Kim, Ha Ram; Man, Tsz-Kwong; Rao, Pulivarthi H.; Yustein, Jason T.] Baylor Coll Med, Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA; [Tsang, Susan, V; Rainusso, Nino; Liu, Meng; Patel, Tajhal D.; Nakahata, Kengo; Kim, Ha Ram; Man, Tsz-Kwong; Rao, Pulivarthi H.; Yustein, Jason T.] Baylor Coll Med, Faris D Virani Ewing Sarcoma Ctr, Houston, TX 77030 USA; [Tsang, Susan, V; Yustein, Jason T.] Baylor Coll Med, Integrat Mol & Biomed Sci Program, Houston, TX 77030 USA; [Rainusso, Nino; Coarfa, Cristian; Yustein, Jason T.] Baylor Coll Med, Dan L Duncan Canc Comprehens Ctr, Houston, TX 77030 USA; [Nomura, Motonari; Nakahata, Kengo] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Suita, Osaka, Japan; [Huang, Shixia; Coarfa, Cristian] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Rajapakshe, Kimal] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Coarfa, Cristian; Yustein, Jason T.] Baylor Coll Med, Canc & Cell Biol Program, Houston, TX 77030 USA; [Yustein, Jason T.] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Osaka University; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Emory University	Yustein, JT (corresponding author), Baylor Coll Med, Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Faris D Virani Ewing Sarcoma Ctr, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Integrat Mol & Biomed Sci Program, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Dan L Duncan Canc Comprehens Ctr, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Canc & Cell Biol Program, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA.	yustein@bcm.edu		Coarfa, Cristian/0000-0002-4183-4939	Cancer Prevention Institute of Texas (CPRIT) [RP160283, RP170005]; NIEHS P30 Center [1P30ES030285]; CPRIT Core Facility Support Award [CPRIT-RP180672]; NIH [CA125123, RR024574]; Core Facility Award [CPRIT-RP170005]; NIEHS P30 Center grant [1P30ES030285]	Cancer Prevention Institute of Texas (CPRIT); NIEHS P30 Center; CPRIT Core Facility Support Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Facility Award; NIEHS P30 Center grant	We would like to acknowledge the Advanced Technologies Core services at the Baylor College of Medicine. This work was funded by The Faris D. Virani Ewing Sarcoma Center (to JTY). SVT was partially supported by Cancer Prevention Institute of Texas (CPRIT) RP160283, KR and CC were partially supported by (CPRIT) RP170005, NIH P30 shared resource grant CA125123, and NIEHS P30 Center grant 1P30ES030285; CPRIT Core Facility Support Award (CPRIT-RP180672), the NIH (CA125123 and RR024574 to the Cytometry and Cell Sorting Core at Baylor College of Medicine); and Core Facility Award (CPRIT-RP170005 to Proteomics and Metabolomics Core at Baylor College of Medicine). We thank Dr. Suzanne Fuqua and Dr. Xiang Zhang for generously providing the breast cancer cell lines.	Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Al-Romaih K, 2003, CANCER GENET CYTOGEN, V144, P91, DOI 10.1016/S0165-4608(02)00929-9; Assouline S, 2019, BLOOD, V134, DOI 10.1182/blood-2019-128773; Brisbin AG, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-156; Brown HK, 2017, CANCER LETT, V386, P189, DOI 10.1016/j.canlet.2016.11.019; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen SS, 2017, ONCOTARGET, V8, P110685, DOI 10.18632/oncotarget.22161; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Colombo T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304208; Czerwinska P, 2017, ONCOTARGET, V8, P863, DOI 10.18632/oncotarget.13273; Dasgupta A, 2021, CANCER RES, V81, P199, DOI 10.1158/0008-5472.CAN-20-0854; Du PZ, 2019, J ONCOL, V2019, DOI 10.1155/2019/9325407; Fan H, 2018, MOL MED REP, V17, P8309, DOI 10.3892/mmr.2018.8907; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Feng Y, 2014, METHODS MOL BIOL, V1165, P115, DOI 10.1007/978-1-4939-0856-1_10; Fong KW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07475-5; Fu C, 2018, NEUROTHERAPEUTICS, V15, P1139, DOI 10.1007/s13311-018-0649-9; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Han D, 2015, CANCER LETT, V361, P13, DOI 10.1016/j.canlet.2015.03.002; Houthuijzen J, 2012, BRIT J CANCER, V106, P1901, DOI 10.1038/bjc.2012.201; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Lang B, 2019, NUCLEIC ACIDS RES, V47, pD601, DOI 10.1093/nar/gky967; Langston SP, 2021, J MED CHEM, V64, P2501, DOI 10.1021/acs.jmedchem.0c01491; Letessier A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-245; Li J, 2017, ONCOGENE, V36, P2991, DOI 10.1038/onc.2016.453; Liu XK, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0164-y; Madsen RR, 2020, BIOCHEM SOC T, V48, P301, DOI 10.1042/BST20190778; Livi CM, 2016, BIOINFORMATICS, V32, P773, DOI 10.1093/bioinformatics/btv629; Mirabello L, 2010, CARCINOGENESIS, V31, P1400, DOI 10.1093/carcin/bgq117; Misaghi A, 2018, SICOT-J, V4, DOI 10.1051/sicotj/2017028; Mohan N, 2016, ONCOTARGET, V7, P52239, DOI 10.18632/oncotarget.10469; Moschos SJ, 2007, ONCOGENE, V26, P4216, DOI 10.1038/sj.onc.1210216; Muff R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125611; Nomura M, 2019, JNCI-J NATL CANCER I, V111, P1216, DOI 10.1093/jnci/djz026; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Peitzsch C, 2017, SEMIN CANCER BIOL, V44, P10, DOI 10.1016/j.semcancer.2017.02.011; Ping GF, 2018, AM J TRANSL RES, V10, P138; Pradhan SA, 2014, NUCLEIC ACIDS RES, V42, P6243, DOI 10.1093/nar/gku278; Rainusso N, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27579; Schiavone K, 2019, ADV EXP MED BIOL, V1139, P187, DOI 10.1007/978-3-030-14366-4_11; Tang JM, 2018, ONCOGENE, V37, P4723, DOI 10.1038/s41388-018-0310-4; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang HT, 2020, CANCER MANAG RES, V12, P7993, DOI 10.2147/CMAR.S263383; Xia P, 2015, AM J CANCER RES, V5, P1602; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110	47	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene												10.1038/s41388-022-02538-w	http://dx.doi.org/10.1038/s41388-022-02538-w		NOV 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	6D2TY	36348010	Green Submitted			2022-12-26	WOS:000882550800003
J	Nyumayo, S; Konje, E; Kidenya, B; Kapesa, A; Hingi, M; Wango, N; Ngimbwa, J; Alphonce, V; Basinda, N				Nyumayo, Said; Konje, Eveline; Kidenya, Benson; Kapesa, Anthony; Hingi, Marko; Wango, Nyagwegwe; Ngimbwa, Joshua; Alphonce, Violeth; Basinda, Namanya			Prevalence of HIV and associated risk factors among street-connected children in Mwanza city	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; VULNERABILITY; ADOLESCENTS; EXPERIENCE; BEHAVIORS; SEX	While on the street, HIV infection among street-connected children is a challenging issue due to the nature of transmission, distribution, and prevention. Lack of proper care and protection, insufficient knowledge of the danger of acquiring HIV, and insufficient or absence of health facilities serving street-connected children have left this vulnerable group engaging in high-risk behaviors exposing them to acquiring HIV. This cross-sectional study aimed at estimating the prevalence of HIV infection and its associated risk factors among street-connected children aged between 10 to17 years in Mwanza City. The study was granted ethical clearance all permissions and restrictions to work with street-connected children were adhered to. A total of 131 participants aged 10-17 years were recruited for interviews and HIV testing. Exact logistic regression was used to determine factors associated with having HIV. A total of 111 (85.0%) boys and 20 (15.0%) girls responded to the questionnaire, with the median age being 15years. The overall HIV prevalence was 12.2% (16/131). Street-children using condoms were less likely to be affected by HIV compared to those who were not using (OR = 0.24; 95% CI 0.04-0.97). Females had higher odds of HIV infection compared to males (OR = 5.24; 95% CI of 1.24-24.65). The study shows a significantly higher prevalence of HIV among street-connected children as compared to the general population. Therefore, there should be tailored reproductive and sexual health programs, with the provision of protective materials like condoms.	[Nyumayo, Said; Kapesa, Anthony; Hingi, Marko; Wango, Nyagwegwe; Ngimbwa, Joshua; Alphonce, Violeth; Basinda, Namanya] Catholic Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Community Med, Mwanza, Tanzania; [Konje, Eveline] Catholic Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Mwanza, Tanzania; Catholic Univ Hlth & Allied Sci, Weill Bugando Sch Med, Dept Biochem, Mwanza, Tanzania		Basinda, N (corresponding author), Catholic Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Community Med, Mwanza, Tanzania.	drbasinda@yahoo.co.uk						Africa RC, 2014, HEADC FINF STREET CH; Amury Z., 2010, COPING STRATEGIES US; Ansari H., 2016, INT J HIGH RISK BEHA, V5; Booysen FL, 2002, J HEALTH POPUL NUTR, V20, P285; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Casaccia Germana, 2009, Congenital Anomalies, V49, P93, DOI 10.1111/j.1741-4520.2009.00230.x; Council N.,, 2012, HIV AIDS PERS EXP HO; Cumber SN., 2016, AFR J PRIM HEALTH CA, V8; Dube L., 1997, J SOCIAL DEV AFRICA, V12, P61; Feleke Moges, 2006, Ethiopian Journal of Health Development, V20, P160; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hauli K., 2014, ALCOHOL ALCOHOLISM, V49, pi5; Karmacharya D, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-25; Kayembe Patrick K, 2008, East Afr J Public Health, V5, P186; Kieffer MP, 2014, JAIDS-J ACQ IMM DEF, V67, pS188, DOI 10.1097/QAI.0000000000000372; KIESEWETTER WB, 1964, AM J SURG, V107, P412, DOI 10.1016/0002-9610(64)90207-7; Lockhart C, 2002, MED ANTHROPOL Q, V16, P294, DOI 10.1525/maq.2002.16.3.294; Lugalla JLP, 1999, INT J URBAN REGIONAL, V23, P329, DOI 10.1111/1468-2427.00198; Mandalazi P, 2013, MALAWI MED J, V25, P1; Mary J., 2014, INT J RES HEAL SCI, V2, P740; Mtaita F, 2015, PERCEPTION STREET CH; Oino P., 2013, DANGER HIVAIDS PREVA, V2; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Poverty EvansR., 2002, GENDER DEV, V10, P51, DOI DOI 10.1080/13552070215916; Roy E, 2000, INT J STD AIDS, V11, P241, DOI 10.1258/0956462001915778; Stojadinovic Aleksandra, 2015, Med Pregl, V68, P245; TACAIDS Z  NB S OCGS I., 2013, TANZ HIV AIDS MAL IN; Tadesse Negash, 2013, BMC Res Notes, V6, P234, DOI 10.1186/1756-0500-6-234; Tanzania N., 2012, MINISTRY FINANCE DAR; Thurman TR, 2006, AIDS BEHAV, V10, P627, DOI 10.1007/s10461-006-9104-8; United Republic of Tanzania MoHaSw, 2013, NAT COMPR GUID HIV T; Williams TP, 2012, CHILD ABUSE NEGLECT, V36, P354, DOI 10.1016/j.chiabu.2011.11.006; Winston SE, 2015, SEX TRANSM INFECT, V91, P353, DOI 10.1136/sextrans-2014-051797	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0271042	10.1371/journal.pone.0271042	http://dx.doi.org/10.1371/journal.pone.0271042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346792	Green Published, gold			2022-12-26	WOS:000894053200002
J	Wang, SF; Wang, GB; Lu, SC; Zhang, JY; Zhang, WW; Han, YY; Cai, XY; Zhuang, Y; Pu, F; Yan, X; Tu, ZW; Wang, L; Huang, XR; Fan, B; Wang, DQ; Zhang, ZJ				Wang, Shufang; Wang, Guibin; Lu, Shichun; Zhang, Jiaying; Zhang, Wenwen; Han, Yuanyuan; Cai, Xiaoyu; Zhuang, Yuan; Pu, Fei; Yan, Xin; Tu, Zhiwei; Wang, Liang; Huang, Xirui; Fan, Bin; Wang, Deqing; Zhang, Zhaojun			Proteome expression profiling of red blood cells during the tumorigenesis of hepatocellular carcinoma	PLOS ONE			English	Article							PERIPHERAL-BLOOD; ERYTHROPOIESIS; RECURRENCE; GLOBIN; CANCER; ROLES; MICE	The early diagnosis of hepatocellular carcinoma (HCC) has not been clinically elucidated, leading to an increased mortality rate in patients with HCC. HCC is a systemic disease related to disorders of blood homeostasis, and the association between red blood cells (RBCs) and HCC tumorigenesis remains elusive. We performed data-independent acquisition proteomic analyses of 72 clinical RBC samples, including HCC (n = 30), liver cirrhosis (LC, n = 17), and healthy controls (n = 25), and characterized the clinical relevance of RBCs and tumorigenesis in HCC. We observed dynamic changes in RBCs during HCC tumorigenesis, and our findings indicate that, based on the protein expression profiles of RBCs, LC is a developmental stage closely approaching HCC. The expression of hemoglobin (HbA and HbF) in peripheral blood dynamically changed during HCC tumorigenesis, suggesting that immature erythroid cells exist in peripheral blood of HCC patients and that erythropoiesis is influenced by the onset of LC. We also identified the disrupted autophagy pathway in RBCs at the onset of LC, which persisted during HCC tumorigenesis. The oxytocin and GnRH pathways were disrupted and first identified during the development of LC into HCC. Significantly differentially expressed SMIM1, ANXA7, HBA1, and HBE1 during tumorigenesis were verified as promising biomarkers for the early diagnosis of HCC using parallel reaction monitoring technology. This study may enhance the understanding of HCC tumorigenesis from a different point of view and aid the early diagnosis of HCC.	[Wang, Shufang; Zhang, Jiaying; Cai, Xiaoyu; Zhuang, Yuan; Pu, Fei; Fan, Bin; Wang, Deqing] Chinese Peoples Liberat Army Gen Hosp, Blood Transfus Dept, Med Ctr 1, Beijing, Peoples R China; [Wang, Guibin; Tu, Zhiwei] Beijing Inst Life, Beijing Proteome Res Ctr, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing, Peoples R China; [Lu, Shichun; Zhang, Wenwen] Chinese Peoples Liberat Army Gen Hosp, Fac Hepatopancreato Biliary Surg, Beijing, Peoples R China; [Han, Yuanyuan; Zhang, Zhaojun] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing Inst Genom, Beijing, Peoples R China; [Han, Yuanyuan; Zhang, Zhaojun] Chinese Acad Sci, Inst Stem Cell & Regenerat, China Natl Ctr Bioinformat, Beijing, Peoples R China; [Han, Yuanyuan] Guizhou Univ, Sch Med, Guiyang, Peoples R China; [Yan, Xin] Xiongxian Cty Ctr Dis Control & Prevent, Baoding, Peoples R China; [Wang, Liang; Huang, Xirui] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Med Ctr 1, Beijing, Peoples R China; [Zhang, Zhaojun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Zhaojun] Beijing Key Lab Genome & Precis Med Technol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Guizhou University; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, DQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Blood Transfus Dept, Med Ctr 1, Beijing, Peoples R China.; Zhang, ZJ (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing Inst Genom, Beijing, Peoples R China.; Zhang, ZJ (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, China Natl Ctr Bioinformat, Beijing, Peoples R China.; Zhang, ZJ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Zhang, ZJ (corresponding author), Beijing Key Lab Genome & Precis Med Technol, Beijing, Peoples R China.	deqingw@vip.sina.com; zhangzhaojun@big.ac.cn			National Natural Science Foundation of China [32071117, 81870097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 32071117, 81870097).	Albeniz I, 2007, HEMATOLOGY, V12, P409, DOI 10.1080/10245330701383841; Allaire M, 2019, J HEPATOL, V70, P985, DOI 10.1016/j.jhep.2019.01.026; Best MG, 2015, CANCER CELL, V28, P666, DOI 10.1016/j.ccell.2015.09.018; Bryk AH, 2017, J PROTEOME RES, V16, P2752, DOI 10.1021/acs.jproteome.7b00025; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Chen BM, 2018, ANAL CHIM ACTA, V1007, P16, DOI 10.1016/j.aca.2017.12.045; Chen J, 2021, CANCER LETT, V499, P85, DOI 10.1016/j.canlet.2020.12.003; Chowdhury MA, 2014, CLIN LAB, V60, P653, DOI 10.7754/Clin.Lab.2013.130403; Cvejic A, 2013, NAT GENET, V45, P542, DOI 10.1038/ng.2603; Fiocchetti M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6315034; Guo CM, 2013, CLIN CHIM ACTA, V423, P83, DOI 10.1016/j.cca.2013.04.018; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Han YM, 2018, CELL, V173, P634, DOI 10.1016/j.cell.2018.02.061; Herr Claudia, 2003, BMC Biochem, V4, P8, DOI 10.1186/1471-2091-4-8; Hu ZD, 2013, CLIN CHEM LAB MED, V51, P1403, DOI 10.1515/cclm-2012-0704; Huang H, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-020-01641-w; JACOBSON RJ, 1978, S AFR MED J, V53, P658; Johns JL, 2012, VET PATHOL, V49, P508, DOI 10.1177/0300985811432344; Koury MJ, 2004, ANNU REV NUTR, V24, P105, DOI 10.1146/annurev.nutr.24.012003.132306; Thuy LTT, 2016, HISTOL HISTOPATHOL, V31, P257, DOI 10.14670/HH-11-694; Ma CY, 2020, J CLIN APHERESIS, V35, P206, DOI 10.1002/jca.21781; Mak Lung-Yi, 2018, Am Soc Clin Oncol Educ Book, V38, P262, DOI 10.1200/EDBK_200939; Mosler Domagoj, 2011, Acta Medica Croatica, V65, P183; Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043; Park SJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005811; Qiu JL, 2017, J CLIN ONCOL, V35, P734, DOI [10.1200/JCO.2016.68.2153, 10.1200/jco.2016.68.2153]; Sen Gupta A, 2019, SHOCK, V52, P70, DOI 10.1097/SHK.0000000000001009; Storry JR, 2013, NAT GENET, V45, P537, DOI 10.1038/ng.2600; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; van der Rijst MVE, 2021, TRANSFUSION, V61, P236, DOI 10.1111/trf.16169; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vogel A, 2020, CANCER TREAT REV, V82, DOI 10.1016/j.ctrv.2019.101946; Wang Chun-Hsiang, 2015, Asian Pac J Cancer Prev, V16, P3595; Wang HH, 2020, INT J CLIN EXP PATHO, V13, P357; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Xie YB, 2019, MOL MED REP, V19, P783, DOI 10.3892/mmr.2018.9713; [许诚笛 Xu Chengdi], 2019, [第二军医大学学报, Academic Journal of Second Military Medical University], V40, P743; Xu QH, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20194405; Yang YD, 2020, BRIEF BIOINFORM, V21, P1006, DOI 10.1093/bib/bbz027; Yousefi S, 2009, BBA-MOL CELL RES, V1793, P1461, DOI 10.1016/j.bbamcr.2008.12.023; Zhao YN, 2018, CANCER BIOMARK, V23, P527, DOI 10.3233/CBM-181651; Zheng B, 2017, SCI CHINA LIFE SCI, V60, P575, DOI 10.1007/s11427-016-9043-9; Zheng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14344; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0276904	10.1371/journal.pone.0276904	http://dx.doi.org/10.1371/journal.pone.0276904			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346805	Green Published, gold			2022-12-26	WOS:000894053200012
J	Tamminga, GG; Jansen, GJ; Wiersma, M				Tamminga, Gerrit G.; Jansen, Gijsbert J.; Wiersma, Marit			Evaluation of a fluorescence in situ hybridization (FISH)-based method for detection of SARS-CoV-2 in saliva	PLOS ONE			English	Article								The use of a non-invasive fluorescence in situ hybridization (FISH)-based method on saliva for the detection of SARS-CoV-2 is evaluated in a proof-of-concept study and thereafter utilized in an outpatient setting with the Biotrack-MED (R) analyzer. For a proof-of-concept study, saliva samples were obtained from 28 persons with mild or moderate COVID-19-related symptoms who were tested RT-PCR positive or negative for SARS-CoV-2. In an outpatient setting, 972 individual saliva samples were utilized. All saliva samples were FISHed with a Cy3-labeled SARS-CoV-2-specific DNA probe and were analyzed manually by fluorescence microscopy (proof-of-concept) or with the SARS-CoV-2 application of the Biotrack-MED (R) analyzer, a semi-autonomous multi-sample filter cytometer. The proof-of-concept study showed a sensitivity of 96.0% and a specificity of 98.5% and is therefore comparable to the RT-PCR analysis of nasopharyngeal swabs. The outpatient setting showed a sensitivity of 90.9% and a specificity of 94.5% and seems therefore a valid assay for the detection of SARS-CoV-2 in individuals that are healthy, mild or moderate symptomatic. In conclusion, the method evaluated in this study, the FISH-based SARS-CoV-2 application of the Biotrack-MED (R) analyzer, is a sensitive and reliable assay for the detection of SARS-CoV-2 in the general population.	[Tamminga, Gerrit G.; Jansen, Gijsbert J.; Wiersma, Marit] Biotrack, Leeuwarden, Netherlands		Wiersma, M (corresponding author), Biotrack, Leeuwarden, Netherlands.	m.wiersma@biotrack.nl		Wiersma, Marit/0000-0002-6669-1110				Abasiyanik MF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91835-7; Ambike S, 2022, NUCLEIC ACIDS RES, V50, P333, DOI 10.1093/nar/gkab1248; Boger B, 2021, AM J INFECT CONTROL, V49, P21, DOI 10.1016/j.ajic.2020.07.011; Braunstein GD, 2021, J OCCUP ENVIRON MED, V63, pE159, DOI 10.1097/JOM.0000000000002138; Callahan C, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00162-21; Frickmann H, 2017, CRIT REV MICROBIOL, V43, P263, DOI 10.3109/1040841X.2016.1169990; Huang N, 2021, NAT MED, V27, P892, DOI 10.1038/s41591-021-01296-8; Jansen GJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256378; Karlsson U, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3944; Kim YG, 2017, J CLIN MICROBIOL, V55, P226, DOI [10.1128/JCM.01704-16, 10.1128/jcm.01704-16]; Kortela E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251661; Kusmartseva I, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.11.005; Layfield LJ, 2021, PATHOL RES PRACT, V225, DOI 10.1016/j.prp.2021.153579; Levsky JM, 2003, J CELL SCI, V116, P2833, DOI 10.1242/jcs.00633; National Institute for Public Health and the Environment, 2021, ANN REPORT SURVEILLA; Sarkodie SA, 2021, ENVIRON DEV SUSTAIN, V23, P5005, DOI 10.1007/s10668-020-00801-2; Scohy A, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104455; Smither SJ, 2020, EMERG MICROBES INFEC, V9, P1415, DOI 10.1080/22221751.2020.1777906; Sullivan A, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.679012; Tamminga GG, 2019, J MICROBIOL METH, V166, DOI 10.1016/j.mimet.2019.105717; Tan SH, 2021, LANCET RESP MED, V9, P562, DOI 10.1016/S2213-2600(21)00178-8; To KKW, 2019, CLIN MICROBIOL INFEC, V25, P372, DOI 10.1016/j.cmi.2018.06.009; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; To KK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.35; van der Schaaf A, 2012, RADIOTHER ONCOL, V105, P115, DOI 10.1016/j.radonc.2011.12.006; Watson J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1808; WHO, 2020, ANT DET DIAGN SARS C; World Health Organization, WHO COR COVID 19 DAS; World Health Organization, 2020, DIR GEN OP REM MED B; World Health Organization, COR DIS COVID 19; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343; Xu RS, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0080-z; Yamayoshi S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121420; Yee R, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02686-20; Ying X, 2018, CHINA PERSPECT-SER, P1, DOI 10.1088/1742-6596/1168/2/022022	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0277367	10.1371/journal.pone.0277367	http://dx.doi.org/10.1371/journal.pone.0277367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346813	gold, Green Published			2022-12-26	WOS:000894053200023
J	Byun, JH; Roh, Y; Yoon, IS; Kim, KS; Jungid, IH				Byun, Jong Hyuk; Roh, Yunil; Yoon, In-Soo; Kim, Kwang Su; Jungid, Il Hyo			Fractional transit compartment model for describing drug delayed response to tumors using Mittag-Leffler distribution on age- structured PKPD model	PLOS ONE			English	Article							EPIDEMIC MODEL	The response of a cell population is often delayed relative to drug injection, and individual cells in a population of cells have a specific age distribution. The application of transit compartment models (TCMs) is a common approach for describing this delay. In this paper, we propose a TCM in which damaged cells caused by a drug are given by a single fractional derivative equation. This model describes the delay as a single equation composed of fractional and ordinary derivatives, instead of a system of ODEs expressed in multiple compartments, applicable to the use of the PK concentration in the model. This model tunes the number of compartments in the existing model and expresses the delay in detail by estimating an appropriate fractional order. We perform model robustness, sensitivity analysis, and change of parameters based on the amount of data. Additionally, we resolve the difficulty in parameter estimation and model simulation using a semigroup property, consisting of a system with a mixture of fractional and ordinary derivatives. This model provides an alternative way to express the delays by estimating an appropriate fractional order without determining the pre-specified number of compartments.	[Byun, Jong Hyuk; Roh, Yunil; Jungid, Il Hyo] Pusan Natl Univ, Dept Math, Coll Nat Sci, Busan, South Korea; [Yoon, In-Soo] Pusan Natl Univ, Dept Mfg Pharm, Coll Pharm, Busan, South Korea; [Yoon, In-Soo] Pusan Natl Univ, Dept Mfg Pharm, Res Inst Drug Dev, Busan, South Korea; [Kim, Kwang Su] Pukyong Natl Univ, Dept Sci Syst Simulat, Busan, South Korea	Pusan National University; Pusan National University; Pusan National University; Pukyong National University	Jungid, IH (corresponding author), Pusan Natl Univ, Dept Math, Coll Nat Sci, Busan, South Korea.	ilhjung@pusan.ac.kr		JUNG, IL HYO/0000-0002-6086-5124	National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF2020R1C1C1A01004631, NRF2022R1C1C2003637, NRF-2019R1A2C2007249, NRF-2022R1A5A1033624]; Research Fund Program of Research Institute for Basic Sciences, Pusan National University, Korea [RIBS-PNU-2022-002]	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Research Fund Program of Research Institute for Basic Sciences, Pusan National University, Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF2020R1C1C1A01004631, NRF2022R1C1C2003637, NRF-2019R1A2C2007249, NRF-2022R1A5A1033624), and by the Research Fund Program of Research Institute for Basic Sciences, Pusan National University, Korea, 2022,YProject No. RIBS-PNU-2022-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ameen I, 2017, APPL MATH MODEL, V43, P78, DOI 10.1016/j.apm.2016.10.054; Angstmann CN, 2021, SIAM REV, V63, P375, DOI 10.1137/21M1398549; Angstmann CN, 2017, SIAM J APPL MATH, V77, P430, DOI 10.1137/16M1069249; Ariza-Hernandez FJ, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8010109; Atangana A., 2017, FRACTIONAL OPERATORS; Bortolussi L., 2012, 2012 Ninth International Conference on Quantitative Evaluation of Systems (QEST 2012), P53, DOI 10.1109/QEST.2012.13; Byun JH, 2020, APPL MATH MODEL, V79, P300, DOI 10.1016/j.apm.2019.10.037; Cassidy T, 2021, SIAM J APPL MATH, V81, P1742, DOI 10.1137/20M1351606; Cassidy T, 2019, MATH BIOSCI ENG, V16, P5419, DOI 10.3934/mbe.2019270; Champredon D, 2018, SIAM J APPL MATH, V78, P3258, DOI 10.1137/18M1186411; Chen B, 2021, PROCEDIA COMPUT SCI, V187, P60, DOI 10.1016/j.procs.2021.04.033; Cong ND, 2021, ARXIV; Dokoumetzidis A, 2010, J PHARMACOKINET PHAR, V37, P507, DOI 10.1007/s10928-010-9170-4; Duan XC, 2014, COMPUT MATH APPL, V68, P288, DOI 10.1016/j.camwa.2014.06.002; Evans L. C., 1998, GRADUATE STUDIES MAT, V19, DOI DOI 10.1090/GSM/019; Garrappa R, 2018, MATHEMATICS-BASEL, V6, DOI 10.3390/math6020016; Getz WM, 2017, J BIOL DYNAM, V12, P16, DOI 10.1080/17513758.2017.1401677; Glass DS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21700-8; Gupta PK, 2018, INT J ENG TECHNOL, V7, P6, DOI [10.14419/ijet.v7i2.28.12872, DOI 10.14419/IJET.V7I2.28.12872]; Haubold HJ, 2011, J APPL MATH, DOI 10.1155/2011/298628; Hinow P, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-14; Hurtado P, 2020, MATH APPL SCI ENG, V1, P410, DOI [10.5206/mase/10857, DOI 10.5206/MASE/10857]; Igor Podlubny, 2001, Arxiv, DOI arXiv:math/0110241; Jarad F, 2020, DISCRETE CONT DYN-S, V13, P709, DOI 10.3934/dcdss.2020039; JUSKO WJ, 1994, CLIN PHARMACOL THER, V56, P406, DOI 10.1038/clpt.1994.155; Kakizoe Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10371; Koch G, 2014, J PHARMACOKINET PHAR, V41, P291, DOI 10.1007/s10928-014-9368-y; Krzyzanski W, 2015, J PHARMACOKINET PHAR, V42, P573, DOI 10.1007/s10928-015-9446-9; Krzyzanski W, 2011, J PHARMACOKINET PHAR, V38, P179, DOI 10.1007/s10928-010-9183-z; MacDonald N, 1978, LECT NOTES BIOMATHEM, V17, P1059; Magni P, 2006, MATH BIOSCI, V200, P127, DOI 10.1016/j.mbs.2005.12.028; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Matthew Adams, 2019, Arxiv, DOI arXiv:1912.05303; Momani S, 2007, J COMPUT APPL MATH, V207, P96, DOI 10.1016/j.cam.2006.07.015; Navarro-Guerrero G, 2017, INT J ADAPT CONTROL, V31, P1350, DOI 10.1002/acs.2769; PILLAI RN, 1990, ANN I STAT MATH, V42, P157, DOI 10.1007/BF00050786; Piotrowska MJ, 2018, COMMUN NONLINEAR SCI, V54, P389, DOI 10.1016/j.cnsns.2017.06.003; Simeoni M, 2004, CANCER RES, V64, P1094, DOI 10.1158/0008-5472.CAN-03-2524; Stein S, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005924; Sun YN, 1998, J PHARM SCI, V87, P732, DOI 10.1021/js970414z; Cassidy T, 2018, Arxiv, DOI arXiv:1811.05930; Ucar E, 2019, MATH MODEL NAT PHENO, V14, DOI 10.1051/mmnp/2019002; Verotta D, 2010, J PHARMACOKINET PHAR, V37, P209, DOI 10.1007/s10928-010-9155-3; Vogel T., 1961, SYSTEMES DEFERLANTS; Wei YH, 2019, CHIN AUTOM CONGR, P1697, DOI 10.1109/CAC48633.2019.8997499	45	0	0	46	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2022	17	11							e0276654	10.1371/journal.pone.0276654	http://dx.doi.org/10.1371/journal.pone.0276654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6I9QV	36331932	gold, Green Published			2022-12-26	WOS:000886465500001
J	Lin, ZY; Chen, A; Cui, HW; Shang, RH; Su, T; Li, XY; Wang, KK; Yang, J; Gao, KL; Lv, J; Shen, J; Wang, SZ; Qi, YH; Guo, MH; Zhu, YJ				Lin, Ziyan; Chen, Ai; Cui, Hongwang; Shang, Ruihua; Su, Tian; Li, Xiaoyan; Wang, Kekun; Yang, Jing; Gao, Keli; Lv, Jie; Shen, Jie; Wang, Shanzhi; Qi, Yonghui; Guo, Minghao; Zhu, Yongjun			Renal tubular epithelial cell necroptosis promotes tubulointerstitial fibrosis in patients with chronic kidney disease	FASEB JOURNAL			English	Article						chronic kidney disease; Interstitial fibroblasts; Necroptosis; Transforming growth factor beta 1; Tubulointerstitial fibrosis	INFLAMMATION; MECHANISMS; INJURY; ORIGIN; BETA	Renal fibrosis, a common pathological manifestation of virtually all types of chronic kidney disease (CKD), ultimately predisposes patients to end-stage renal disease. However, there is no effective therapy for renal fibrosis. Our earlier studies proved that RIP3-mediated necroptosis might be an important mode of renal tubular cell death in rats with chronic renal injury. Under transmission electron microscopy (TEM), we found morphological changes in the necrosis of human renal tissue, and the percentage of necrotic cells increased significantly in patients with stages 2 and 3a CKD. Immunofluorescence analyses showed that the percentages of TUNEL+/RIP3(+) double-positive and TUNEL+/MLKL+ double-positive tubular epithelial cells in renal tubules of patients with stages 2 and 3a CKD were significantly increased compared to those in control patients without renal disease. Immunohistochemistry analyses of renal biopsy specimens from patients with CKD revealed RIP3, MLKL, and p-MLKL upregulation in patients with stages 2 and 3a CKD, suggesting that necroptosis of renal tubular epithelial cells in CKD patients occurs, and the peak of necroptosis was in stages 2 and 3a CKD. We showed that profibrotic factor proteins (TGF-beta 1, Smad2 and Smad3) and fibroblast activation markers (alpha-SMA and Vimentin) were specifically upregulated in stage 2 and 3a CKD patients. In addition, Pearson correlation analysis showed that the percentage of necroptotic renal tubular epithelial cells was positively correlated with TGF-beta 1 and collagen-I. We also showed that RIP1/3 or MLKL inhibitors decreased the expression of RIP3, MLKL, TGF-beta 1, and Smad3 in HK-2 cells treated with TNF-alpha. FGF-2, alpha-SMA, Vimentin and FN were overexpressed in the hRIFs cultured with the supernatant of necroptotic HK-2 cells, whereas necroptosis blockers (Nec-1s, GSK'872 and NSA) and TGF-beta 1/Smad3 pathway antagonists (LY364947 and SIS3) reduced FGF-2, alpha-SMA, Vimentin and FN levels. Collectively, necroptosis of renal tubular epithelial cells in CKD patients occurs, and the peak of necroptosis was in stages 2 and 3a CKD. Renal tubular epithelial cell necroptosis mediates renal tubulointerstitial fibrosis in patients with chronic kidney disease, which is related to the TGF-beta 1/Smad3 signaling pathway.	[Lin, Ziyan; Chen, Ai; Li, Xiaoyan; Yang, Jing; Gao, Keli; Lv, Jie; Shen, Jie; Wang, Shanzhi; Zhu, Yongjun] Hainan Med Univ, Dept Nephrol, Affiliated Hosp 1, Haikou, Peoples R China; [Cui, Hongwang; Su, Tian] Hainan Med Univ, Dept Orthoped, Affiliated Hosp 1, Haikou, Peoples R China; [Shang, Ruihua; Guo, Minghao] Xinxiang Med Univ, Dept Nephrol, Affiliated Hosp 1, Urumqi, Peoples R China; [Wang, Kekun] Qionghai Peoples Hosp, Dept Nephrol, Qionghai, Peoples R China; [Qi, Yonghui] Hainan Med Univ, Blood Purificat Ctr, Hannan Affiliated Hosp, Haikou, Peoples R China	Hainan Medical University; Hainan Medical University; Xinxiang Medical University; Hainan Medical University	Zhu, YJ (corresponding author), Hainan Med Univ, Dept Nephrol, Affiliated Hosp 1, 31 Longhua Rd, Haikou 570102, Hainan, Peoples R China.; Guo, MH (corresponding author), Xinxiang Med Univ, Dept Nephrol, Affiliated Hosp 1, 88 Jiankang Rd, Xinxiang 453100, Henan, Peoples R China.	guomh@163.com; zyj418207195@yeah.net			Key Research and Development Project of Hainan Province (Key R&D Project of Hainan Province) [2019215]; National Natural Science Foundation of China (NSFC) [82060143]; Natural Science Foundation of Hainan Province [821RC693]	Key Research and Development Project of Hainan Province (Key R&D Project of Hainan Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province	Key Research and Development Project of Hainan Province (Key R&D Project of Hainan Province), Grant/Award Number: 2019215; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82060143; Natural Science Foundation of Hainan Province, Grant/Award Number: 821RC693	Cho Min Hyun, 2010, Korean J Pediatr, V53, P735, DOI 10.3345/kjp.2010.53.7.735; Collins A, 2006, KIDNEY INT, V69, P781, DOI 10.1038/sj.ki.5000250; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Elson EL, 2019, PROG BIOPHYS MOL BIO, V144, P30, DOI 10.1016/j.pbiomolbio.2018.08.004; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Liu SH, 2021, CELL MOL LIFE SCI, V78, P7199, DOI 10.1007/s00018-021-03947-y; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YP, 2019, INT J MOL MED, V44, P771, DOI 10.3892/ijmm.2019.4244; Ma TT, 2019, ADV EXP MED BIOL, V1165, P347, DOI 10.1007/978-981-13-8871-2_16; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Meng YX, 2021, CELL DEATH DIFFER, V28, P861, DOI 10.1038/s41418-020-00722-7; Murakami K, 1997, PEDIATR NEPHROL, V11, P334, DOI 10.1007/s004670050289; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Nikolic-Paterson DJ, 2014, KIDNEY INT SUPPL, V4, P34, DOI 10.1038/kisup.2014.7; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Sun YBY, 2016, DIFFERENTIATION, V92, P102, DOI 10.1016/j.diff.2016.05.008; Tan RJ, 2016, KIDNEY DIS-BASEL, V2, P136, DOI 10.1159/000446336; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Zhan CN, 2021, THERANOSTICS, V11, P4759, DOI 10.7150/thno.54072; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902; Zhu YJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228385; Zhu YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156729; Zhu YJ, 2015, BIOCHEM BIOPH RES CO, V461, P575, DOI 10.1016/j.bbrc.2015.03.164	27	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22625	10.1096/fj.202200706RR	http://dx.doi.org/10.1096/fj.202200706RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5X6WI	36331546				2022-12-26	WOS:000878739400001
J	Chen, R; Ma, TB; Du, SY; Luo, JY; Zhang, H; Xu, X; Cao, ZJ; Yuan, ZQ; Sun, H; Liu, MG; Xiong, B; Shi, QH; Liu, JY				Chen, Rui; Ma, Tingbin; Du, Shiyue; Luo, Junyu; Zhang, Huan; Xu, Xuan; Cao, Zhijian; Yuan, Zhangqi; Sun, Hao; Liu, Mugen; Xiong, Bo; Shi, Qinghua; Liu, Jing Yu			Impaired fertility in 4930590J08Rik mutant male mice is associated with defective sperm energy metabolism	FASEB JOURNAL			English	Article						energy metabolism; fertility; progressive motility; sperm-egg interaction; testis-specifically expressed gene	ACROSIN ACTIVITY; MOUSE; PROTEIN; FERTILIZATION; GENES; INFERTILITY; MECHANISMS; ENVELOPE; MOTILITY; CYCLE	Testis-specifically expressed genes are important for male reproduction according to their unique expression patterns. However, the functions of most of these genes in reproduction are unclear. Here, we showed that mouse 4930590J08Rik was a testis-specifically expressed gene. 4930590J08Rik knockout mice exhibited a delay in the first wave of spermatogenesis and a reduction of cauda epididymal sperm. Furthermore, knockout spermatozoa exhibited defective acrosome reactions and decreased progressive motility, which led to impaired in vivo fertilization. Transcriptome analysis of testes revealed that most of the differentially expressed genes in knockout testes were associated with metabolic processes. 4930590J08Rik knockout sperm exhibited oxidative phosphorylation deficiency and were highly dependent on increased anaerobic glycolysis to compensate for ATP demands. Taken together, the 4930590J08Rik-disrupted mouse partially mimics the phenotypes of human asthenospermia and oligozoospermia, which provides a new model for further understanding the pathogenesis of idiopathic male infertility.	[Chen, Rui; Du, Shiyue; Luo, Junyu; Cao, Zhijian; Yuan, Zhangqi; Sun, Hao; Liu, Mugen] Huazhong Univ Sci & Technol HUST, Coll Life Sci & Technol, Wuhan, Peoples R China; [Ma, Tingbin; Xu, Xuan; Liu, Jing Yu] Chinese Acad Sci, Inst Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, State Key Lab Neurosci, Shanghai, Peoples R China; [Zhang, Huan; Shi, Qinghua] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Biomed Sci & Hlth Lab Anhui Prov,Sch Basic Med Sc, Affiliated Hosp USTC 1,Div Reprod & Genet,Div Lif, Hefei, Peoples R China; [Xiong, Bo] Tongji Med Coll, Dept Forens Med, Wuhan, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huazhong University of Science & Technology	Liu, JY (corresponding author), Chinese Acad Sci, Inst Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, State Key Lab Neurosci, Shanghai 200031, Peoples R China.; Shi, QH (corresponding author), Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Biomed Sci & Hlth Lab Anhui Prov,Sch Basic Med Sc, Affiliated Hosp USTC 1,Div Reprod & Genet,Div Lif, Hefei 230027, Peoples R China.	qshi@ustc.edu.cn; liujy@ion.ac.cn			National Natural Science Foundation of China [31871262]; Shanghai Municipal Science and Technology [2018SHZDZX05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology	National Natural Science Foundation of China, Grant/Award Number: 31871262; Shanghai Municipal Science and Technology, Grant/Award Number: 2018SHZDZX05	AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Balbach M, 2020, BIOL REPROD, V103, P791, DOI 10.1093/biolre/ioaa114; Barry DM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916643724; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Bracke A, 2018, REPROD BIOMED ONLINE, V36, P327, DOI 10.1016/j.rbmo.2017.12.005; Chen LG, 2020, BIOMED CHROMATOGR, V34, DOI 10.1002/bmc.4769; Chen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0183-x; Chen Y, 2018, CELL RES, V28, P879, DOI 10.1038/s41422-018-0074-y; Cheng ST, 2016, EXP BIOL MED, V241, P205, DOI 10.1177/1535370215597199; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; de Rooij DG, 2017, DEVELOPMENT, V144, P3022, DOI 10.1242/dev.146571; Devlin DJ, 2020, BIOL REPROD, V103, P205, DOI 10.1093/biolre/ioaa082; Engeli KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211679; Fujihara Y, 2020, P NATL ACAD SCI USA, V117, P9393, DOI 10.1073/pnas.1917060117; Gao J, 2008, UROL INT, V81, P256, DOI 10.1159/000151400; Gibbs GM, 2010, ENDOCRINOLOGY, V151, P2331, DOI 10.1210/en.2009-1255; HECHT NB, 1990, J REPROD FERTIL, V88, P679, DOI 10.1530/jrf.0.0880679; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P364, DOI 10.1002/jemt.20785; Hidalgo DM, 2020, MOL REPROD DEV, V87, P1037, DOI 10.1002/mrd.23421; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Kashiwabara SI, 2016, J REPROD DEVELOP, V62, P305, DOI 10.1262/jrd.2016-023; KENNEDY WP, 1989, J ANDROL, V10, P221; Kleene KC, 2013, REPRODUCTION, V146, pR1, DOI 10.1530/REP-12-0362; Krausz C, 2018, NAT REV UROL, V15, P369, DOI 10.1038/s41585-018-0003-3; Kuang WH, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109025; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lu YG, 2019, BIOL REPROD, V101, P501, DOI 10.1093/biolre/ioz103; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miwa N, 2015, MOLECULES, V20, P9468, DOI 10.3390/molecules20059468; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Noda T, 2020, P NATL ACAD SCI USA, V117, P11493, DOI 10.1073/pnas.1922650117; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Odet F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108530; Oud MS, 2017, HUM MUTAT, V38, P1592, DOI 10.1002/humu.23312; Oyama Y, 2022, ASIAN J ANDROL, V24, P266, DOI 10.4103/aja.aja_63_21; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Robertson MJ, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00826-z; Rydell-Tormanen K, 2019, METHODS MOL BIOL, V1940, P3, DOI 10.1007/978-1-4939-9086-3_1; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shahrokhi SZ, 2020, ANDROLOGIA, V52, DOI 10.1111/and.13463; Shang X, 2018, CELL MOL LIFE SCI, V75, P4371, DOI 10.1007/s00018-018-2878-9; Shen CL, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107086; Shu FP, 2015, J ASSIST REPROD GEN, V32, P1643, DOI 10.1007/s10815-015-0548-5; Sreedhar A, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800353; Sreedhar A, 2017, ONCOTARGET, V8, P95504, DOI 10.18632/oncotarget.20762; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; SUAREZ SS, 1992, BIOL REPROD, V46, P686, DOI 10.1095/biolreprod46.4.686; Taft Robert, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.prot094508; Takasaki N, 2014, P NATL ACAD SCI USA, V111, P1120, DOI 10.1073/pnas.1310777111; Wang GF, 2015, CRYOBIOLOGY, V71, P464, DOI 10.1016/j.cryobiol.2015.08.016; Wang XN, 2018, CELL PHYSIOL BIOCHEM, V50, P952, DOI 10.1159/000494479; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Xiong WF, 2019, MOL REPROD DEV, V86, P935, DOI 10.1002/mrd.23180; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhao K, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8327506; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104	62	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22634	10.1096/fj.202200805RR	http://dx.doi.org/10.1096/fj.202200805RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5X6WQ	36331537				2022-12-26	WOS:000878740300001
J	Gaulton, N; Wakelin, G; Young, LV; Wotherspoon, S; Kamal, M; Parise, G; Nederveen, JP; Holwerda, A; Verdijk, LB; van Loon, LJC; Snijders, T; Johnston, AP				Gaulton, Nick; Wakelin, Griffen; Young, Laura V.; Wotherspoon, Scott; Kamal, Michael; Parise, Gianni; Nederveen, Joshua P.; Holwerda, Andy; Verdijk, Lex B.; van Loon, Luc J. C.; Snijders, Tim; Johnston, Adam P.			Twist2-expressing cells reside in human skeletal muscle and are responsive to aging and resistance exercise training	FASEB JOURNAL			English	Article						aging; progenitor cells; sarcopenia; skeletal muscle; Twist2	SATELLITE CELLS; STEM-CELLS	Skeletal muscle is maintained and repaired by sub-laminar, Pax7-expressing satellite cells. However, recent mouse investigations have described a second myogenic progenitor population that resides within the myofiber interstitium and expresses the transcription factor Twist2. Twist2-expressing cells exclusively repair and maintain type IIx/b muscle fibers. Currently, it is unknown if Twist2-expressing cells are present in human skeletal muscle and if they function as myogenic progenitors. Here, we perform a combination of single-cell RNA sequencing analysis and immunofluorescence staining to demonstrate the identity and localization of Twist2-expressing cells in human skeletal muscle. Twist2-expressing cells were identified to be anatomically and transcriptionally comparable to fibro-adipogenic progenitors (FAPs) and lack expression of typical satellite cell markers such as Pax7. Comparative analysis revealed that human and mouse Twist2-expressing cells were highly transcriptionally analogous and resided within the same anatomical structures in vivo. Examination of young and aged skeletal muscle biopsy samples revealed that Twist2-positive cells are more prevalent in aged muscle and increase following 12-weeks of resistance exercise training (RET) in humans. However, the quantity of Twist2-positive cells was not correlated with indices of muscle mass or muscle fiber cross-sectional area (CSA) in young or older muscle, and their abundance was surprisingly, negatively correlated with CSA and myonuclear domain size following RET. Taken together, we have identified cells expressing Twist2 in human skeletal muscle which are responsive to aging and exercise. Further examination of their myogenic potential is warranted.	[Gaulton, Nick; Wakelin, Griffen; Young, Laura V.; Johnston, Adam P.] Univ Prince Edward Isl, Dept Appl Human Sci, Charlottetown, PE, Canada; [Wakelin, Griffen; Johnston, Adam P.] Dalhousie Univ, Dept Med Neurosci, Halifax, NS, Canada; [Wotherspoon, Scott] Queen Elizabeth Hosp, Charlottetown, PE, Canada; [Kamal, Michael; Parise, Gianni] McMaster Univ, Fac Sci, Dept Kinesiol, Hamilton, ON, Canada; [Nederveen, Joshua P.] McMaster Univ, Dept Pediat, Childrens Hosp, Hamilton, ON, Canada; [Holwerda, Andy; Verdijk, Lex B.; van Loon, Luc J. C.; Snijders, Tim] Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands	University of Prince Edward Island; Dalhousie University; McGill University; McMaster University; McMaster University; Maastricht University	Johnston, AP (corresponding author), Life Sci Res Inst, Brain Repair Ctr, Dept Med Neurosci, 1348 Summer St, Halifax, NS B3H 4R2, Canada.	adamjohnston@dal.ca			Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05747]; USRA; Naomi Cermac Grant	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); USRA; Naomi Cermac Grant	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: RGPIN-2016-05747 and USRA; Naomi Cermac Grant	Alasdair C., 2022, AM J PHYSIOL-CELL PH, DOI [10.1152/ajpcell.00364.2022, DOI 10.1152/AJPCELL.00364.2022]; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen W, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200048; Dalle S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01045; De Micheli AJ, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00236-3; Fragala MS, 2019, J STRENGTH COND RES, V33, P2019, DOI 10.1519/JSC.0000000000003230; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Hepple RT, 2016, J PHYSIOL-LONDON, V594, P1965, DOI 10.1113/JP270561; Holwerda AM, 2018, J NUTR, V148, P1723, DOI 10.1093/jn/nxy169; Joanisse S, 2017, GERONTOLOGY, V63, P91, DOI 10.1159/000450922; Johnston APW, 2008, APPL PHYSIOL NUTR ME, V33, P191, DOI 10.1139/H07-141; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Li S, 2019, DEV CELL, V51, P89, DOI 10.1016/j.devcel.2019.08.002; Li S, 2019, GENE DEV, V33, P626, DOI 10.1101/gad.324467.119; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Mackey AL, 2007, SCAND J MED SCI SPOR, V17, P34, DOI 10.1111/j.1600-0838.2006.00534.x; McKendry J, 2021, COMPR PHYSIOL, V11, P2249, DOI 10.1002/cphy.c200029; Mcleod JC, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00645; Moore DR, 2018, J CACHEXIA SARCOPENI, V9, P747, DOI 10.1002/jcsm.12306; Morton RW, 2018, CURR OPIN CRIT CARE, V24, P124, DOI 10.1097/MCC.0000000000000488; Murach KA, 2019, J APPL PHYSIOL, V127, P1632, DOI 10.1152/japplphysiol.00624.2019; Ning XX, 2018, J CELL MOL MED, V22, P1383, DOI 10.1111/jcmm.13465; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Snijders T, 2019, J PHYSIOL-LONDON, V597, P105, DOI 10.1113/JP276260; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Sousa-Victor P, 2014, CELL CYCLE, V13, P3183, DOI 10.4161/15384101.2014.965072; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050	32	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22642	10.1096/fj.202201349RR	http://dx.doi.org/10.1096/fj.202201349RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6D9SJ	36374263				2022-12-26	WOS:000883024500001
J	Matsumura, S; Miyakita, M; Miyamori, H; Kyo, S; Ishikawa, F; Sasaki, T; Jinno, T; Tanaka, J; Fujita, K; Yokokawa, T; Goto, T; Momma, K; Takenaka, S; Inoue, K				Matsumura, Shigenobu; Miyakita, Motoki; Miyamori, Haruka; Kyo, Satomi; Ishikawa, Fuka; Sasaki, Tsutomu; Jinno, Tomoki; Tanaka, Jin; Fujita, Kotomi; Yokokawa, Takumi; Goto, Tsuyoshi; Momma, Keiko; Takenaka, Shigeo; Inoue, Kazuo			CRTC1 deficiency, specifically in melanocortin-4 receptor-expressing cells, induces hyperphagia, obesity, and insulin resistance	FASEB JOURNAL			English	Article						high-fat diet; melanocortins; obesity; transcription factors	COACTIVATOR CRTC1; CREB; ACTIVATION; PROMOTERS; MUTATIONS; TRANSPORT; GLUCOSE; FAMILY; ACID; GENE	Melanocortin-4 receptor (MC4R) is a critical regulator of appetite and energy expenditure in rodents and humans. MC4R deficiency causes hyperphagia, reduced energy expenditure, and impaired glucose metabolism. Ligand binding to MC4R activates adenylyl cyclase, resulting in increased levels of intracellular cyclic adenosine monophosphate (cAMP), a secondary messenger that regulates several cellular processes. Cyclic adenosine monophosphate responsive element-binding protein-1-regulated transcription coactivator-1 (CRTC1) is a cytoplasmic coactivator that translocates to the nucleus in response to cAMP and is reportedly involved in obesity. However, the precise mechanism through which CRTC1 regulates energy metabolism remains unknown. Additionally, there are no reports linking CRTC1 and MC4R, although both CRTC1 and MC4R are known to be involved in obesity. Here, we demonstrate that mice lacking CRTC1, specifically in MC4R cells, are sensitive to high-fat diet (HFD)-induced obesity and exhibit hyperphagia and increased body weight gain. Moreover, the loss of CRTC1 in MC4R cells impairs glucose metabolism. MC4R-expressing cell-specific CRTC1 knockout mice did not show changes in body weight gain, food intake, or glucose metabolism when fed a normal-chow diet. Thus, CRTC1 expression in MC4R cells is required for metabolic adaptation to HFD with respect to appetite regulation. Our results revealed an important protective role of CRTC1 in MC4R cells against dietary adaptation.	[Matsumura, Shigenobu; Miyakita, Motoki; Miyamori, Haruka; Ishikawa, Fuka; Jinno, Tomoki; Tanaka, Jin; Yokokawa, Takumi; Goto, Tsuyoshi; Inoue, Kazuo] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto, Japan; [Matsumura, Shigenobu; Fujita, Kotomi; Takenaka, Shigeo] Osaka Metropolitan Univ, Dept Nutr, 3-7-30 Habikino, Osaka 5838555, Japan; [Kyo, Satomi; Momma, Keiko] Kyoto Womens Univ, Dept Food & Nutr, Kyoto, Japan; [Sasaki, Tsutomu] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan	Kyoto University; Osaka Metropolitan University; Kyoto Womens University; Osaka University	Matsumura, S (corresponding author), Osaka Metropolitan Univ, Dept Nutr, 3-7-30 Habikino, Osaka 5838555, Japan.	smatsumura@omu.ac.jp		Matsumura, Shigenobu/0000-0002-7149-1375	JSPS [19H02909, 18K19174]; Sugiyama Sangyo-Kagaku General Incorporated Foundation; Takeda Life Science Foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sugiyama Sangyo-Kagaku General Incorporated Foundation; Takeda Life Science Foundation	JSPS, Grant/Award Number: 19H02909 and 18K19174; Sugiyama Sangyo-Kagaku General Incorporated Foundation; Takeda Life Science Foundation	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Baldini G, 2019, J ENDOCRINOL, V241, pR1, DOI 10.1530/JOE-18-0596; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Belgacem YH, 2017, ADV EXP MED BIOL, V1015, P19, DOI 10.1007/978-3-319-62817-2_2; Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; Breuillaud L, 2012, BIOL PSYCHIAT, V72, P528, DOI 10.1016/j.biopsych.2012.04.011; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Gannon NP, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700756; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Grill HJ, 1998, J NEUROSCI, V18, P10128; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Li C, 2021, MOL PSYCHIATR, V26, P3701, DOI 10.1038/s41380-020-00922-0; Li L, 2017, MOL BIOSYST, V13, P2392, DOI 10.1039/c7mb00167c; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mann G, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.702826; Matsumura S, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqab076; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Di Bonaventura EM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113502; Mitchell CS, 2021, J NEUROENDOCRINOL, V33, DOI 10.1111/jne.12952; Moghei M, 2016, AM J PHYSIOL-CELL PH, V311, pC518, DOI 10.1152/ajpcell.00062.2016; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Muller TD, 2021, NAT METAB, V3, P1134, DOI 10.1038/s42255-021-00451-2; Nibuya M, 1996, J NEUROSCI, V16, P2365; Ortega-Martinez S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00046; Pan Y, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109398; Panaro BL, 2013, P NATL ACAD SCI USA, V110, P7050, DOI 10.1073/pnas.1304707110; Parra-Damas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18215-y; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Podyma B, 2018, J BIOL CHEM, V293, P10993, DOI 10.1074/jbc.RA118.003450; Ravnskjaer K, 2016, HANDB EXP PHARMACOL, V233, P29, DOI 10.1007/164_2015_32; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sharma S., 2019, MOL BASEL SWITZERLAN, V24; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Tan K, 2009, ENDOCRINOLOGY, V150, P114, DOI 10.1210/en.2008-0721; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; van der Klaauw AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13055; Watts AG, 2011, J NEUROENDOCRINOL, V23, P754, DOI 10.1111/j.1365-2826.2011.02178.x; Xia GB, 2021, MOL PSYCHIATR, V26, P2837, DOI 10.1038/s41380-021-01053-w; Yoneshiro T, 2019, NATURE, V572, P614, DOI 10.1038/s41586-019-1503-x; Zhang WB, 2020, NEUROREPORT, V31, P1007, DOI 10.1097/WNR.0000000000001508	47	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22645	10.1096/fj.202200617R	http://dx.doi.org/10.1096/fj.202200617R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5Z7VW	36349991				2022-12-26	WOS:000880177400001
J	Martin-Gutierrez, G; Martin-Perez, C; Toledo, H; Sanchez-Cantalejo, E; Lepe, JA				Martin-Gutierrez, Guillermo; Martin-Perez, Carlos; Toledo, Hector; Sanchez-Cantalejo, Emilio; Lepe, Jose Antonio			FlowUTI: An interactive web-application for optimizing the use of flow cytometry as a screening tool in urinary tract infections	PLOS ONE			English	Article							BACTERIURIA; DIAGNOSIS; VALUES	Due to the high prevalence of patients attending with urinary tract infection (UTI) symptoms, the use of flow-cytometry as a rapid screening tool to avoid unnecessary cultures is becoming a widely used system in clinical practice. However, the recommended cut-points applied in flow-cytometry systems differ substantially among authors, making it difficult to obtain reliable conclusions. Here, we present FlowUTI, a shiny web-application created to establish optimal cut-off values in flow-cytometry for different UTI markers, such as bacterial or leukocyte counts, in urine from patients with UTI symptoms. This application provides a user-friendly graphical interface to perform robust statistical analysis without a specific training. Two datasets are analyzed in this manuscript: one composed of 204 urine samples from neonates and infants (<= 3 months old) attended in the emergency department with suspected UTI; and the second dataset including 1174 urines samples from an elderly population attended at the primary care level. The source code is available on GitHub (https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI). The web application can be executed locally from the R console. Alternatively, it can be freely accessed at https://covidiario.shinyapps.io/flowuti/. FlowUTI provides an easy-to-use environment for evaluating the efficiency of the urinary screening process with flow-cytometry, reducing the computational burden associated with this kind of analysis.	[Martin-Gutierrez, Guillermo; Toledo, Hector; Lepe, Jose Antonio] Univ Hosp Virgen Rocio, Clin Unit Infect Dis Microbiol & Parasitol, Seville, Spain; [Martin-Gutierrez, Guillermo; Lepe, Jose Antonio] Inst Biomed Sevilla IBiS, Seville, Spain; [Martin-Gutierrez, Guillermo; Lepe, Jose Antonio] Ctr Invest Biomed Red Enfermedades Infecciosas, Madrid, Spain	Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Martin-Gutierrez, G (corresponding author), Univ Hosp Virgen Rocio, Clin Unit Infect Dis Microbiol & Parasitol, Seville, Spain.; Martin-Gutierrez, G (corresponding author), Inst Biomed Sevilla IBiS, Seville, Spain.; Martin-Gutierrez, G (corresponding author), Ctr Invest Biomed Red Enfermedades Infecciosas, Madrid, Spain.	gmartin-ibis@us.es			Carlos III Health Institute [JR19/00039]	Carlos III Health Institute(Instituto de Salud Carlos III)	Guillermo Marti ' n-Gutie ' rrez holds a Juan Rode ' s Contract (JR19/00039) from the Carlos III Health Institute.	Alvarez-Barrientos A, 2000, CLIN MICROBIOL REV, V13, P167, DOI 10.1128/CMR.13.2.167-195.2000; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Broeren MAC, 2011, J CLIN MICROBIOL, V49, P1025, DOI 10.1128/JCM.01669-10; Chang Winston, 2021, CRAN; Church D., 2004, Clinical Microbiology Newsletter, V26, P179, DOI 10.1016/j.clinmicnews.2004.11.003; de Cueto M, 2017, ENFERM INFEC MICR CL, V35, P314, DOI 10.1016/j.eimc.2016.11.005; European association of urology, 2021, GUIDELINES UROLOGICA; European association of urology, 2018, US; Fjalstad JW, 2018, J ANTIMICROB CHEMOTH, V73, P569, DOI 10.1093/jac/dkx426; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Gajdacs M, 2019, CENT EUR J UROL, V72, P209, DOI 10.5173/ceju.2019.1909; Garcia-Coca M, 2017, J MICROBIOL METH, V137, P14, DOI 10.1016/j.mimet.2017.03.010; Hamilton-Miller JMT, 1999, WORLD J UROL, V17, P396, DOI 10.1007/s003450050165; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; Jolkkonen S, 2010, J CLIN MICROBIOL, V48, P3117, DOI 10.1128/JCM.00617-10; Kim SY, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.02004-17, 10.1128/jcm.02004-17]; Klein RD, 2020, NAT REV MICROBIOL, V18, P211, DOI 10.1038/s41579-020-0324-0; Kubik M. J., 2012, Clinical Microbiology Newsletter, V34, P185, DOI 10.1016/j.clinmicnews.2012.11.001; Manoni F, 2009, DIAGN MICR INFEC DIS, V65, P103, DOI 10.1016/j.diagmicrobio.2009.06.003; Mejuto P, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/8532736; Mody L, 2014, JAMA-J AM MED ASSOC, V311, P844, DOI 10.1001/jama.2014.303; Nicolle L, 2019, CLIN MICROBIOL INFEC, V25, P779, DOI 10.1016/j.cmi.2019.03.013; Okada H, 2000, J CLIN MICROBIOL, V38, P2870, DOI 10.1128/JCM.38.8.2870-2872.2000; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Saadeh SA, 2011, PEDIATR NEPHROL, V26, P1967, DOI 10.1007/s00467-011-1801-5; Schaeffer AJ, 2016, NEW ENGL J MED, V374, P562, DOI 10.1056/NEJMcp1503950; SCHIFMAN RB, 1984, J CLIN MICROBIOL, V20, P644, DOI 10.1128/JCM.20.4.644-648.1984; Shang YJ, 2013, CLIN CHIM ACTA, V424, P90, DOI 10.1016/j.cca.2013.05.014; Shortliffe LMD, 2002, AM J MED, V113, p55S; Steinhauser S, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0196-1; Stevenson M, 2021, CRAN REPOSITORY	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0277340	10.1371/journal.pone.0277340	http://dx.doi.org/10.1371/journal.pone.0277340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346782	gold, Green Published			2022-12-26	WOS:000894053200022
J	Andres, F; Hannan, NJ; Walker, SP; MacDonald, TM; Wong, GRP; Murphy, C; Cannon, P; Kandel, M; Masci, J; Nguyen, TV; Abboud, A; Idzes, D; Kyritsis, V; Pritchard, N; Tong, SP; Kaituu-Lino, TJ				Andres, Faith; Hannan, Natalie J.; Walker, Susan P.; MacDonald, Teresa M.; Wong, Georgia P.; Murphy, Ciara; Cannon, Ping; Kandel, Manju; Masci, Joshua; Nguyen, Tuong-Vi; Abboud, Alison; Idzes, Danica; Kyritsis, Valerie; Pritchard, Natasha; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha J.			Endothelial protein C receptor is increased in preterm preeclampsia and fetal growth restriction	FASEB JOURNAL			English	Article						EPCR; placenta; preeclampsia; protein C; SGA	HYPERTENSION; COAGULATION; EXPRESSION; EFFICACY; SAFETY; WOMEN; EPCR	Placental dysfunction is the leading cause of both preeclampsia and fetal growth restriction. This study aimed to characterize endothelial protein C receptor (EPCR) in preterm preeclampsia, term preeclampsia, and fetal growth restriction (defined by delivery of a small for gestational age [SGA] infant [<10% birthweight centile]) and examine its regulation in primary syncytiotrophoblast. Placental EPCR mRNA and protein were significantly increased in patients with preterm preeclampsia (<34 weeks gestation) compared to gestation-matched controls (p < .0001). In the plasma, EPCR was also significantly elevated (p = .01) in established preterm preeclampsia while its substrate, protein C (PC) was significantly reduced (p = .0083). Placentas from preterm small for gestational age (SGA) cases, had elevated EPCR mRNA expression (p < .0001) relative to controls. At 36 weeks, no significant changes in plasma EPCR were detected in samples from patients destined to develop preeclampsia or deliver an SGA infant at term. In terms of syncytiotrophoblast, hypoxia significantly increased EPCR mRNA expression (p = .008), but Tumor Necrosis Factor Alpha (TNF-alpha) decreased EPCR mRNA. Interleukin-6 (IL-6) had no significant effect on EPCR mRNA expression. When isolated syncytiotrophoblast was treated with metformin under hypoxia (1% O-2) or normoxia (8% O-2), EPCR mRNA expression was significantly reduced (p = .008) relative to control. In conclusion, EPCR is markedly elevated in the placenta and the circulation of patients with established preterm preeclampsia and placental increases may be associated with hypoxia. Additionally, fetal growth-restricted pregnancies (as defined by the delivery of an SGA infant) also demonstrated elevated placental EPCR.	[Andres, Faith; Walker, Susan P.; MacDonald, Teresa M.; Wong, Georgia P.; Murphy, Ciara; Cannon, Ping; Kandel, Manju; Masci, Joshua; Nguyen, Tuong-Vi; Pritchard, Natasha; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha J.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia; [Andres, Faith; Hannan, Natalie J.; Walker, Susan P.; MacDonald, Teresa M.; Wong, Georgia P.; Murphy, Ciara; Cannon, Ping; Kandel, Manju; Masci, Joshua; Nguyen, Tuong-Vi; Abboud, Alison; Idzes, Danica; Kyritsis, Valerie; Pritchard, Natasha; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha J.] Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia; [Hannan, Natalie J.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Therapeut Discovery & Vasc Funct Grp, Heidelberg, Vic, Australia	University of Melbourne; University of Melbourne	Kaituu-Lino, TJ (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, 163 Studley Rd, Heidelberg, Vic 3084, Australia.	t.klino@unimelb.edu.au			National Health and Medical Research Council;  [1183854];  [1160711];  [2000732];  [1159261];  [1146128];  [1136418]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ; ; ; ; ; 	National Health and Medical Research Council, Grant/Award Number: 1183854, 1160711, 2000732, 1159261, 1146128 and 1136418	[Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; Aouache R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051496; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Cluver C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025809; Cluver CA, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2103; de Alwis N, 2020, PLACENTA, V102, P10, DOI 10.1016/j.placenta.2020.08.022; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kaitu'u-Lino TJ, 2014, PREGNANCY HYPERTENS, V4, P287, DOI 10.1016/j.preghy.2014.09.003; Lamarca B, 2010, Minerva Ginecol, V62, P105; LaMarca BBD, 2005, HYPERTENSION, V46, P1022, DOI 10.1161/01.HYP.0000175476.26719.36; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; Nardozza LMM, 2017, ARCH GYNECOL OBSTET, V295, P1061, DOI 10.1007/s00404-017-4341-9; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McCarthy FP, 2018, PREGNANCY HYPERTENS, V14, P72, DOI 10.1016/j.preghy.2018.03.010; Moser G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225639; Murphy CN, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147467; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Phillips JK, 2010, J MATERN-FETAL NEO M, V23, P622, DOI 10.3109/14767050903258746; Phipps EA, 2019, NAT REV NEPHROL, V15, P275, DOI 10.1038/s41581-019-0119-6; Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rousseau A, 2009, EUR J OBSTET GYN R B, V146, P46, DOI 10.1016/j.ejogrb.2009.06.001; Saposnik B, 2012, THROMB RES, V129, P152, DOI 10.1016/j.thromres.2011.07.023; Shamshirsaz AA, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/374047; Simcox LE, 2015, INT J MOL SCI, V16, P28418, DOI 10.3390/ijms161226104; Sood R, 2006, BLOOD, V107, P3173, DOI 10.1182/blood-2005-10-4111; Stevens W, 2017, AM J OBSTET GYNECOL, V217, P237, DOI 10.1016/j.ajog.2017.04.032; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; Tong S, 2022, AM J OBSTET GYNECOL, V226, pS1157, DOI 10.1016/j.ajog.2020.09.014; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; von Dadelszen P, 2018, PREGNANCY HYPERTENS, V13, P121, DOI 10.1016/j.preghy.2018.05.009; Wang H, 2020, J CELL MOL MED, V24, P3370, DOI 10.1111/jcmm.15011; Yan SB, 2001, CHEST, V120, P915, DOI 10.1378/chest.120.3.915	37	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22651	10.1096/fj.202201150R	http://dx.doi.org/10.1096/fj.202201150R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1MY	36394528				2022-12-26	WOS:000887955700001
J	Huddart, S; Geocaniga-Gaviola, DM; Crowder, R; Lim, AR; Lopez, E; Valdez, CL; Berger, CA; Destura, R; Kato-Maeda, M; Cattamanchi, A; Garfin, AMC				Huddart, Sophie; Geocaniga-Gaviola, Donna Mae; Crowder, Rebecca; Lim, Alexander Rupert; Lopez, Evanisa; Valdez, Chelsea Lyn; Berger, Christopher A.; Destura, Raul; Kato-Maeda, Midori; Cattamanchi, Adithya; Garfin, Anna Marie Celina			Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines	PLOS ONE			English	Article								Introduction High levels of treatment adherence are critical for achieving optimal treatment outcomes among patients with tuberculosis (TB), especially for drug-resistant TB (DR TB). Current tools for identifying high-risk non-adherence are insufficient. Here, we apply trajectory analysis to characterize adherence behavior early in DR TB treatment and assess whether these patterns predict treatment outcomes. Methods We conducted a retrospective analysis of Philippines DR TB patients treated between 2013 and 2016. To identify unique patterns of adherence, we performed group-based trajectory modelling on adherence to the first 12 weeks of treatment. We estimated the association of adherence trajectory group with six-month and final treatment outcomes using univariable and multivariable logistic regression. We also estimated and compared the predictive accuracy of adherence trajectory group and a binary adherence threshold for treatment outcomes. Results Of 596 patients, 302 (50.7%) had multidrug resistant TB, 11 (1.8%) extremely drug-resistant (XDR) TB, and 283 (47.5%) pre-XDR TB. We identified three distinct adherence trajectories during the first 12 weeks of treatment: a high adherence group (n = 483), a moderate adherence group (n = 93) and a low adherence group (n = 20). Similar patterns were identified at 4 and 8 weeks. Being in the 12-week moderate or low adherence group was associated with unfavorable six-month (adjusted OR [aOR] 3.42, 95% CI 1.90-6.12) and final (aOR 2.71, 95% 1.73-4.30) treatment outcomes. Adherence trajectory group performed similarly to a binary threshold classification for the prediction of final treatment outcomes (65.9% vs. 65.4% correctly classified), but was more accurate for prediction of six-month treatment outcomes (79.4% vs. 60.0% correctly classified). Conclusions Adherence patterns are strongly predictive of DR TB treatment outcomes. Trajectory-based analyses represent an exciting avenue of research into TB patient adherence behavior seeking to inform interventions which rapidly identify and support patients with high-risk adherence patterns.	[Huddart, Sophie; Crowder, Rebecca; Berger, Christopher A.; Kato-Maeda, Midori; Cattamanchi, Adithya] Univ Calif San Francisco, Ctr TB, San Francisco, CA 94143 USA; [Huddart, Sophie; Crowder, Rebecca; Berger, Christopher A.; Kato-Maeda, Midori; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Geocaniga-Gaviola, Donna Mae; Lim, Alexander Rupert; Lopez, Evanisa; Valdez, Chelsea Lyn; Garfin, Anna Marie Celina] Dis Prevent & Control Bur, Dept Hlth, Manila, Philippines; [Destura, Raul] Univ Philippines, Natl Inst Hlth, Manila, Philippines	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Philippine Department Health; University of the Philippines System; University of the Philippines Manila	Huddart, S (corresponding author), Univ Calif San Francisco, Ctr TB, San Francisco, CA 94143 USA.; Huddart, S (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	sophie.huddart@ucsf.edu	; Huddart, Sophie/AAF-8844-2020	Cattamanchi, Adithya/0000-0002-6553-2601; Berger, Christopher A./0000-0002-0034-7544; Huddart, Sophie/0000-0001-6425-3371; Valdez, Chelsea Lyn/0000-0002-8390-7083	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [R01AI121144]; National Heart, Lung, and Blood Institute (NHLBI) of the NIH [5K12HL138046-04]; University of California San Francisco (UCSF) Nina Ireland Program for Lung Health; NIH/NIAID [R25AI147375]; Canadian Institute of Health Research Postdoctoral Fellowship; UCSF Division of Pulmonary and Critical Medicine T32 Fellowship; UCSF Center for Tuberculosis	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute (NHLBI) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of California San Francisco (UCSF) Nina Ireland Program for Lung Health; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institute of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); UCSF Division of Pulmonary and Critical Medicine T32 Fellowship; UCSF Center for Tuberculosis	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Number R01AI121144 (AC, MKM), the National Heart, Lung, and Blood Institute (NHLBI) of the NIH under Award Number 5K12HL138046-04 (CB), the University of California San Francisco (UCSF) Nina Ireland Program for Lung Health (CB), the UCSF Center for Tuberculosis and NIH/NIAID under Award Number R25AI147375 (SH), a Canadian Institute of Health Research Postdoctoral Fellowship (SH) and a UCSF Division of Pulmonary and Critical Medicine T32 Fellowship (SH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Berger C., 2022, PATIENT FACTORS ASS; De Geest S, 2018, ANN INTERN MED, V169, P30, DOI 10.7326/M18-0543; Elmer J, 2016, NEUROCRIT CARE, V25, P415, DOI 10.1007/s12028-016-0263-9; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Imperial MZ, 2018, NAT MED, V24, P1708, DOI 10.1038/s41591-018-0224-2; Liu Q, 2021, AM J RESP CRIT CARE, V204, P347, DOI 10.1164/rccm.202007-2634OC; Nagin DS, 2014, ANN NUTR METAB, V65, P205, DOI 10.1159/000360229; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Salmasi S, 2021, J AM COLL CARDIOL, V78, P2395, DOI 10.1016/j.jacc.2021.09.1370; Stagg HR, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00315-2020; Subbaraman R., 2021, OPEN FORUM INFECT DI, P8, DOI [10.1093/ofid/ofab190, DOI 10.1093/OFID/OFAB190]	12	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0277078	10.1371/journal.pone.0277078	http://dx.doi.org/10.1371/journal.pone.0277078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346814	Green Published, Green Submitted, gold			2022-12-26	WOS:000894053200014
J	Akhtar, S; Luqman, M; Awan, MUF; Saba, I; Khan, ZI; Ahmad, K; Muneeb, A; Nadeem, M; Batool, AI; Shahzadi, M; Memona, H; Ahmad Shad, H; Mustafa, G; Zubair, RM				Akhtar, Shahzad; Luqman, Muhammad; Awan, Muhammad Umer Farooq; Saba, Iram; Khan, Zafar Iqbal; Ahmad, Kafeel; Muneeb, Ahmed; Nadeem, Muhammad; Batool, Aima Iram; Shahzadi, Mahpara; Memona, Hafsa; Shad, Hazoor Ahmad; Mustafa, Ghulam; Zubair, Rana Muhammad			Health risk implications of iron in wastewater soil-food crops grown in the vicinity of peri urban areas of the District Sargodha	PLOS ONE			English	Article							HEAVY-METALS; SEWAGE WATER; TOXICITY; PLANTS; ACCUMULATION; VEGETABLES	Irrigation using sewage water can be beneficial, as it can increase the productivity of crops but has negative consequences on crops, soil contamination, and human health. It contains a variety of toxins, such as chemicals and heavy metals, which damage the soil and crops. In this regard, the aim of the research was to assess the potential health hazards of iron (Fe) metal in food crops (leafy and root crops) treated with wastewater (T_1), canal water (T_2), and tube well water (T_3). Water, soil, and edible components of food crops were collected at random from three distinct locations. Fe concentration in samples was estimated using atomic absorption spectrophotometer, following wet digestion method. The Fe concentrations, ranged from 0.408 to 1.03 mg/l in water, 31.55 to 187.47 mgkg(-1) in soil and 4.09 to 32.583 mgkg(-1) in crop samples; which were within permissible limits of the World Health Organization (WHO). There was a positive correlation between soils and crops. The bioconcentration factor, enrichment factor (EF), daily intake of metals (DIM), health risk index (HRI), and target hazard quotient (THQ) all values were <1, except for a pollution load index >1, which indicated soil contamination, but there was no Fe toxicity in crops, no health risk, and no-carcinogenic risk for these food crops in humans. To prevent the excessive accumulation of Fe metal in the food chain, regular monitoring is needed.	[Akhtar, Shahzad; Khan, Zafar Iqbal; Ahmad, Kafeel; Mustafa, Ghulam; Zubair, Rana Muhammad] Univ Sargodha, Dept Bot, Sargodha, Punjab, Pakistan; [Luqman, Muhammad] Univ Vet & Anim Sci UVAS, Dept Environm Sci, Lahore, Pakistan; [Awan, Muhammad Umer Farooq] GC Univ Lahore, Dept Bot, Lahore, Pakistan; [Saba, Iram] Women Univ Sialkot, Dept Chem, Govt Coll, Sialkot, Pakistan; [Muneeb, Ahmed] Univ Educ, Div Sci & Technol, Dept Bot, Lahore, Pakistan; [Nadeem, Muhammad] Univ Sargodha, Inst Food Sci & Nutr, Sargodha, Pakistan; [Batool, Aima Iram] Univ Sargodha, Dept Zool, Sargodha, Pakistan; [Shahzadi, Mahpara] Ghazi Univ, Dept Plant Breeding & Genet, Dear Ghazi Khan, Pakistan; [Memona, Hafsa] Queen Mary Coll, Dept Zool, Lahore, Pakistan; [Shad, Hazoor Ahmad] Govt Associate Coll Gojra Rd, Dept Chem, Jhang, Punjab, Pakistan	University of Sargodha; University of Veterinary & Animal Science - Pakistan; Government College University Lahore; University of Lahore; University of Sargodha; University of Sargodha	Akhtar, S (corresponding author), Univ Sargodha, Dept Bot, Sargodha, Punjab, Pakistan.	79shahzadrana@gmail.com						Ahmad K, 2016, HUM ECOL RISK ASSESS, V22, P597, DOI 10.1080/10807039.2015.1095630; Akhtar S, 2022, AGR WATER MANAGE, V271, DOI 10.1016/j.agwat.2022.107743; Alghobar MA., 2016, APPL ECOLOGY ENV SCI, V4, P53, DOI DOI 10.12691/aees-4-3-1; Balkhair KS, 2016, SAUDI J BIOL SCI, V23, pS32, DOI 10.1016/j.sjbs.2015.09.023; Barton LL., 2007, IRON NUTR PLANTS RHI; Basit F, 2021, ENVIRON SCI POLLUT R, V28, P44768, DOI 10.1007/s11356-021-15087-8; Becker M, 2005, J PLANT NUTR SOIL SC, V168, P558, DOI 10.1002/jpln.200520504; Brumbarova T, 2015, TRENDS PLANT SCI, V20, P124, DOI 10.1016/j.tplants.2014.11.004; Casiraghi F, 2016, INTERPLAY PHOTORESPI; Channegowda M, 2020, NANOSCALE ADV, V2, P5529, DOI 10.1039/d0na00650e; Chen F, 2022, AGR WATER MANAGE, V272, DOI 10.1016/j.agwat.2022.107833; Chen K., 2021, ESSENTIALS FOOD CHEM, P511; Chien LC, 2002, SCI TOTAL ENVIRON, V285, P177, DOI 10.1016/S0048-9697(01)00916-0; Chiroma T. M., 2014, Journal of Environmental Science & Engineering, V56, P31; Cui YJ, 2004, ENVIRON INT, V30, P785, DOI 10.1016/j.envint.2004.01.003; Curie C, 2017, NEW PHYTOL, V214, P521, DOI 10.1111/nph.14364; Demasi S, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1931-3; Dosumu O., 2005, CENTREPOINT, V13, P23; Ejaz A., 2022, ENVIRON SCI POLLUT R, P1; FAO/WHO. Codex Alimentarius Commission, 2001, WHO FOOD STANDARDS P, V1, P1; Frieden E, 1974, Adv Exp Med Biol, V48, P1; Ghori NH, 2019, INT J ENVIRON SCI TE, V16, P1807, DOI 10.1007/s13762-019-02215-8; Ghosh M., 2005, Applied Ecology and Environmental Research, V3, P67; Hadif WM, 2015, AIP CONF PROC, V1678, DOI 10.1063/1.4931221; Hanke GT., 2021, CYANOBACTERIA BIOTEC, P33; Horn PJ, 2021, PHYTOCHEM REV, V20, P367, DOI 10.1007/s11101-020-09738-w; Izah SC., 2017, BIOSCIENCE METHODS, V8; Jennings S, 2016, FISH FISH, V17, P893, DOI 10.1111/faf.12152; Jorfi S, 2017, DATA BRIEF, V15, P584, DOI 10.1016/j.dib.2017.10.017; Kafeel Ahmad, 2018, Biologia (Pakistan), V64, P15; Karthika K., 2018, PLANT NUTR ABIOTIC S, P1, DOI DOI 10.1007/978-981-10-9044-8_1; Kasowska D, 2018, ENVIRON SCI POLLUT R, V25, P824, DOI 10.1007/s11356-017-0451-y; Khan ZI, 2019, ENVIRON SCI POLLUT R, V26, P14277, DOI 10.1007/s11356-019-04721-1; Khan ZI, 2017, FRESEN ENVIRON BULL, V26, P223; Khan ZI, 2017, ENVIRON SCI POLLUT R, V24, P947, DOI 10.1007/s11356-016-7865-9; Khan ZI, 2016, PAK J BOT, V48, P535; Khan ZI, 2016, HUM ECOL RISK ASSESS, V22, P302, DOI 10.1080/10807039.2015.1052959; Khan Z, 2022, ENVIRON DEV SUSTAIN, DOI 10.1007/s10668-022-02727-3; Kolodziejczak-Radzimska A, 2014, MATERIALS, V7, P2833, DOI 10.3390/ma7042833; Krohling CA, 2016, SOIL SCI PLANT NUTR, V62, P39, DOI 10.1080/00380768.2015.1123116; Ma L., 2021, ESSENTIALS FOOD CHEM, P433; Maqsood A, 2022, ENVIRON SCI POLLUT R, V29, P21634, DOI 10.1007/s11356-021-17264-1; McCauley A., 2009, NUTR MANAGEMENT MODU, V9, P1, DOI DOI 10.1155/2015/756120; Moloantoa KM, 2015, BIOGEOCHEMICAL KINET; Natasha, 2020, ENVIRON GEOCHEM HLTH, DOI 10.1007/s10653-020-00702-3; Naveedullah, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/590306; Netty S., 2013, IOSR J ENG, V3, P1, DOI DOI 10.9790/3021-03510106; Odetola L, 2021, J EXPO SCI ENV EPID, V31, P972, DOI 10.1038/s41370-021-00352-2; Ofori S, 2021, SCI TOTAL ENVIRON, V760, DOI 10.1016/j.scitotenv.2020.144026; Ololade I. A., 2014, Journal of Environmental Protection, V5, P970, DOI 10.4236/jep.2014.511098; Osman KT., 2013, SOILS, P129, DOI [10.1007/978-94-007-5663-2_10, DOI 10.1007/978-94-007-5663-2_10]; Owliaie H., 2016, J ADV AGR ENV ENG, V3, P2349; Parashar P, 2013, STUDY HEAVY METAL AC; Qadir M, 2010, AGR WATER MANAGE, V97, P561, DOI 10.1016/j.agwat.2008.11.004; Radzki W, 2013, ANTON LEEUW INT J G, V104, P321, DOI 10.1007/s10482-013-9954-9; Ravisankar Tadiboyina, 2016, International Journal of Environmental & Science Education, V11, P3215; Regan EN, 2009, NURSE PRACT, V34, P25, DOI 10.1097/01.NPR.0000352285.81981.d5; Rhue R, 1983, ANAL PROCEDURES USED; Rout G.R., 2015, REV AGR SCI, V3, P1, DOI [10.7831/ras.3.1, DOI 10.7831/RAS.3.1]; Roy RN., 2006, GUIDE INTEGRATED NUT, V16, P368, DOI DOI 10.1017/S0014479706394537; Sajjad Khan, 2009, World Applied Sciences Journal, V6, P1602; Sanaei F, 2021, ENVIRON SCI POLLUT R, V28, P1479, DOI 10.1007/s11356-020-10450-7; Sandeep G., 2019, INT J CHEM STUD, V7, P1612; Sarwar T, 2020, ENVIRON GEOCHEM HLTH, V42, P4281, DOI 10.1007/s10653-019-00358-8; Schroder P, 2019, SCI TOTAL ENVIRON, V678, P146, DOI 10.1016/j.scitotenv.2019.04.212; Serba DD., 2020, GENOMIC DESIGNING CL, P221, DOI DOI 10.1007/978-3-319-93381-8_6; Singh A, 2010, FOOD CHEM TOXICOL, V48, P611, DOI 10.1016/j.fct.2009.11.041; Skalnaya MG., 2018, ESSENTIAL TRACE ELEM, P224; Thomas PJ, 2014, CHEMOSPHERE, V96, P57, DOI 10.1016/j.chemosphere.2013.07.020; Wang D, 2017, CHEM SOC REV, V46, P816, DOI 10.1039/c6cs00629a; WWF, 2007, REP NAT SURF WAT CLA; Xiang MT, 2021, ENVIRON POLLUT, V278, DOI 10.1016/j.envpol.2021.116911; Yap D., 2009, AM EURASIAN J AGR EN, V6, P16; Zaheer IE, 2020, PLANT PHYSIOL BIOCH, V155, P70, DOI 10.1016/j.plaphy.2020.07.034; Zhang WW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230178	76	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0275497	10.1371/journal.pone.0275497	http://dx.doi.org/10.1371/journal.pone.0275497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346788	gold, Green Published			2022-12-26	WOS:000894053200005
J	Huang, YT; Jiang, MY; Hwang, JC				Huang, Yun-Ting; Jiang, Ming-Yan; Hwang, Jyh-Chang			Albumin to prealbumin ratio in peritoneal dialysis patients: Clinical implication and outcome prediction	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SERUM PREALBUMIN; HEMODIALYSIS; MORTALITY; PROTEIN; INFLAMMATION; HYPOKALEMIA; SURVIVAL; MASS	Background Serum prealbumin level is slightly higher, whereas albumin is lower in peritoneal dialysis (PD) than hemodialysis (HD) patients. It is unknown whether albumin to prealbumin ratio (APR) is associated with mortality risk among PD patients. This study aimed to evaluate the clinical implications of APR and its prediction value on long-term outcomes of PD patients. Methods The study population were prevalent PD patients at a tertiary hospital. Based on APR, a total of 220 PD patients were divided into 3 groups: group 1: top tertile, median APR: 121.1; IQR:109.5-131.9 (n = 73, male: 37%; age: 5913); group 2: middle tertile, median APR: 97.1; IQR 93.5-100.0 (n = 73, male:37%; age: 5414), and group3: bottom tertile, median APR: 81.3; IQR:76.8-85.0 (n = 74, male:38%; 54 +/- 11). Patients were followed up for a maximum of 5 years. Outcome of interest was all-cause mortality. Results Group 1 was characterized by older age, higher prevalence of diabetes, lower nPCR, higher Davies score and hs-CRP level. APR positively correlated to hs-CRP (beta = 0.149, p = 0.045), but negatively correlated to nPCR (beta = -0.161, p = 0.034). Hyperprealbuminemia, accounting for 0%, 23.3%, and 82.4% in groups 1,2, and 3, was associated with a lower risk for mortality (HR:0.41, 95%CI = 0.23-0.73). The cumulative survival is significantly lower in group 1 than the other two groups. By multivariable Cox regression, APR (HR:1.02; 95%CI:1.01-1.03) was found to be an independent predictor of long-term mortality. Conclusion PD patients with high APR are characterized by having more comorbidities and marked malnutrition-inflammation status, and are associated with long-term mortality, whereas hyperprealbuminemia and lower APR are favorable prognostic factors.	[Huang, Yun-Ting; Jiang, Ming-Yan; Hwang, Jyh-Chang] Chi Mei Med Ctr, Div Nephrol, Tainan, Taiwan; [Jiang, Ming-Yan] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Hwang, JC (corresponding author), Chi Mei Med Ctr, Div Nephrol, Tainan, Taiwan.	alfonjch@gmail.com		Jiang, Ming-Yan/0000-0002-9817-3131				Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Beck FK, 2002, AM FAM PHYSICIAN, V65, P1575; Cano NJM, 2002, CLIN CHEM LAB MED, V40, P1313, DOI 10.1515/CCLM.2002.226; Chertow GM, 2005, KIDNEY INT, V68, P2794, DOI 10.1111/j.1523-1755.2005.00751.x; Cueto-Manzano AM, 2000, KIDNEY INT, V57, P314, DOI 10.1046/j.1523-1755.2000.00817.x; Davies SJ, 2002, NEPHROL DIAL TRANSPL, V17, P1085, DOI 10.1093/ndt/17.6.1085; Davis CJ, 2012, JPEN-PARENTER ENTER, V36, P197, DOI 10.1177/0148607111413896; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Fein PA, 2003, KIDNEY INT, V64, pS87, DOI 10.1046/j.1523-1755.64.s87.13.x; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Goldwasser P, 2002, KIDNEY INT, V62, P276, DOI 10.1046/j.1523-1755.2002.00415.x; Hao N, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1433-8; Heimburger O, 2000, AM J KIDNEY DIS, V36, P1213, DOI 10.1053/ajkd.2000.19837; Hwang JC, 2011, BLOOD PURIFICAT, V32, P254, DOI 10.1159/000325226; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Keshaviah P R, 1991, ASAIO Trans, V37, pM400; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Lee KH, 2016, KIDNEY RES CLIN PRAC, V35, P169, DOI 10.1016/j.krcp.2016.06.002; Maraj M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010069; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Rambod M, 2008, AM J CLIN NUTR, V88, P1485, DOI 10.3945/ajcn.2008.25906; Shinaberger CS, 2006, AM J KIDNEY DIS, V48, P37, DOI 10.1053/j.ajkd.2006.03.049; Steiber A, 2007, J RENAL NUTR, V17, P336, DOI 10.1053/j.jrn.2007.05.004; Szeto CC, 2005, AM J KIDNEY DIS, V46, P128, DOI 10.1053/j.ajkd.2005.03.015	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0276159	10.1371/journal.pone.0276159	http://dx.doi.org/10.1371/journal.pone.0276159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346823	Green Published, gold			2022-12-26	WOS:000894053200007
J	Jessen, MT; Auge, H; Harpole, WS; Hautier, Y; Eskelinen, A				Jessen, Maria-Theresa; Auge, Harald; Harpole, W. Stan; Hautier, Yann; Eskelinen, Anu			Grazing and light modify Silene latifolia responses to nutrients and future climate	PLOS ONE			English	Article							PLANT COMMUNITY RESPONSES; NITROGEN DEPOSITION; SPECIES RICHNESS; ALPINE GRASSLAND; EUROPEAN CLIMATE; EXTREME DROUGHT; TRAITS; PERFORMANCE; HERBIVORY; MODEL	Altered climate, nutrient enrichment and changes in grazing patterns are important environmental and biotic changes in temperate grassland systems. Singly and in concert these factors can influence plant performance and traits, with consequences for species competitive ability, and thus for species coexistence, community composition and diversity. However, we lack experimental tests of the mechanisms, such as competition for light, driving plant performance and traits under nutrient enrichment, grazer exclusion and future climate. We used transplants of Silene latifolia, a widespread grassland forb in Europe, to study plant responses to interactions among climate, nutrients, grazing and light. We recorded transplant biomass, height, specific leaf area (SLA) and foliar carbon to nitrogen ratio (C:N) in full-factorial combinations of future climate treatment, fertilization, grazer exclusion and light addition via LED-lamps. Future climate and fertilization together increased transplant height but only in unlighted plots. Light addition increased SLA in ambient climate, and decreased C:N in unfertilized plots. Further, transplants had higher biomass in future climatic conditions when protected from grazers. In general, grazing had a strong negative effect on all measured variables regardless of added nutrients and light. Our results show that competition for light may lead to taller individuals and interacts with climate and nutrients to affect traits related to resource-use. Furthermore, our study suggests grazing may counteract the benefits of future climate on the biomass of species such as Silene latifolia. Consequently, grazers and light may be important modulators of individual plant performance and traits under nutrient enrichment and future climatic conditions.	[Jessen, Maria-Theresa; Auge, Harald; Harpole, W. Stan; Eskelinen, Anu] iDiv Halle Jena Leipzig, German Ctr Integrat Biodivers Res, Leipzig, Germany; [Jessen, Maria-Theresa; Auge, Harald] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Jessen, Maria-Theresa; Harpole, W. Stan; Eskelinen, Anu] UFZ Helmholtz Ctr Environm Res, Dept Physiol Div, Leipzig, Germany; [Harpole, W. Stan] Martin Luther Univ Halle Wittenberg, Halle, Germany; [Hautier, Yann] Univ Utrecht, Dept Biol, Ecol & Biodivers Grp, Utrecht, Netherlands; [Eskelinen, Anu] Univ Oulu, Dept Ecol & Genet, Oulu, Finland	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg; Utrecht University; University of Oulu	Jessen, MT (corresponding author), iDiv Halle Jena Leipzig, German Ctr Integrat Biodivers Res, Leipzig, Germany.; Jessen, MT (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.; Jessen, MT (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Physiol Div, Leipzig, Germany.	maria-theresa.jessen@ufz.de	; Auge, Harald/D-4802-2015	Jessen, Maria-Theresa/0000-0002-5238-7118; Auge, Harald/0000-0001-7432-8453	Flexpool program of the German Centre for Integrative Biodiversity Research (iDiv)-Halle, Jena, Leipzig [34600565-11]; Finnish Academy [29719]	Flexpool program of the German Centre for Integrative Biodiversity Research (iDiv)-Halle, Jena, Leipzig; Finnish Academy(Academy of Finland)	This work was supported by the Flexpool program of the German Centre for Integrative Biodiversity Research (iDiv)-Halle, Jena, Leipzig [grant no. 34600565-11] and by a research grant from the Finnish Academy to A.E. [project 29719].	Altermann M, 2005, J PLANT NUTR SOIL SC, V168, P725, DOI 10.1002/jpln.200521814; Anten NPR, 2009, AM NAT, V173, P241, DOI 10.1086/595761; Barton KE, 2013, ANN BOT-LONDON, V112, P643, DOI 10.1093/aob/mct139; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Bjorkman AD, 2018, NATURE, V562, P57, DOI 10.1038/s41586-018-0563-7; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; Blondeel H, 2020, PLANT BIOLOGY, V22, P601, DOI 10.1111/plb.13103; Borer ET, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19870-y; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; Boutin M, 2017, J ECOL, V105, P1199, DOI 10.1111/1365-2745.12743; Breitschwerdt E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27017-9; Buras A, 2020, BIOGEOSCIENCES, V17, P1655, DOI [10.5194/bg-17-1655-2020, 10.5194/bg-17-1655-2020,2020]; Chollet S, 2014, ECOLOGY, V95, P737, DOI 10.1890/13-0751.1; Christensen JH, 2007, CLIMATIC CHANGE, V81, P7, DOI 10.1007/s10584-006-9210-7; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Crawley M.J., 2007, R BOOK; De Boeck HJ, 2016, NEW PHYTOL, V209, P531, DOI 10.1111/nph.13601; Delph LF, 2002, J EVOLUTION BIOL, V15, P1011, DOI 10.1046/j.1420-9101.2002.00467.x; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Dotterl S, 2006, NEW PHYTOL, V169, P707, DOI 10.1111/j.1469-8137.2005.01509.x; Ehrlen J, 1997, OIKOS, V80, P428, DOI 10.2307/3546615; Eskelinen A, 2008, J ECOL, V96, P155, DOI 10.1111/j.1365-2745.2007.01322.x; Eskelinen A, 2006, J VEG SCI, V17, P245, DOI 10.1111/j.1654-1103.2006.tb02443.x; Eskelinen A, 2017, GLOBAL CHANGE BIOL, V23, P245, DOI 10.1111/gcb.13397; Eskelinen A, 2015, P NATL ACAD SCI USA, V112, P13009, DOI 10.1073/pnas.1508170112; Evju M, 2009, OECOLOGIA, V161, P77, DOI 10.1007/s00442-009-1358-1; Favre A, 2011, J ECOL, V99, P1415, DOI 10.1111/j.1365-2745.2011.01865.x; Fox J., 2018, R COMPANION APPL REG, VThird; Frei ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098677; Fridley JD, 2016, NAT CLIM CHANGE, V6, P865, DOI 10.1038/NCLIMATE3032; Funk JL, 2021, ECOLOGY, V102, DOI 10.1002/ecy.3318; Gibson D, 2019, ECOL REV, pXIII; Goldberg DE, 2017, AM NAT, V190, P229, DOI 10.1086/692438; Gossner MM, 2016, NATURE, V540, P266, DOI 10.1038/nature20575; Gough L, 2007, OIKOS, V116, P407, DOI 10.1111/j.0030-1299.2007.15449.x; Hamann E, 2021, NEW PHYTOL, V229, P1894, DOI 10.1111/nph.17036; Hari V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68872-9; Harrison PA, 2019, REG ENVIRON CHANGE, V19, P695, DOI 10.1007/s10113-018-1352-4; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; Herz K, 2017, ECOL EVOL, V7, P8958, DOI 10.1002/ece3.3393; Hickman KR, 2002, PLANT ECOL, V159, P23, DOI 10.1023/A:1015534721939; Jessen MT, 2020, GLOBAL CHANGE BIOL, V26, P6742, DOI 10.1111/gcb.15378; Jung V, 2014, J ECOL, V102, P45, DOI 10.1111/1365-2745.12177; Kaarlejarvi E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00554-z; Kaarlejarvi E, 2013, FUNCT ECOL, V27, P1244, DOI 10.1111/1365-2435.12113; Kafle D, 2019, J ECOL, V107, P58, DOI 10.1111/1365-2745.13038; Kahl SM, 2019, J ECOL, V107, P1918, DOI 10.1111/1365-2745.13133; Keddy P, 2002, J VEG SCI, V13, P5, DOI 10.1111/j.1654-1103.2002.tb02018.x; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Koch P., 2020, BEITR GE JAGDUND WIL, P45; Komatsu KJ, 2019, P NATL ACAD SCI USA, V116, P17867, DOI 10.1073/pnas.1819027116; Landesamt fur Landwirtschaft Umwelt und landliche Raume des Landes Schleswig-Holstein (LLUR)., 2010, SCHRIFTENREIHE LANDE, V18, P1; Lang B, 2020, ECOL EVOL, V10, P678, DOI 10.1002/ece3.5895; Le Bagousse-Pinguet Y, 2017, J ECOL, V105, P1058, DOI 10.1111/1365-2745.12735; Lennartsson T, 1998, ECOLOGY, V79, P1061, DOI 10.1890/0012-9658(1998)079[1061:IOOITF]2.0.CO;2; Liancourt P, 2015, GLOBAL CHANGE BIOL, V21, P3489, DOI 10.1111/gcb.12934; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Manning P, 2019, SCIENCE, V366, P801, DOI 10.1126/science.aaz9000; MARTEN GC, 1987, AGRON J, V79, P980, DOI 10.2134/agronj1987.00021962007900060006x; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Moles AT, 2004, OIKOS, V106, P193, DOI 10.1111/j.0030-1299.2004.13101.x; Olofsson J, 2009, GLOBAL CHANGE BIOL, V15, P2681, DOI 10.1111/j.1365-2486.2009.01935.x; Osem Y, 2004, J ECOL, V92, P297, DOI 10.1111/j.0022-0477.2004.00859.x; Pedersen T.L, 2018, GGRAPH IMPLEMENTATIO; Penner JF, 2021, OECOLOGIA, V196, P851, DOI 10.1007/s00442-021-04960-5; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poirier M, 2012, GLOBAL CHANGE BIOL, V18, P3632, DOI 10.1111/j.1365-2486.2012.02800.x; Poorter H, 2019, NEW PHYTOL, V223, P1073, DOI 10.1111/nph.15754; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Rozendaal DMA, 2006, FUNCT ECOL, V20, P207, DOI 10.1111/j.1365-2435.2006.01105.x; Schadler M, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2635; Schroeder-Georgi T, 2016, J ECOL, V104, P206, DOI 10.1111/1365-2745.12489; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Siebenkas A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv029; Siefert A, 2016, OECOLOGIA, V181, P245, DOI 10.1007/s00442-016-3563-z; Speed JDM, 2010, ECOLOGY, V91, P3414, DOI 10.1890/09-2300.1; Stevens CJ, 2015, ECOLOGY, V96, P1459, DOI 10.1890/14-1902.1; Stocker T. F., 2013, CLIMATE CHANGE 2013; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tatarko AR, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2087; Team R. R, 2020, R LANG ENV STAT COMP; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2016, PLANT ECOL DIVERS, V9, P237, DOI 10.1080/17550874.2016.1210262; Van Der Wal R, 2000, J ECOL, V88, P317, DOI 10.1046/j.1365-2745.2000.00450.x; Weisshuhn K, 2011, BASIC APPL ECOL, V12, P21, DOI 10.1016/j.baae.2010.11.005; Wellstein C, 2017, GLOBAL CHANGE BIOL, V23, P2473, DOI 10.1111/gcb.13662; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wilfahrt PA, 2020, J ECOL, V108, P2352, DOI 10.1111/1365-2745.13396; Wolfe LM, 2002, AM NAT, V160, P705, DOI 10.1086/343872; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100	101	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0276789	10.1371/journal.pone.0276789	http://dx.doi.org/10.1371/journal.pone.0276789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346799	gold, Green Published			2022-12-26	WOS:000894053200010
J	Kong, FT; Lu, MT; Dong, J; Wang, DH; Shi, JY; Li, ZH				Kong, Fantu; Lu, Meiting; Dong, Jie; Wang, Donghui; Shi, Junyue; Li, Zhenghuan			Effect of linear accelerator carbon fiber couch on radiotherapy dose	PLOS ONE			English	Article							REGION; TOP	This study aimed to explore the effect of carbon fiber couch on radiotherapy dose attenuation and gamma pass rate in intensity-modulated radiotherapy (IMRT) plans. A phantom inserted with an ionization chamber was placed at different positions of the couch, and the dose was measured by the chamber. Under the same positioning, the phantom dose was calculated using the real and virtual couch images, and the difference in the planned dose of radiotherapy was compared. Ten clinical IMRT plans were selected as dose verification data, and the gamma pass rates were compared between couch addition and non-addition conditions. When the radiation field was near 110 degrees and 250 degrees, the measured value attenuation coefficient of the ionization chamber at the joint of the couch was up to 34%; the attenuation coefficient of the treatment couch from the actual couch image calculated using the treatment planning system (TPS) was up to 33%; the attenuation coefficient of the virtual couch calculated using the TPS was up to 4.0%. The gamma pass rate of the dose verification near gantry angles 110 degrees and 250 degrees was low, and that of the joint could be lower than 85% under the condition of 3%/3 mm. The gamma pass rates of the radiation field passing through the couch were all affected. The dose was affected by the radiation field passing through the couch, with the largest effect when passing through the joint part of the treatment couch, followed by that of the main couch plate and extension plate. When the irradiation field passed through the joint and near 110 degrees and 250 degrees of the main couch, the dose difference was large, making it unsuitable for treatment.	[Kong, Fantu; Lu, Meiting; Dong, Jie; Wang, Donghui; Li, Zhenghuan] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China; [Shi, Junyue] Foresea Life Insurance Guangzhou Gen Hosp, Guangzhou, Peoples R China; [Shi, Junyue] China Inst Atom Energy, Beijing, Peoples R China	Sun Yat Sen University; China Institute of Atomic Energy	Li, ZH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China.; Shi, JY (corresponding author), Foresea Life Insurance Guangzhou Gen Hosp, Guangzhou, Peoples R China.; Shi, JY (corresponding author), China Inst Atom Energy, Beijing, Peoples R China.	shijunyue@aliyun.com; huanliz2819@163.com		Kong, Fantu/0000-0003-3649-6194	Postdoctoral research foundation of china [2019M6632]	Postdoctoral research foundation of china(China Postdoctoral Science Foundation)	Postdoctoral research foundation of china, Award Number: No.2019M6632, Recipient: Donghui Wang.	[Anonymous], 2013, RAD ONCOLOGY ACCESSO, P27; [Anonymous], 1976, 24 ICRU; [曹婷婷 Cao Tingting], 2018, [中国医学物理学杂志, Chinese Journal of Medical Physics], V35, P14; Dingyu L., 2016, RADIOL PRACT, V31, P662; Feiyue S., 2016, CHINA MED DEVICES, V31, P108, DOI [10.3760/cma.j.issn.1004-4221.2016.06.016, DOI 10.3760/CMA.J.ISSN.1004-4221.2016.06.016]; Fraass B, 1998, MED PHYS, V25, P1773, DOI 10.1118/1.598373; Hongbo G., 2018, CHIN J CANC PREV TRE, V25, P1376, DOI [10.16073/j.cnki.cjcpt, DOI 10.16073/J.CNKI.CJCPT]; Liangying W., 2017, CHIN J MED DEV, V23, P1; Njeh CF, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-190; Olch AJ, 2014, MED PHYS, V41, DOI 10.1118/1.4876299; Pulliam KB, 2011, PHYS MED BIOL, V56, P7435, DOI 10.1088/0031-9155/56/23/007; Sheykhoo A, 2017, REP PRACT ONCOL RADI, V22, P19, DOI 10.1016/j.rpor.2016.09.001; [时颖华 Shi Yinghua], 2019, [中国医学物理学杂志, Chinese Journal of Medical Physics], V36, P867; Shuting C., 2018, CHIN J MED DEV, V31, P41; Smith DW, 2010, MED PHYS, V37, P3595, DOI 10.1118/1.3451114; [宋洪兵 Song Hongbing], 2021, [中国医学物理学杂志, Chinese Journal of Medical Physics], V38, P157; Tugrul T, 2018, REP PRACT ONCOL RADI, V23, P1, DOI 10.1016/j.rpor.2017.10.004; [尹朝晟 Yin Zhaosheng], 2016, [中国医学物理学杂志, Chinese Journal of Medical Physics], V33, P770; [张若辉 Zhang Ruohui], 2016, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V25, P618	19	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0277332	10.1371/journal.pone.0277332	http://dx.doi.org/10.1371/journal.pone.0277332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346802	Green Published, gold			2022-12-26	WOS:000894053200021
J	Li, M; Tsavachidis, S; Wang, FCC; Bui, TY; Nguyen, TDT; Luo, LJ; Multani, AS; Bondy, ML; Hunt, KK; Keyomarsi, K				Li, Mi; Tsavachidis, Spiridon; Wang, Fuchenchu; Bui, Tuyen; Tuyen Duong Thanh Nguyen; Luo, Linjie; Multani, Asha S.; Bondy, Melissa L.; Hunt, Kelly K.; Keyomarsi, Khandan			Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer	ONCOGENE			English	Article; Early Access							HUMAN-CELLS; COMBINATION; SUBTYPES; ORIGINS; GROWTH	Low-molecular-weight cyclin E (LMW-E) is an N-terminus deleted (40 amino acid) form of cyclin E detected in breast cancer, but not in normal cells or tissues. LMW-E overexpression predicts poor survival in breast cancer patients independent of tumor proliferation rate, but the oncogenic mechanism of LMW-E and its unique function(s) independent of full-length cyclin E (FL-cycE) remain unclear. In the current study, we found LMW-E was associated with genomic instability in early-stage breast tumors (n = 725) and promoted genomic instability in human mammary epithelial cells (hMECs). Mechanistically, FL-cycE overexpression inhibited the proliferation of hMECs by replication stress and DNA damage accumulation, but LMW-E facilitated replication stress tolerance by upregulating DNA replication and damage repair. Specifically, LMW-E interacted with chromatin and upregulated the loading of minichromosome maintenance complex proteins (MCMs) in a CDC6 dependent manner and promoted DNA repair in a RAD51- and Cl 7orf53-dependent manner. Targeting the ATR-CHK1-RAD51 pathway with ATR inhibitor (ceralasertib), CHK1 inhibitor (rabusertib), or RAD51 inhibitor (B02) significantly decreased the viability of LMW-E-overexpressing hMECs and breast cancer cells. Collectively, our findings delineate a novel role for LMW-E in tumorigenesis mediated by replication stress tolerance and genomic instability, providing novel therapeutic strategies for LMW-E-overexpressing breast cancers.	[Li, Mi; Keyomarsi, Khandan] Univ Texas MD Anderson Canc Ctr UTHlth Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Li, Mi; Bui, Tuyen; Tuyen Duong Thanh Nguyen; Luo, Linjie; Keyomarsi, Khandan] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Tsavachidis, Spiridon] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Wang, Fuchenchu] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Multani, Asha S.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Bondy, Melissa L.] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA; [Hunt, Kelly K.] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Stanford University; University of Texas System; UTMD Anderson Cancer Center	Keyomarsi, K (corresponding author), Univ Texas MD Anderson Canc Ctr UTHlth Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA.; Keyomarsi, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	kkeyomar@mdanderson.org	; Keyomarsi, Khandan/H-2716-2016	Li, Mi/0000-0002-6038-4144; Keyomarsi, Khandan/0000-0002-5440-0849; Hunt, Kelly K./0000-0001-9156-8723	Cancer Prevention Research Institute of Texas - Multi-Investigator Research Award (CPRIT-MIRA) [RP180712]; National Cancer Institute (NCI) [R01CA223772, R01CA255960]; CPRIT Research Training Program [RP170067, RP210028]; NCI through MD Anderson's Cancer Center Support Grant [P30CA016672]	Cancer Prevention Research Institute of Texas - Multi-Investigator Research Award (CPRIT-MIRA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CPRIT Research Training Program; NCI through MD Anderson's Cancer Center Support Grant	Research reported in this manuscript was supported by Cancer Prevention Research Institute of Texas - Multi-Investigator Research Award (CPRIT-MIRA #RP180712) to KK and KKH, by the National Cancer Institute (NCI) R01CA223772 and R01CA255960 to KK, CPRIT Research Training Program grant RP170067 and RP210028 to ML and by the NCI through MD Anderson's Cancer Center Support Grant (P30CA016672).	Akli S, 2004, CANCER RES, V64, P3198, DOI 10.1158/0008-5472.CAN-03-3672; Akli S, 2007, CANCER RES, V67, P7212, DOI 10.1158/0008-5472.CAN-07-0599; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; Bianchini G, 2022, NAT REV CLIN ONCOL, V19, P91, DOI 10.1038/s41571-021-00565-2; Bonnet F, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-54; Carey JPW, 2018, CANCER RES, V78, P742, DOI 10.1158/0008-5472.CAN-17-1494; Caruso JA, 2018, CANCER RES, V78, P5481, DOI 10.1158/0008-5472.CAN-18-1235; Caruso JA, 2010, CANCER RES, V70, P7125, DOI 10.1158/0008-5472.CAN-10-1547; Chen X, 2018, CLIN CANCER RES, V24, P6594, DOI 10.1158/1078-0432.CCR-18-1446; Chu C, 2021, TRENDS CELL BIOL, V31, P732, DOI 10.1016/j.tcb.2021.05.001; Delk NA, 2009, CANCER RES, V69, P2817, DOI 10.1158/0008-5472.CAN-08-4182; Duong MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002538; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Fagundes R, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.774845; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Gorecki L, 2021, CANCERS, V13, DOI 10.3390/cancers13040795; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Hunt KK, 2017, CLIN CANCER RES, V23, P2991, DOI 10.1158/1078-0432.CCR-16-2217; Jabbour-Leung NA, 2016, MOL CANCER THER, V15, P593, DOI 10.1158/1535-7163.MCT-15-0519; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Kettner NM, 2019, CLIN CANCER RES, V25, P3996, DOI 10.1158/1078-0432.CCR-18-3274; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Kim R, 2022, ANN ONCOL, V33, P193, DOI 10.1016/j.annonc.2021.10.009; Kim ST, 2021, CLIN CANCER RES, V27, P4700, DOI 10.1158/1078-0432.CCR-21-0251; Loibl S, 2021, LANCET, V397, P1750, DOI 10.1016/S0140-6736(20)32381-3; Lu XY, 2009, J BIOL CHEM, V284, P35325, DOI 10.1074/jbc.M109.035949; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Masoud V, 2017, WORLD J CLIN ONCOL, V8, P120, DOI 10.5306/wjco.v8.i2.120; Nanos-Webb A, 2012, BREAST CANCER RES TR, V132, P575, DOI 10.1007/s10549-011-1638-4; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Petropoulos M, 2019, TRENDS BIOCHEM SCI, V44, P752, DOI 10.1016/j.tibs.2019.03.011; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Teixeira LK, 2015, CURR BIOL, V25, P1327, DOI 10.1016/j.cub.2015.03.022; Thompson PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023543; Toledo L, 2017, MOL CELL, V66, P735, DOI 10.1016/j.molcel.2017.05.001; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vijayaraghavan S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15916; Wang C, 2020, DNA REPAIR, V95, DOI 10.1016/j.dnarep.2020.102946; Yap TA, 2021, CLIN CANCER RES, V27, P5213, DOI 10.1158/1078-0432.CCR-21-1032; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099	47	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene												10.1038/s41388-022-02527-z	http://dx.doi.org/10.1038/s41388-022-02527-z		NOV 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5Z0JJ	36344674	Green Accepted			2022-12-26	WOS:000879664600002
J	Hu, HT; Zhang, HQ; Xing, Y; Zhou, Y; Chen, JN; Li, C; Xu, JJ; Guo, YY; Wang, J; He, Q; Liu, XM; Sheng, JZ; Song, EW; Wu, YT; Huang, HF				Hu, Hongtao; Zhang, Hanqiu; Xing, Yue; Zhou, Yan; Chen, Jianing; Li, Cheng; Xu, Jingjing; Guo, Yanyan; Wang, Jie; He, Qi; Liu, Xinmei; Sheng, Jianzhong; Song, Erwei; Wu, Yanting; Huang, Hefeng			The lncRNA THOR interacts with and stabilizes hnRNPD to promote cell proliferation and metastasis in breast cancer	ONCOGENE			English	Article							NONCODING RNAS; MESSENGER-RNA; LINCRNAS	Emerging evidence shows that the lncRNA THOR is deeply involved in the development of various cancers. However, the effects and underlying molecular mechanisms of THOR in breast cancer (BRCA) initiation and progression have not been fully elucidated. Here we show that THOR is critical for BRCA tumorigenesis by interacting with hnRNPD to regulate downstream signaling pathways. THOR expression was significantly higher in BRCA tissues than in normal tissues, and THOR upregulation was associated with a poor prognosis in BRCA patients. Functionally, THOR knockdown impaired cell proliferation, migration and invasion in BRCA cells in vitro and inhibited tumorigenesis and metastasis in a tumor xenograft model and THOR-deficient MMTV-PyMT model in vivo. Mechanistically, THOR bound to the hnRNPD protein and increased hnRNPD protein levels by maintaining hnRNPD protein stability through inhibition of the proteasome-dependent degradation pathway. The increased hnRNPD protein levels led to stabilization of its target mRNAs, including pyruvate dehydrogenase kinase 1 (PDK1), further activating downstream PI3K-AKT and MAPK signaling pathways to regulate BRCA cell proliferation and metastasis. Together, our findings indicate that THOR is a promising prognostic predictor for BRCA patients and that the THOR-hnRNPD-PDK1-MAPK/PI3K-AKT axis might be a potential therapeutic target for BRCA treatment.	[Hu, Hongtao] Nanjing Med Univ, Dept Gynecol, Affiliated Hosp 1, Nanjing, Peoples R China; [Hu, Hongtao; Zhang, Hanqiu; Xu, Jingjing; Guo, Yanyan; Wang, Jie; He, Qi] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai, Peoples R China; [Hu, Hongtao; Zhang, Hanqiu; Li, Cheng; Xu, Jingjing; Liu, Xinmei; Huang, Hefeng] Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China; [Xing, Yue; Zhou, Yan; Chen, Jianing; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China; [Xing, Yue; Zhou, Yan; Chen, Jianing; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Peoples R China; [Li, Cheng; Liu, Xinmei; Wu, Yanting; Huang, Hefeng] Fudan Univ, Obstet & Gynecol Hosp, Inst Reprod & Dev, Shanghai, Peoples R China; [Liu, Xinmei; Huang, Hefeng] Chinese Acad Med Sci, Res Units Embryo Original Dis, Shanghai, Peoples R China; [Sheng, Jianzhong] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; Sun Yat Sen University; Sun Yat Sen University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Zhejiang University	Huang, HF (corresponding author), Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China.; Wu, YT; Huang, HF (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Inst Reprod & Dev, Shanghai, Peoples R China.; Huang, HF (corresponding author), Chinese Acad Med Sci, Res Units Embryo Original Dis, Shanghai, Peoples R China.	yanting_wu@163.com; huanghefg@sjtu.edu.cn		Hu, Hongtao/0000-0003-3704-6646; Xu, Jing-Jing/0000-0002-4496-0228	National Natural Science Foundation of China [82088102, 82171686]; National Key Research and Development Program of China [2021YFC2700701]; Collaborative Innovation Program of Shanghai Municipal Health Commission [2020CXJQ01]; CAMS Innovation Fund for Medical Sciences [2019-I2M-5064]; Clinical Research Plan of SHDC [SHDC2020CR1008A]; Shanghai Municipal Key Clinical Specialty [shslczdzk06302]; Program of Shanghai Academic Research Leader [20XD1424100]; Outstanding Youth Medical Talents of Shanghai Rising Stars of Medical Talent Youth Development Program; Interdisciplinary Program of Shanghai Jiao Tong University [ZH2018QNB15, YG2019GD04, YG2020YQ29]; Youth Talents development Program of Jiangsu Women And Children Health Hospital [FYRC202004]; Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University [PY2021009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Collaborative Innovation Program of Shanghai Municipal Health Commission; CAMS Innovation Fund for Medical Sciences; Clinical Research Plan of SHDC; Shanghai Municipal Key Clinical Specialty; Program of Shanghai Academic Research Leader; Outstanding Youth Medical Talents of Shanghai Rising Stars of Medical Talent Youth Development Program; Interdisciplinary Program of Shanghai Jiao Tong University; Youth Talents development Program of Jiangsu Women And Children Health Hospital; Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (82088102, 82171686), National Key Research and Development Program of China (2021YFC2700701), Collaborative Innovation Program of Shanghai Municipal Health Commission (2020CXJQ01), CAMS Innovation Fund for Medical Sciences (2019-I2M-5064), Clinical Research Plan of SHDC (SHDC2020CR1008A), Shanghai Municipal Key Clinical Specialty (shslczdzk06302), Program of Shanghai Academic Research Leader (20XD1424100), Outstanding Youth Medical Talents of Shanghai Rising Stars of Medical Talent Youth Development Program, and Interdisciplinary Program of Shanghai Jiao Tong University (ZH2018QNB15, YG2019GD04, YG2020YQ29), Youth Talents development Program of Jiangsu Women And Children Health Hospital (FYRC202004), and Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University (PY2021009). The funding agencies had no role in the study design, data collection and analysis, or decision to submit the article for publication.	Abdolahi S, 2022, J TRANSL MED, V20, DOI 10.1186/s12967-022-03405-8; Al-Khalaf HH, 2014, J BIOL CHEM, V289, P31433, DOI 10.1074/jbc.M114.593004; Amelio I, 2021, SEMIN CANCER BIOL, V72, P36, DOI 10.1016/j.semcancer.2020.06.019; Anwar S, 2021, BBA-REV CANCER, V1876, DOI 10.1016/j.bbcan.2021.188568; Bartonicek N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0530-6; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Ding J, 2020, HEPATOLOGY, V72, P1666, DOI 10.1002/hep.31195; Du X, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.681736; Fabbiano F, 2020, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12043; Feng XF, 2018, INT J BIOL SCI, V14, P1630, DOI 10.7150/ijbs.26932; Gagliardi PA, 2018, SEMIN CANCER BIOL, V48, P27, DOI 10.1016/j.semcancer.2017.04.014; Ge J, 2020, J OVARIAN RES, V13, DOI 10.1186/s13048-020-00672-1; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hosono Y, 2017, CELL, V171, P1559, DOI 10.1016/j.cell.2017.11.040; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Jin X, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01210-9; Li J, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1150-y; Liang YR, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01206-5; Lin CR, 2018, TRENDS CELL BIOL, V28, P287, DOI 10.1016/j.tcb.2017.11.008; Liu SJ, 2021, NAT REV CANCER, V21, P446, DOI 10.1038/s41568-021-00353-1; Ma HL, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1123-y; Ma WR, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01150-4; Mattijssen S, 2021, RNA BIOL, V18, P259, DOI 10.1080/15476286.2020.1868753; Moore AE, 2014, WIRES RNA, V5, P549, DOI 10.1002/wrna.1230; Portz B, 2021, TRENDS BIOCHEM SCI, V46, P550, DOI 10.1016/j.tibs.2020.12.005; Qiu HB, 2021, CANCER COMMUN, V41, P1037, DOI 10.1002/cac2.12197; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shang YM, 2018, BIOMED PHARMACOTHER, V106, P1243, DOI 10.1016/j.biopha.2018.07.052; Song H, 2018, BIOMED PHARMACOTHER, V108, P338, DOI 10.1016/j.biopha.2018.09.057; St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007; Statello L, 2021, NAT REV MOL CELL BIO, V22, P96, DOI 10.1038/s41580-020-00315-9; Tsagakis I, 2020, J PATHOL, V250, P480, DOI 10.1002/path.5405; Tsitsipatis D, 2021, NUCLEIC ACIDS RES, V49, P1631, DOI 10.1093/nar/gkaa1246; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang BB, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923507; Wang SS, 2019, CANCER LETT, V443, P13, DOI 10.1016/j.canlet.2018.11.028; Wang Y, 2020, CELL DEATH DIFFER, V27, P695, DOI 10.1038/s41418-019-0381-y; Wang YQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21993-9; Xue J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2093-0; Yang HJ, 2019, BIOCHIMIE, V165, P9, DOI 10.1016/j.biochi.2019.06.012; Yang MH, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0955-9; Yi M, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-021-00310-y; Zhang M, 2019, J CELL PHYSIOL, V234, P6361, DOI 10.1002/jcp.27369; Zheng F., 2021, NAT COMMUN, V12; Zhu YF, 2020, INT J SURG, V84, P3, DOI 10.1016/j.ijsu.2020.10.004	48	0	0	6	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 2	2022	41	49					5298	5314		10.1038/s41388-022-02495-4	http://dx.doi.org/10.1038/s41388-022-02495-4		NOV 2022	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	6R9BX	36329124				2022-12-26	WOS:000878459600002
J	Dang, D; Meng, ZL; Zhang, C; Li, ZY; Wei, JQ; Wu, H				Dang, Dan; Meng, Zhaoli; Zhang, Chuan; Li, Zhenyu; Wei, Jiaqi; Wu, Hui			Heme induces intestinal epithelial cell ferroptosis via mitochondrial dysfunction in transfusion-associated necrotizing enterocolitis	FASEB JOURNAL			English	Article						ferroptosis; heme; intestinal epithelial cell; mitochondrial dysfunction; necrotizing enterocolitis	ANEMIA; INFANTS; DAMAGE	Transfusion-associated necrotising enterocolitis (TANEC) is a life-threatening disease with a poor prognosis in preterm infants. This study explored whether and how heme induces ferroptosis in TANEC gut injury. A TANEC mouse model and a cell culture system for heme and Caco-2 cells were established. Ferroptosis was assessed by measuring iron and malondialdehyde (MDA) levels and mitochondrial morphology in intestinal tissues and Caco-2 cells. Mitochondrial dysfunction was evaluated by measuring mitochondrial reactive oxygen species (ROS) production and membrane potential using JC-1. The intestinal injury grade was higher in the anemia-transfusion group than in the control group (p < .0001). Higher intestinal iron concentration (p < .0001), elevated levels of lipid peroxidation MDA (p = .0021), and ferroptotic mitochondrial morphological changes were found in mice of the anemia-transfusion group; specific ferroptosis inhibitor could alleviate anemia-transfusion gut injury, suggesting that ferroptosis play a role in the TANEC gut injury. Next, we explored whether heme released by hemolysis of erythrocytes induces ferroptosis in intestinal epithelial cells in vitro. The viability of Caco-2 cells significantly decreased after heme treatment (p < .0001). Iron accumulation, MDA elevated levels, and mitochondrial dysfunction also existed in the co-culture system, which ferroptosis inhibitors could reduce. In summary, ferroptosis was discovered in TANEC, and heme could induce ferroptosis in intestinal epithelial cells via mitochondrial dysfunction. Heme-inducing ferroptosis may be a possible mechanism and therapeutic target for TANEC.	[Dang, Dan; Li, Zhenyu; Wei, Jiaqi; Wu, Hui] First Hosp Jilin Univ, Dept Neonatol, 1 Xinmin St, Changchun 130021, Jilin, Peoples R China; [Meng, Zhaoli] First Hosp Jilin Univ, Dept Translat Med Res Inst, Changchun, Peoples R China; [Zhang, Chuan] First Hosp Jilin Univ, Dept Pediat Surg, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Wu, H (corresponding author), First Hosp Jilin Univ, Dept Neonatol, 1 Xinmin St, Changchun 130021, Jilin, Peoples R China.	wuhui@jlu.edu.cn						Arthur CM, 2019, TRANSFUSION, V59, P1233, DOI 10.1111/trf.15254; Bailey SM, 2015, BLOOD TRANSFUS-ITALY, V13, P429, DOI 10.2450/2015.0212-14; Barcellos-de-Souza P, 2013, AM J PHYSIOL-CELL PH, V304, pC170, DOI 10.1152/ajpcell.00078.2012; Canesin G, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071801; Christensen RD, 2010, TRANSFUSION, V50, P1106, DOI 10.1111/j.1537-2995.2009.02542.x; Cunningham KE, 2017, J SURG RES, V213, P158, DOI 10.1016/j.jss.2017.02.029; Dani C, 2017, TRANSFUSION, V57, P1304, DOI 10.1111/trf.14080; Deng GH, 2020, FREE RADICAL BIO MED, V148, P151, DOI 10.1016/j.freeradbiomed.2019.12.026; Gan BY, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202105043; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Li YY, 2020, SMALL, V16, DOI 10.1002/smll.202001356; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Luo LJ, 2022, BMC PEDIATR, V22, DOI 10.1186/s12887-022-03276-4; Ma HD, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9067610; Maheshwari A, 2018, SEMIN PEDIATR SURG, V27, P47, DOI 10.1053/j.sempedsurg.2017.11.009; Mayr L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15646-6; Meng ZJ, 2021, LIFE SCI, V284, DOI 10.1016/j.lfs.2021.119935; Menon AV, 2022, BLOOD, V139, P936, DOI 10.1182/blood.2020008455; MohanKumar K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11199-5; NaveenKumar SK, 2019, BBA-MOL BASIS DIS, V1865, P2303, DOI 10.1016/j.bbadis.2019.05.009; NaveenKumar SK, 2018, ACS CHEM BIOL, V13, P1996, DOI 10.1021/acschembio.8b00458; Nie HB, 2016, FREE RADICAL RES, V50, P1200, DOI 10.1080/10715762.2016.1225955; Oates PS, 2006, WORLD J GASTROENTERO, V12, P4281, DOI 10.3748/wjg.v12.i27.4281; Osiak W, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7140496; Patankar JV, 2020, NAT REV GASTRO HEPAT, V17, P543, DOI 10.1038/s41575-020-0326-4; Piel RB, 2019, MOL GENET METAB, V128, P198, DOI 10.1016/j.ymgme.2019.01.006; Pietropaoli AP, 2019, TRANSFUSION, V59, P2007, DOI 10.1111/trf.15218; Ryter SW, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115509; Ryter SW, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030515; Say B, 2015, TRANSFUSION MED, V25, P170, DOI 10.1111/tme.12207; Sayari AJ, 2016, J PEDIATR SURG, V51, P927, DOI 10.1016/j.jpedsurg.2016.02.052; Singh R, 2012, SEMIN PERINATOL, V36, P277, DOI 10.1053/j.semperi.2012.04.008; Stone CA, 2018, NEONATOLOGY, V113, P366, DOI 10.1159/000487388; Subramanian Saravanan, 2020, Shengli Xuebao, V72, P308, DOI 10.13294/j.aps.2020.0039; Tang DL, 2021, CELL RES, V31, P107, DOI 10.1038/s41422-020-00441-1; Tang ZM, 2021, REDOX BIOL, V43, DOI 10.1016/j.redox.2021.101971; Xu MY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2299-1; Xu S, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03559-1; Xu YF, 2021, AM J TRANSL RES, V13, P10315; Yang WC, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.865689; Zhu LJ, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6551069	41	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22649	10.1096/fj.202200853RRR	http://dx.doi.org/10.1096/fj.202200853RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6F9WX	36383399				2022-12-26	WOS:000884412400001
J	Yan, D; Fan, Q				Yan, Da; Fan, Qiongqiong			Online informal learning community for interpreter training amid COVID-19: A pilot evaluation	PLOS ONE			English	Article							HIGHER-EDUCATION; TEACHERS	Sudden shifts towards online education since the outbreak of Covid-19 propelled the unprepared changes in teaching and learning over the world. The impact of transferring Interpreter training from face-to-face instruction and practices to a fully online environment was viewed differently. Issues such as relatively inferior engagement in learning and dissatisfied performance in competence building were highlighted and compounded by the concern of academic burnout and learning stress caused by the abiding pandemic. To curb the unsatisfactory situation, alternative learning methods and innovative pedagogical approaches were advocated. The present study was a pioneering effort to integrate informal learning into remote interpreter training by developing and implementing an online informal learning communities for undergraduate interpreting trainees in a Chinese university. The researcher recruited 36 students (n = 36) from the institution as participants in the 1.5-year piloting project. The findings of the research revealed the impact of informal learning in supplementing formal education by engaging involved students. Student-centered learning supported by collaborative and experiential activities in an informal environment was well-received for its ability to galvanize student's engagement and academic achievements. The perceptions from participants revealed preference and expectation from students for expanded roles of trainers in interpreter training.	[Yan, Da; Fan, Qiongqiong] Xinyang Agr & Forestry Univ, Sch Foreign Languages, Xinyang, Peoples R China	Xinyang Agriculture & Forestry University	Fan, Q (corresponding author), Xinyang Agr & Forestry Univ, Sch Foreign Languages, Xinyang, Peoples R China.	2012280003@xyafu.edu.cn	Da, Yan/AAE-3520-2022	Yan, Da/0000-0002-1265-9772				Abdel Latif MMM, 2020, TRANSLATOR INTERPRET, P39, DOI [10.1007/978-981-15-8550-0_3, DOI 10.1007/978-981-15-8550-0_3]; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Chen TG, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030200; Costa-Sanchez C, 2020, SOC MEDIA SOC, V6, DOI 10.1177/2056305120942886; Creswell J.W., 2011, DESIGNING CONDUCTING; Crezee I, 2021, INT J INTERPRETER ED, V7, P74; Dos Santos LM, 2022, ADV ED MARKETING ADM, P49, DOI [10.4018/978-1-7998-8279-4.ch004, DOI 10.4018/978-1-7998-8279-4.CH004]; Sagar Paul, 1992, Notornis, V39, P1, DOI 10.1145/143103.143108; Ferri F, 2020, SOCIETIES, V10, DOI 10.3390/soc10040086; Gerken M, 2018, INFORMAL LEARNING WO; Godsell S, 2022, EDUC CHANGE, V26, P1, DOI 10.25159/1947-9417/8680; Gonzalez J, 2021, INT J INTERPRETER ED, V2, P148; Gramatakos AL, 2019, INT J SUST HIGHER ED, V20, P378, DOI 10.1108/IJSHE-10-2018-0177; Han C, 2020, PERSPECT STUD TRANSL, V28, P109, DOI 10.1080/0907676X.2019.1615516; Huang J, 2020, J CHEM EDUC, V97, P2810, DOI 10.1021/acs.jchemed.0c00671; Hubscher-Davidson S, 2021, J SPEC TRANSL, P184; Ivars AJ, 2013, LEBENDE SPRACHEN, V58, P341, DOI [10.1515/les-2013-0020, DOI 10.1515/LES-2013-0020]; Jiang HZ, 2021, EDUC INF TECHNOL, V26, P6747, DOI 10.1007/s10639-021-10519-x; Juan C, 2020, INT J EMERG TECHNOL, V15, P4, DOI 10.3991/ijet.v15i17.14581; Karakose T, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19041951; Kawinkoonlasate P, 2020, ENGLISH LANGUAGE TEA, V13, P15, DOI [10.5539/elt.v13n12p15, DOI 10.5539/ELT.V13N12P15]; Kiger ME, 2020, MED TEACH, V42, P846, DOI 10.1080/0142159X.2020.1755030; Ko L, 2008, META, V53, P814, DOI 10.7202/019649ar; Lai KW, 2018, INNOV HIGH EDUC, V43, P369, DOI 10.1007/s10755-018-9434-2; Li L, 2022, DIGITAL COMMUNICATIO, P183, DOI [10.1007/978-981-16-8329-9_10, DOI 10.1007/978-981-16-8329-9_10]; Li XD, 2018, INTERPRET TRANSL TRA, V12, P48, DOI 10.1080/1750399X.2017.1418581; Lim L, 2020, KEY ISSUES TRANSLATI, P143, DOI [10.1007/978-981-15-5865-8_7, DOI 10.1007/978-981-15-5865-8_7]; Lindner KT, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.702606; MAH SEUNG HYE, 2020, [The Journal of Translation Studies, 번역학연구], V21, P39, DOI 10.15749/jts.2020.21.4.002; Mehrvarz M, 2021, COMPUT EDUC, V167, DOI 10.1016/j.compedu.2021.104184; Mellinger CD, 2018, HERMES J LANGUAGE CO, P195, DOI [10.7146/hjlcb.v0i57, DOI 10.7146/HJLCB.V0I57.106205, DOI 10.7146/HJLCB.V0I57]; Mellinger CD, 2019, TRADUMATICA, P33, DOI 10.5565/rev/tradumatica.228; Mheidly N, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.574969; Naderifar M, 2017, STRIDES DEV MED ED, V14, DOI [10.5812/sdme.67670, DOI 10.5812/SDME.67670]; Ocana Mauro, 2021, Artificial Intelligence, Computer and Software Engineering Advances. Proceedings of the CIT 2020. Advances in Intelligent Systems and Computing (AISC 1327), P400, DOI 10.1007/978-3-030-68083-1_30; Owen S, 2014, AUST J ADULT LEARN, V54, P54; Oyelere SS, 2021, EDUC INF TECHNOL, V26, P5311, DOI 10.1007/s10639-021-10535-x; Pavlovic N, 2021, CURR TRENDS TRANSL T, V8, P31, DOI 10.51287/cttl_e_2021_3_natasa_pavlovic.pdf; Perez E, 2021, CURR TRENDS TRANSL T, V8, P276, DOI 10.51287/cttle20219; Pieters J, 2019, COLLABORATIVE CURRIC, DOI [10.1007/978-3-030-20062-6, DOI 10.1007/978-3-030-20062-6]; Pochhacker F, 2010, TRANSL INTERPRET, V2, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Reuge N, 2021, INT J EDUC DEV, V87, DOI 10.1016/j.ijedudev.2021.102485; Sandrelli A, 2015, MONTI, P111, DOI 10.6035/MonTI.2015.ne2.4; Segers M, 2018, INFORMAL LEARNING WO; Smith A., 2021, INT J MULTIDISCIPLIN, V6, P122, DOI [10.32674/jimphe.v6i1.2640, DOI 10.32674/JIMPHE.V6I1.2640]; Temban MM, 2021, ACAD J INTERDISCIP S, V10, P272, DOI [10., DOI 10.36941/AJIS-2021-0083]; Toffoli D, 2020, NEW LANG LEARN TEACH, P23, DOI 10.1007/978-3-030-37876-9_2; Toffoli D, 2015, COMPUT ASSIST LANG L, V28, P7, DOI 10.1080/09588221.2013.776970; Torrey T., 2020, J TECHNOLOGY TEACHER, V28, P189; Trinidad JE, 2021, J EDUC ADM HIST, V53, P67, DOI 10.1080/00220620.2020.1858764; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wu D, 2019, PERSPECT STUD TRANSL, V27, P74, DOI 10.1080/0907676X.2018.1485715; Xu M, 2021, CONT TRANSLATION STU, P197, DOI [10.46679/978819484830107, DOI 10.46679/978819484830107]; Yan D, 2022, FRONT PSYCHOL, V13, DOI 10.3389/fpsyg.2022.939689; Yu HQ, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.596582; Zanot I, 2021, INTERPRETERSNEWSLETT, V26, P213, DOI [10.13137/2421-714X/33272, DOI 10.13137/2421-714X/33272]; Zhang WN, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13030055	58	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2022	17	11							e0277228	10.1371/journal.pone.0277228	http://dx.doi.org/10.1371/journal.pone.0277228			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6Q9RA	36327335	gold, Green Published			2022-12-26	WOS:000891945300001
J	Garza, S; Chen, LT; Galano, M; Cheung, G; Sottas, C; Li, L; Li, YC; Zirkin, BR; Papadopoulos, V				Garza, Samuel; Chen, Liting; Galano, Melanie; Cheung, Garett; Sottas, Chantal; Li, Lu; Li, Yuchang; Zirkin, Barry R.; Papadopoulos, Vassilios			Mitochondrial dynamics, Leydig cell function, and age-related testosterone deficiency	FASEB JOURNAL			English	Article						aging; bioenergetics; hypogonadism; mitochondrial fusion; optic atrophy 1; steroidogenesis; testosterone; translocator protein	PROTEIN 18 KDA; BENZODIAZEPINE-RECEPTOR; CONTACT SITES; TSPO; CHOLESTEROL; CRISTAE; FUSION; METABOLISM; STEROIDOGENESIS; ACTIVATION	The mitochondrial translocator protein (18 kDa; TSPO) is a high-affinity cholesterol-binding protein that is an integral component of the cholesterol trafficking scaffold responsible for determining the rate of cholesterol import into the mitochondria for steroid biosynthesis. Previous studies have shown that TSPO declines in aging Leydig cells (LCs) and that its decline is associated with depressed circulating testosterone levels in aging rats. However, TSPO's role in the mechanistic decline in LC function is not fully understood. To address the role of TSPO depletion in LC function, we first examined mitochondrial quality in Tspo knockout mouse tumor MA-10 nG1 LCs compared to wild-type MA-10 cells. Tspo deletion caused a disruption in mitochondrial function and membrane dynamics. Increasing mitochondrial fusion via treatment with the mitochondrial fusion promoter M1 or by optic atrophy 1 (OPA1) overexpression resulted in the restoration of mitochondrial function and mitochondrial morphology as well as in steroid formation in TSPO-depleted nG1 LCs. LCs isolated from aged rats form less testosterone than LCs isolated from young rats. Treatment of aging LCs with M1 improved mitochondrial function and increased androgen formation, suggesting that aging LC dysfunction may stem from compromised mitochondrial dynamics caused by the age-dependent LC TSPO decline. These results, taken together, suggest that maintaining or enhancing mitochondrial fusion may provide therapeutic strategies to maintain or restore testosterone levels with aging.	[Garza, Samuel; Chen, Liting; Galano, Melanie; Cheung, Garett; Sottas, Chantal; Li, Lu; Li, Yuchang; Papadopoulos, Vassilios] Univ Southern Calif, Dept Pharmacol & Pharmaceut Sci, Sch Pharm, 1985 Zonal Ave, Los Angeles, CA 90089 USA; [Zirkin, Barry R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA	University of Southern California; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Papadopoulos, V (corresponding author), Univ Southern Calif, Dept Pharmacol & Pharmaceut Sci, Sch Pharm, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	vpapadop@usc.edu		Papadopoulos, Vassilios/0000-0002-1183-8568; Garza, Samuel/0000-0001-9688-5445	USC | School of Pharmacy, University of Southern California (USC School of Pharmacy)	USC | School of Pharmacy, University of Southern California (USC School of Pharmacy)	USC | School of Pharmacy, University of Southern California (USC School of Pharmacy)	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; Barron AM, 2018, BIOCHEM J, V475, P75, DOI 10.1042/BCJ20170645; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Bose HS, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101295; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; BROWNING JY, 1981, ENDOCRINOLOGY, V109, P667, DOI 10.1210/endo-109-2-667; Chung JY, 2013, ENDOCRINOLOGY, V154, P2156, DOI 10.1210/en.2012-2226; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Culty M, 2002, J ANDROL, V23, P439; Culty M, 1999, J STEROID BIOCHEM, V69, P123, DOI 10.1016/S0960-0760(99)00056-4; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; de la Barca JMC, 2016, NEUROBIOL DIS, V90, P20, DOI 10.1016/j.nbd.2015.08.015; Del Dotto V, 2018, BBA-BIOENERGETICS, V1859, P263, DOI 10.1016/j.bbabio.2018.01.005; Dimmer KS, 2017, BBA-MOL CELL BIOL L, V1862, P69, DOI 10.1016/j.bbalip.2016.07.010; Ding MG, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13428; Duarte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045829; Elustondo P, 2017, BBA-MOL CELL BIOL L, V1862, P90, DOI 10.1016/j.bbalip.2016.08.012; Fan JJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010252; Fan JJ, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa001; Fan JJ, 2018, ENDOCRINOLOGY, V159, P1130, DOI 10.1210/en.2017-03065; Fan JJ, 2015, P NATL ACAD SCI USA, V112, P7261, DOI 10.1073/pnas.1502670112; Fan JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076701; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Georges E., 2021, J BIOCHEM, V170, P239; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Handelsman DJ., 2000, ENDOTEXT; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiser C, 2021, J BIOENERG BIOMEMBR, V53, P463, DOI 10.1007/s10863-021-09905-4; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Hu C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03152-y; Issop L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152919; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Khanum A, 1997, ENDOCRINOLOGY, V138, P1612, DOI 10.1210/en.138.4.1612; Li F, 2016, BIOCHEMISTRY-US, V55, P2821, DOI 10.1021/acs.biochem.6b00142; Li L, 2021, NAT REV UROL, V18, P487, DOI 10.1038/s41585-021-00480-2; Li YC, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102457; LIAO C, 1993, J STEROID BIOCHEM, V46, P39, DOI 10.1016/0960-0760(93)90207-D; Liu GJ, 2017, CELL CYCLE, V16, P436, DOI 10.1080/15384101.2017.1281477; Midzak AS, 2011, BIOL REPROD, V84, P976, DOI 10.1095/biolreprod.110.087460; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Owen DR, 2017, BIOCHEM J, V474, P3985, DOI 10.1042/BCJ20170648; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; Papadopoulos V, 2021, VITAM HORM, V115, P585, DOI 10.1016/bs.vh.2020.12.023; Papadopoulos V, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12500; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; SIMPSON ER, 1983, CAN J BIOCHEM CELL B, V61, P692, DOI 10.1139/o83-088; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Sokanovic SJ, 2021, J GERONTOL A-BIOL, V76, P177, DOI 10.1093/gerona/glaa132; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Thomson M, 2003, BIOESSAYS, V25, P252, DOI 10.1002/bies.10243; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Veenman L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.294; Wang DL, 2012, ANGEW CHEM INT EDIT, V51, P9302, DOI 10.1002/anie.201204589; Weiser BP, 2014, J PHYS CHEM B, V118, P9852, DOI 10.1021/jp504516a; Zirkin BR, 2018, BIOL REPROD, V99, P101, DOI 10.1093/biolre/ioy059; Zirkin BR, 2000, BIOL REPROD, V63, P977, DOI 10.1095/biolreprod63.4.977	67	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22637	10.1096/fj.202201026R	http://dx.doi.org/10.1096/fj.202201026R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5Z7VX	36349989				2022-12-26	WOS:000880177500001
J	Siegel, EL; Olivera, M; Roig, EM; Perry, M; Li, AY; D'hers, S; Elman, NM; Rich, SM				Siegel, Eric L.; Olivera, Marcos; Roig, Esteban Martinez; Perry, Melynda; Li, Andrew Y.; D'hers, Sebastian; Elman, Noel M.; Rich, Stephen M.			Spatial repellents transfluthrin and metofluthrin affect the behavior of Dermacentor variabilis, Amblyomma americanum, and Ixodes scapularis in an in vitro vertical climb assay	PLOS ONE			English	Article							PERSONAL PROTECTIVE MEASURES; INSECT REPELLENTS; BLACKLEGGED TICKS; LYME-DISEASE; DEET; ACARI; RESPONSES; EFFICACY; IXODIDAE; CONTACT	Repellents serve an important role in bite protection. Tick repellents largely rely on biomechanisms that induce responses with direct contact, but synthetic pyrethroids used as spatial repellents against insects have received recent attention for potential use in tick protection systems. An in vitro vertical climb assay was designed to assess spatial repellency against Dermacentor variabilis, Amblyomma americanum, and Ixodes scapularis adult, female ticks. Climbing behavior was assessed with and without the presence of two spatial repellents, transfluthrin and metofluthrin. Repellency parameters were defined to simulate the natural questing behavior of ambushing ticks, including measures of detachment, pseudo-questing duration, climbing deterrence, and activity. Significant effects were observed within each parameter. D. variabilis showed the greatest general susceptibility to each repellent, followed by A. americanum, and I. scapularis. The most important and integrative measure of repellency was climbing deterrence-a measure of the spatial repellent's ability to disrupt a tick's natural propensity to climb. Transfluthrin deterred 75% of D. variabilis, 67% of A. americanum, and 50% of I. scapularis. Metofluthrin was slightly more effective, deterring 81% of D. variabilis, 73% of A. americanum, and 72% of I. scapularis. The present study poses a novel paradigm for repellency and reports a preliminary assessment of spatial repellent effect on tick behavior. Further research will assess spatial repellency in a more natural setting, scale exposure conditions, and incorporate host cues.	[Siegel, Eric L.; Rich, Stephen M.] Univ Massachusetts, Dept Microbiol, Lab Med Zool, Amherst, MA 01003 USA; [Olivera, Marcos; Roig, Esteban Martinez; D'hers, Sebastian] Inst Tecnol Buenos Aires ITBA, Computat Mech Ctr, Buenos Aires, Argentina; [Perry, Melynda] United States Army Garrison Natick, Combat Capabil Dev Command Soldier Ctr, Textile Mat Evaluat Team, Natick, MA USA; [Li, Andrew Y.] United States Dept Agr, Agr Res Serv, Invas Insect Biocontrol Behav Lab, Beltsville, MD USA; [Elman, Noel M.] Ltd Liabil Co, GearJump Technol, Brookline, MA USA	University of Massachusetts System; University of Massachusetts Amherst; United States Department of Agriculture (USDA)	Rich, SM (corresponding author), Univ Massachusetts, Dept Microbiol, Lab Med Zool, Amherst, MA 01003 USA.	smrich@umass.edu		D'hers, Sebastian/0000-0002-4979-8813; MARTINEZ ROIG, ESTEBAN/0000-0003-2507-7795	DoD Tick-borne Disease Program from the Congressional Directed Medical Research Program [W81XWH1920028]	DoD Tick-borne Disease Program from the Congressional Directed Medical Research Program	This study was supported by the DoD Tick-borne Disease Program from the Congressional Directed Medical Research Program, grant #W81XWH1920028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; Altman D.G., 1991, PRACTICAL STATISTIC; Andreazza F, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009546; [Anonymous], GRAPHPAD PRISM RRIDS; [Anonymous], SPSS STAT WINDOWS RR; Beard CB, 2021, J MED ENTOMOL, V58, P1487, DOI 10.1093/jme/tjab064; Belova OA, 2012, TICKS TICK-BORNE DIS, V3, P240, DOI 10.1016/j.ttbdis.2012.05.005; Benelli G, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9080664; Bernier UR, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007188; Bernier UR, 2016, J MED ENTOMOL, V53, P470, DOI 10.1093/jme/tjv190; Bernier UR, 2015, J CONTROL RELEASE, V220, P1, DOI 10.1016/j.jconrel.2015.09.049; Bernier UR, 2005, J MED ENTOMOL, V42, P306, DOI 10.1603/0022-2585(2005)042[0306:COCASR]2.0.CO;2; Bibbs CS, 2016, J MED ENTOMOL, V53, P861, DOI 10.1093/jme/tjw039; Bissinger BW, 2011, MED VET ENTOMOL, V25, P217, DOI 10.1111/j.1365-2915.2010.00923.x; Bissinger BW, 2010, PESTIC BIOCHEM PHYS, V96, P63, DOI 10.1016/j.pestbp.2009.09.010; Bowman NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196410; Carr AL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221659; Carr AL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071563; Carroll JF, 2014, J MED ENTOMOL, V51, P629, DOI 10.1603/ME12214; Carroll JF, 2004, J MED ENTOMOL, V41, P249, DOI 10.1603/0022-2585-41.2.249; Carroll SP, 2008, J MED ENTOMOL, V45, P706, DOI 10.1603/0022-2585(2008)45[706:PEOIRA]2.0.CO;2; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connally NP, 2006, J VECTOR ECOL, V31, P364, DOI 10.3376/1081-1710(2006)31[364:APEFAP]2.0.CO;2; Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x; Cummings P, 2011, ARCH PEDIAT ADOL MED, V165, P592, DOI 10.1001/archpediatrics.2011.97; de la Fuente J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005488; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007; Eisen L, 2022, TICKS TICK-BORNE DIS, V13, DOI 10.1016/j.ttbdis.2022.101944; Eisen L, 2017, TICKS TICK-BORNE DIS, V8, P837, DOI 10.1016/j.ttbdis.2017.06.010; Eisen L, 2016, J MED ENTOMOL, V53, P1063, DOI 10.1093/jme/tjw103; Eisen RJ, 2018, TRENDS PARASITOL, V34, P295, DOI 10.1016/j.pt.2017.12.006; EthoVision XT, ETHOVISION XT RRID S; Faraone N, 2020, INSECTS, V11, DOI 10.3390/insects11080502; Faraone N, 2019, EXP APPL ACAROL, V79, P195, DOI 10.1007/s10493-019-00421-0; Faulde MK, 2008, EXP APPL ACAROL, V44, P137, DOI 10.1007/s10493-008-9131-4; Ferreira LL, 2017, VET PARASITOL, V239, P42, DOI 10.1016/j.vetpar.2017.04.021; Fischhoff IR, 2019, AM J EPIDEMIOL, V188, P1742, DOI 10.1093/aje/kwz130; Fleiss J.L., 1994, HDB RES SYNTHESIS, P245; Flor-Weiler LB, 2022, EXP APPL ACAROL, V86, P299, DOI 10.1007/s10493-022-00692-0; Foster E, 2020, J MED ENTOMOL, V57, P1141, DOI 10.1093/jme/tjaa008; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; FRYAUFF DJ, 1994, J MED ENTOMOL, V31, P23, DOI 10.1093/jmedent/31.1.23; Halos L, 2012, PARASITOLOGY, V139, P419, DOI 10.1017/S0031182011002228; Harmon JR, 2015, TICKS TICK-BORNE DIS, V6, P246, DOI 10.1016/j.ttbdis.2015.01.004; Josek T, 2018, TICKS TICK-BORNE DIS, V9, P1317, DOI 10.1016/j.ttbdis.2018.05.013; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Knap N, 2009, VET PARASITOL, V164, P275, DOI 10.1016/j.vetpar.2009.06.001; Kulma M, 2019, J AM MOSQUITO CONTR, V35, P279, DOI 10.2987/19-6849.1; LANE RS, 1989, EXP APPL ACAROL, V6, P343, DOI 10.1007/BF01193304; Lang TA., 2016, MED WRITING, V25, P31, DOI [10.1002/9781118715598.ch25, DOI 10.1002/9781118715598.CH25]; Leal WS, 2014, CURR OPIN INSECT SCI, V6, P93, DOI 10.1016/j.cois.2014.10.007; Madison-Antenucci S, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00083-18; Murgia MV., 2022, CURRENT RES PARASITO, V2, P100070, DOI [10.1016/j.crpvbd.2021.100070, DOI 10.1016/J.CRPVBD.2021.100070]; Norris EJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020124; O'Shea B, 2002, T ROY SOC TROP MED H, V96, P117, DOI 10.1016/S0035-9203(02)90273-7; Pages F, 2014, VECTOR-BORNE ZOONOT, V14, P85, DOI 10.1089/vbz.2013.1410; Paules CI, 2018, NEW ENGL J MED, V379, P701, DOI 10.1056/NEJMp1807870; Perret JL, 2003, J EXP BIOL, V206, P1809, DOI 10.1242/jeb.00345; Ray A, 2015, CURR OPIN NEUROBIOL, V34, P158, DOI 10.1016/j.conb.2015.06.014; Richardson M, 2019, PREV MED REP, V13, P16, DOI 10.1016/j.pmedr.2018.11.004; Rochlin I, 2020, J MED MICROBIOL, V69, P781, DOI 10.1099/jmm.0.001206; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; SCHRECK CE, 1995, J AM MOSQUITO CONTR, V11, P136; Sonenshine Daniel E., 2014, P122; Stevenson JC, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2558-0; Sukkanon C, 2019, AUSTRAL ENTOMOL, V58, P866, DOI 10.1111/aen.12420; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; U.S. Environmental Protection Agency (EPA), 2010, 712C10001 EPA; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Verhulst Niels O, 2021, Curr Res Insect Sci, V1, P100002, DOI 10.1016/j.cris.2020.100002; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111	74	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0269150	10.1371/journal.pone.0269150	http://dx.doi.org/10.1371/journal.pone.0269150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346809	Green Published, gold			2022-12-26	WOS:000894053200001
J	Sun, SJ; Ai, YJ; Duan, KL; Zhang, JY; Zhang, C; Sun, YP; Xiong, Y; Guan, KL; Yuan, HX				Sun, Si-Jia; Ai, Ying-Jie; Duan, Kun-Long; Zhang, Jin-Ye; Zhang, Cheng; Sun, Yi-Ping; Xiong, Yue; Guan, Kun-Liang; Yuan, Hai-Xin			TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expression	ONCOGENE			English	Article; Early Access							COA REDUCTASE INHIBITORS; 5-HYDROXYMETHYLCYTOSINE; CANCER; MECHANISM; MUTATION; PATHWAY; SAFETY; GENES	TET2 (ten-eleven-translocation) protein is a Fe(II)- and alpha-ketoglutarate-dependent dioxygenase that catalyzes DNA demethylation to regulate gene expression. While TET2 gene is frequently mutated in hematological cancer, its enzymatic activity is also compromised in various solid tumors. Whether TET2 deficiency creates vulnerability for cancer cells has not been studied. Here we reported that TET2 deficiency is associated with the change of lipid metabolism processes in acute myeloid leukemia (AML) patient. We demonstrate that statins, the inhibitors of beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase and commonly used cholesterol-lowering medicines, significantly sensitize TET2 deficient tumor cells to apoptosis. TET2 directly regulates the expression of HMG-CoA synthase (HMGCS1) by catalyzing demethylation on its promoter region, and conversely TET2 deficiency leads to significant down-regulation of HMGCS1 expression and the mevalonate pathway. Consistently, overexpression of HMGCS1 in TET2-deficient cells rescues statin-induced apoptosis. We further reveal that decrease of geranylgeranyl diphosphate (GGPP), an intermediate metabolite in the mevalonate pathway, is responsible for statin-induced apoptosis. GGPP shortage abolishes normal membrane localization and function of multiple small GTPases, leading to cell dysfunction. Collectively, our study reveals a vulnerability in TET2 deficient tumor and a potential therapeutic strategy using an already approved safe medicine.	[Sun, Si-Jia; Duan, Kun-Long; Zhang, Jin-Ye; Zhang, Cheng; Sun, Yi-Ping; Yuan, Hai-Xin] Fudan Univ, Shanghai Coll Med, Peoples Hosp Shanghai 5, Inst Biomed Sci,Mol & Cell Biol Res Lab, Shanghai, Peoples R China; [Ai, Ying-Jie] Fudan Univ, Zhongshan Hosp, Shanghai Coll Med, Dept Gastroenterol & Hepatol, Shanghai, Peoples R China; [Xiong, Yue] Cullgen Inc, 12730 High Bluff Dr, San Diego, CA 92130 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92093 USA; [Yuan, Hai-Xin] Chongqing Med Univ, Inst Life Sci, Ctr Novel Target & Therapeut Intervent, Chongqing 400016, Peoples R China	Fudan University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Chongqing Medical University	Yuan, HX (corresponding author), Fudan Univ, Shanghai Coll Med, Peoples Hosp Shanghai 5, Inst Biomed Sci,Mol & Cell Biol Res Lab, Shanghai, Peoples R China.; Yuan, HX (corresponding author), Chongqing Med Univ, Inst Life Sci, Ctr Novel Target & Therapeut Intervent, Chongqing 400016, Peoples R China.	yuanhaixin@fudan.edu.cn		Yuan, Hai-Xin/0000-0002-1624-3934	National Key Research and Development Project of China [2018YFA0800304]; NSFC [82172595]; Development Fund for Shanghai Talents [2019109]; Supporting Fund for Innovation and Entrepreneurship by Chongqing Returned Oversea Scholars	National Key Research and Development Project of China; NSFC(National Natural Science Foundation of China (NSFC)); Development Fund for Shanghai Talents; Supporting Fund for Innovation and Entrepreneurship by Chongqing Returned Oversea Scholars	This work was supported by the National Key Research and Development Project of China (No. 2018YFA0800304 to H.-X.Y.), the NSFC grants (No. 82172595 to H.-X.Y.), and the Development Fund for Shanghai Talents (No. 2019109 to H.-X.Y.). H.-X.Y. is also supported by the Supporting Fund for Innovation and Entrepreneurship by Chongqing Returned Oversea Scholars.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bottorff M, 2000, ARCH INTERN MED, V160, P2273, DOI 10.1001/archinte.160.15.2273; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Bullinger L, 2017, J CLIN ONCOL, V35, P934, DOI 10.1200/JCO.2016.71.2208; Chen L, 2019, J LIPID RES, V60, P1765, DOI 10.1194/jlr.RA119000201; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Cheng ML, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00266; Davidson MH, 2001, DRUGS, V61, P197, DOI 10.2165/00003495-200161020-00005; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Farmer JA, 2000, DRUG SAFETY, V23, P197, DOI 10.2165/00002018-200023030-00003; Garcia-Bermudez J, 2019, NATURE, V567, P118, DOI 10.1038/s41586-019-0945-5; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Illingworth DR, 2001, ADV PROTEIN CHEM, V56, P77; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jawert F, 2013, ANTICANCER RES, V33, P4325; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Kazanets A, 2016, BBA-REV CANCER, V1865, P275, DOI 10.1016/j.bbcan.2016.04.001; Killian JK, 2013, CANCER DISCOV, V3, P648, DOI 10.1158/2159-8290.CD-13-0092; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Laukka T, 2016, J BIOL CHEM, V291, P4256, DOI 10.1074/jbc.M115.688762; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Nibourel O, 2010, BLOOD, V116, P1132, DOI 10.1182/blood-2009-07-234484; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Waller DD, 2019, CRIT REV BIOCHEM MOL, V54, P41, DOI 10.1080/10409238.2019.1568964; Wang YP, 2015, MOL CELL, V57, P662, DOI 10.1016/j.molcel.2014.12.023; Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Wu D, 2018, NATURE, V559, P637, DOI 10.1038/s41586-018-0350-5; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YP, 2019, J CLIN INVEST, V129, P4316, DOI 10.1172/JCI129317; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Zhang XX, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01456-9	40	0	0	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene												10.1038/s41388-022-02531-3	http://dx.doi.org/10.1038/s41388-022-02531-3		NOV 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	6D2TY	36348011				2022-12-26	WOS:000882550800001
J	Hayat, F; Khan, NU; Khan, AU; Ahmad, I; Alamri, AM; Iftikhar, B				Hayat, Faiza; Khan, Najeeb Ullah; Khan, Aakif Ullah; Ahmad, Iftikhar; Alamri, Ahmad M.; Iftikhar, Bushra			Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan	PLOS ONE			English	Article							MINERAL DENSITY; DNA METHYLATION; RANKL/RANK/OPG; EXPRESSION; PATHWAY; SYSTEM	Introduction The receptor activator NF-kappa B ligand (RANKL) and Osteoprotegrin (OPG) single nucleotide polymorphisms (SNPs) have been associated with the risk of breast cancer to bone metastasis. This study was designed to investigate the association of RANKL and OPG gene polymorphisms with breast to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan. Materials and methods A total of 215 participants were enrolled containing 106 breast cancer patients, 58 breast to bone metastasis and 51 age and gender matched healthy controls. RANKL (rs9533156) and OPG (rs2073618, rs3102735) polymorphisms were genotyped in genomic DNA, using Tetra-ARMS PCR protocol. The results were analyzed among the three groups and P-value less then 0.05 were considered statistically significant. Results Our results displayed significant association of OPG (rs3102735) risk allele and corresponding genotypes in breast cancer vs healthy controls, bone metastasis vs healthy controls and breast cancer vs breast to bone metastasis as a disease risk. However, there was no association observed for OPG (rs2073618) risk allele and corresponding genotypes with the diseases risk. Similarly, RANKL (rs9533156) risk allele and corresponding genotypes in breast cancer vs healthy controls, bone metastasis vs healthy controls and breast cancer vs breast to bone metastasis exhibited significant association except for the risk allele carrying genotypes in breast to bone metastasis. Conclusion OPG (rs3102735) and RANKL (rs9533156) exhibited significant association with breast to bone metastasis while OPG (rs2073618) didn't show significant association with breast to bone metastasis in Pashtun population of Pakistan. However, this study unlocks more questions to investigate the exact scenario of genetic predisposition of breast to bone metastasis.	[Hayat, Faiza; Khan, Najeeb Ullah] Univ Agr, Inst Biotechnol & Genet Engn, Hlth Div, Peshawar, Pakistan; [Khan, Aakif Ullah; Ahmad, Iftikhar] Inst Radiotherapy & Nucl Med IRNUM, Peshawar, Pakistan; [Alamri, Ahmad M.] King Khalid Univ, Res Ctr Adv Mat Sci RCAMS, Abha, Saudi Arabia; [Iftikhar, Bushra] Khyber Med Coll Peshawar, Peshawar, Pakistan	Agricultural University Peshawar; University of Agriculture Faisalabad; King Khalid University	Khan, NU (corresponding author), Univ Agr, Inst Biotechnol & Genet Engn, Hlth Div, Peshawar, Pakistan.; Alamri, AM (corresponding author), King Khalid Univ, Res Ctr Adv Mat Sci RCAMS, Abha, Saudi Arabia.; Iftikhar, B (corresponding author), Khyber Med Coll Peshawar, Peshawar, Pakistan.	najeebkhan@aup.edu.pk; aalamri@kku.edu.sa; bushraiftikhar@hotmail.com			Research Center for Advanced Materials Science (RCAMS) at King Khalid University Abha, Saudi Arabia [RCAMS/KKU/22]	Research Center for Advanced Materials Science (RCAMS) at King Khalid University Abha, Saudi Arabia	The authors appreciate the support of the Research Center for Advanced Materials Science (RCAMS) at King Khalid University Abha, Saudi Arabia through a project number RCAMS/KKU/22.	Adnan F, 2020, INFECT AGENTS CANCER, V15, DOI 10.1186/s13027-020-00285-9; Assmann G, 2012, J CLIN ONCOL, V30; Bale R, 2019, CANCERS, V11, DOI 10.3390/cancers11091341; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brosnan EM, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.35; Fisher JL, 2006, CANCER RES, V66, P3620, DOI 10.1158/0008-5472.CAN-05-3119; Geerts D, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00462; Hein A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/842452; Hsu YH, 2006, HUM GENET, V118, P568, DOI 10.1007/s00439-005-0062-4; Hu Y, 2008, BIOCHEM BIOPH RES CO, V370, P440, DOI 10.1016/j.bbrc.2008.03.106; Infante M, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-018-1001-2; Katz J, 2011, INT J ORAL MAX SURG, V40, P605, DOI 10.1016/j.ijom.2011.02.002; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Menhas R, 2015, IRAN J PUBLIC HEALTH, V44, P586; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Ney JT, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-40; Omar HS, 2015, MOL CELL BIOCHEM, V403, P219, DOI 10.1007/s11010-015-2352-z; Parkes A, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0054-x; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Santini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019234; Sarink D, 2017, CANCER PREV RES, V10, P525, DOI 10.1158/1940-6207.CAPR-17-0125; Shah M, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1310; Shaker OG, 2019, CLIN BREAST CANCER, V19, pE220, DOI 10.1016/j.clbc.2018.09.004; Sisay M, 2017, ONCOTARGETS THER, V10, P3801, DOI 10.2147/OTT.S135867; Soni A, 2015, AM J CLIN PATHOL, V143, P471, DOI 10.1309/AJCPYO5FSV3UPEXS; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wang JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133964; Weitzmann MN, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/125705; Xiao WK, 2018, CANCER MED-US, V7, P922, DOI 10.1002/cam4.1370	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0276813	10.1371/journal.pone.0276813	http://dx.doi.org/10.1371/journal.pone.0276813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346787	gold, Green Published			2022-12-26	WOS:000894053200011
J	Lv, PW; Shang, Y; Zhang, Y; Wang, WK; Liu, YX; Su, DD; Wang, W; Li, CF; Ma, CQ; Yang, CY				Lv, Peiwen; Shang, Yan; Zhang, Ye; Wang, Wenkai; Liu, Yuanxiang; Su, Dandan; Wang, Wei; Li, Chunfang; Ma, Cuiqing; Yang, Chunyu			Structural basis for the arsenite binding and translocation of Acr3 antiporter with NhaA folding pattern	FASEB JOURNAL			English	Article						antiporter; arsenite; Bacillus subtilis; FRET; site-directed mutagenesis; structural model	TRANSPORT ACTIVITY; NA+/H+ ANTIPORTER; CRYSTAL-STRUCTURE; CATION-BINDING; ARSB PROTEIN; PREDICTION; TOPOLOGY; AS(III)/H+; RESISTANCE; STABILITY	The arsenical resistance-3 (ACR3) family constitutes the most common pathway that confers high-level resistance to toxic metalloids in various microorganisms and lower plants. Based on the structural model constructed by AlphaFold2, the Acr3 antiporter from Bacillus subtilis (Acr3(Bs)) exhibits a typical NhaA structure fold, with two discontinuous helices of transmembrane (TM) segments, TM4 and TM9, interacting with each other and forming an X-shaped structure. As the structural information available for these important arsenite-efflux pumps is limited, we investigated the evolutionary conservation among 300 homolog sequences and identified three conserved motifs in both the discontinuous helices and TM5. Through site-directed mutagenesis, microscale thermophoresis (MST), and fluorescence resonance energy transfer (FRET) analyses, the identified Motif C in TM9 was found to be a critical element for substrate binding, in which N292 and E295 are involved in substrate coordination, while R118 in TM4 and E322 in TM10 is responsible for structural stabilization. In addition, the highly conserved residues on Motif B of TM5 are potentially key factors in the protonation/deprotonation process. These consensus motifs and residues are essential for metalloid compound translocation of Acr3 antiporters, by framing the core domain and the typical X-shaped of NhaA fold.	[Lv, Peiwen; Shang, Yan; Zhang, Ye; Wang, Wenkai; Liu, Yuanxiang; Su, Dandan; Wang, Wei; Li, Chunfang; Ma, Cuiqing; Yang, Chunyu] Shandong Univ, Inst Microbial Technol, State Key Lab Microbial Technol, Qingdao 266237, Peoples R China	Shandong University	Yang, CY (corresponding author), Shandong Univ, Inst Microbial Technol, State Key Lab Microbial Technol, Qingdao 266237, Peoples R China.	ycy21th@sdu.edu.cn						Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Calinescu O, 2017, J BIOL CHEM, V292, P7932, DOI 10.1074/jbc.M117.778175; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chen QY, 2021, ANNU REV PHARMACOL, V61, P47, DOI 10.1146/annurev-pharmtox-030220-013418; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cramer P, 2021, NAT STRUCT MOL BIOL, V28, P704, DOI 10.1038/s41594-021-00650-1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Francisco P, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182212226; DOU DX, 1992, J BIOL CHEM, V267, P25768; Dwivedi M, 2021, BIOCHIMIE, V180, P79, DOI 10.1016/j.biochi.2020.10.017; Fu HL, 2009, J BIOL CHEM, V284, P19887, DOI 10.1074/jbc.M109.011882; Hegedus T, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-021-04112-1; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Hu XM, 2021, CHEMOSPHERE, V274, DOI 10.1016/j.chemosphere.2021.129790; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hallgren J, 2022, bioRxiv, DOI 10.1101/2022.04.08.487609; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kumar R, 2020, CHEMOSPHERE, V239, DOI 10.1016/j.chemosphere.2019.124832; Lee C, 2014, J GEN PHYSIOL, V144, P529, DOI 10.1085/jgp.201411219; Lu PH, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.166764; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maciaszczyk-Dziubinska E, 2014, BBA-BIOMEMBRANES, V1838, P747, DOI 10.1016/j.bbamem.2013.11.013; Maciaszczyk-Dziubinska E, 2012, INT J MOL SCI, V13, P3527, DOI 10.3390/ijms13033527; Maciaszczyk-Dziubinska E, 2011, BBA-BIOMEMBRANES, V1808, P1855, DOI 10.1016/j.bbamem.2011.03.014; Majumder S, 2019, J ENVIRON MANAGE, V233, P184, DOI 10.1016/j.jenvman.2018.12.034; Markowska K, 2015, MOL MICROBIOL, V98, P162, DOI 10.1111/mmi.13113; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Olkhova E, 2009, PROTEINS, V76, P548, DOI 10.1002/prot.22368; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Pasquier C, 1999, PROTEIN ENG, V12, P381, DOI 10.1093/protein/12.5.381; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Rascol E, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-09217-6; Rimon A, 2018, J MOL BIOL, V430, P867, DOI 10.1016/j.jmb.2018.01.014; Saltikov CW, 2002, APPL ENVIRON MICROB, V68, P280, DOI 10.1128/AEM.68.1.280-288.2002; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Tu YH, 2020, J HAZARD MATER, V388, DOI 10.1016/j.jhazmat.2019.121997; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Villadangos AF, 2012, J BIOL CHEM, V287, P723, DOI 10.1074/jbc.M111.263335; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wawrzycka D, 2017, BBA-BIOMEMBRANES, V1859, P117, DOI 10.1016/j.bbamem.2016.11.004; WU JH, 1992, J BIOL CHEM, V267, P12570; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Xia XB, 2008, MOL MEMBR BIOL, V25, P691, DOI 10.1080/09687680802535930; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yang Z, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00831	52	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22659	10.1096/fj.202201280R	http://dx.doi.org/10.1096/fj.202201280R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6K1IR	36394534				2022-12-26	WOS:000887265600001
J	Yu, SQ; Wang, HS; Liu, M; Pei, F; Liu, H; Zhang, JL; Zhang, L; Li, QH; Chen, Z				Yu, Siqi; Wang, Haisheng; Liu, Ming; Pei, Fei; Liu, Huan; Zhang, Jiali; Zhang, Lu; Li, Qiuhui; Chen, Zhi			Loss of ATG5 in KRT14(+) cells leads to accumulated functional impairments of salivary glands via pyroptosis	FASEB JOURNAL			English	Article						autophagy; pyroptosis; salivary glands; Sjogren's syndrome; xerostomia	SJOGRENS-SYNDROME; AUTOPHAGY; XEROSTOMIA; MICE	Macroautophagy/autophagy is critically involved in the process of salivary gland (SG) diseases such as xerostomia, which has a serious impact on quality of life. KRT14(+) progenitor cells are found to be the main progenitors for maintaining the ductal homeostasis of the submandibular SGs. In this study, we investigated the role of ATG5 in SG KRT14(+) cells in mice and humans. Human labial salivary glands (LSG) from primary Sjogren's syndrome (pSS) and non-pSS patients (normal), and submandibular glands (SMG) from Atg5(flox/flox); Krt14-Cre (cKO) mice were used. ATG5(+)KRT14(+) and p62(+)KRT14(+) cells were detected by immunofluorescence staining in LSG. TUNEL, immunofluorescence, immunohistochemistry, and western blot were performed to detect cell death in SMG. Saliva was collected in 12-week-old (12 W) and 32-week-old (32 W) mice, then the concentration of calcium and buffering capacity were detected to analyze the function of SG. We found that LSG from pSS patients showed increased p62 and decreased ATG5 in KRT14(+) cells. We further revealed that in 32 W, (1) the function of salivary glands was significantly impaired in cKO mice, (2) cell death increased in cKO mice, but cl-Caspase 3 was not significantly changed, and (3) cleaved gasdermin D increased and was highly expressed in KRT14(+) cells of cKO mice. After applying a pyroptosis inhibitor to 32 W mice, the reduced saliva flow rate was rescued. In addition, pyroptosis was also found in KRT14(+) cells of pSS patients. Collectively, our results indicate that Atg5 deficiency would induce pyroptosis in mice SG, which could lead to functional impairments of SG.	[Yu, Siqi; Wang, Haisheng; Liu, Ming; Pei, Fei; Liu, Huan; Zhang, Jiali; Zhang, Lu; Li, Qiuhui; Chen, Zhi] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; [Yu, Siqi; Wang, Haisheng; Liu, Ming; Pei, Fei; Liu, Huan; Zhang, Jiali; Zhang, Lu; Li, Qiuhui; Chen, Zhi] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China; [Yu, Siqi; Wang, Haisheng; Liu, Ming; Pei, Fei; Liu, Huan; Zhang, Jiali; Zhang, Lu; Li, Qiuhui; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Wuhan, Peoples R China; [Pei, Fei; Zhang, Lu; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Dept Cariol & Endodont, Wuhan, Peoples R China; [Liu, Huan] Wuhan Univ, Sch & Hosp Stomatol, Dept Periodont, Wuhan, Peoples R China; [Zhang, Jiali] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Pathol, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University	Li, QH (corresponding author), Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China.; Li, QH; Chen, Z (corresponding author), Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China.; Li, QH; Chen, Z (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Wuhan, Peoples R China.	qiuhui.li@whu.edu.cn; zhichen@whu.edu.cn	Chen, Zhi/V-2214-2017	Chen, Zhi/0000-0003-2095-1324	National Natural Science Foundation of China (NSFC) [81800963, 81771066, 81802973]; Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation) [2020CFB844]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81800963, 81771066 and 81802973; Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation), Grant/Award Number: 2020CFB844	Bagavant H, 2018, JOVE-J VIS EXP, DOI 10.3791/57203; Barrera MJ, 2021, RHEUMATOLOGY, V60, P1951, DOI 10.1093/rheumatology/keaa670; Byun YS, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010071; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Emmerson E, 2018, GENESIS, V56, DOI 10.1002/dvg.23211; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Hong SM, 2020, IMMUNE NETW, V20, DOI 10.4110/in.2020.20.e39; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Hukkanen RR., 2017, COMP ANATOMY HISTOLO, V2nd ed, P135; Imgenberg-Kreuz J, 2021, RHEUMATOLOGY, V60, P2085, DOI 10.1093/rheumatology/key330; Kamiya M, 2015, BIORESEARCH OPEN ACC, V4, P307, DOI 10.1089/biores.2015.0017; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin L, 2022, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.809955; Lombaert IMA, 2013, STEM CELL REP, V1, P604, DOI 10.1016/j.stemcr.2013.10.013; Malallah OS, 2018, INT J PHARMACEUT, V541, P157, DOI 10.1016/j.ijpharm.2018.02.004; Maruyama CL, 2019, ORAL DIS, V25, P403, DOI 10.1111/odi.12840; May AJ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166363; Mitsias DI, 2006, LUPUS, V15, P255, DOI 10.1191/0961203306lu2290rr; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nandula SR, 2007, ARTHRITIS RHEUM-US, V56, P1798, DOI 10.1002/art.22715; Nikoletopoulou V, 2015, CELL DEATH DIFFER, V22, P398, DOI 10.1038/cdd.2014.204; Parashar K, 2020, FASEB J, V34, P7733, DOI 10.1096/fj.201902196R; Patel VN, 2014, SEMIN CELL DEV BIOL, V25, P52, DOI 10.1016/j.semcdb.2013.12.001; Pei F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.397; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]; Sordi MB, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010372; Thalayasingam N, 2021, RHEUMATOLOGY, V60, P53, DOI 10.1093/rheumatology/keab466; Turner M, 2008, J AM DENT ASSOC, V139, P146, DOI 10.14219/jada.archive.2008.0129; Wang B, 2021, BIODRUGS, V35, P593, DOI 10.1007/s40259-021-00505-7; Wang HS, 2019, J DENT RES, V98, P1271, DOI 10.1177/0022034519869580; Xiang RL, 2020, J CELL PHYSIOL, V235, P232, DOI 10.1002/jcp.28962; Zhang CY, 2021, J HAZARD MATER, V416, DOI 10.1016/j.jhazmat.2021.126138; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zheng T, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00320-z	37	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22631	10.1096/fj.202200946R	http://dx.doi.org/10.1096/fj.202200946R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5Y7NH	36342387				2022-12-26	WOS:000879468400001
J	Cui, KS; Gong, L; Zhang, H; Chen, Y; Liu, BX; Gong, ZC; Li, JM; Wang, YB; Sun, SB; Li, YJ; Zhang, Q; Cao, YL; Li, QL; Fei, BJ; Huang, ZH				Cui, Kaisa; Gong, Liang; Zhang, Han; Chen, Ying; Liu, Bingxin; Gong, Zhicheng; Li, Jiuming; Wang, Yuanben; Sun, Shengbai; Li, Yajun; Zhang, Qiang; Cao, Yulin; Li, Qilin; Fei, Bojian; Huang, Zhaohui			EXOSC8 promotes colorectal cancer tumorigenesis via regulating ribosome biogenesis-related processes	ONCOGENE			English	Article; Early Access							RNA EXOSOME; P53; DELIVERY; SUBUNIT; NUCLEAR	Extensive protein synthesis is necessary for uncontrolled cancer cell proliferation, requiring hyperactive ribosome biogenesis. Our previous Pan-cancer study has identified EXOSC8 as a potential copy number variation (CNV)-driven rRNA metabolism-related oncogene in colorectal cancer (CRC). Herein, we further investigated proliferation-prompting functions and mechanisms of EXOSC8 in CRC by performing in silico analyses and wet-lab experiments. We uncovered that increased EXOSC8 expression and CNV levels are strongly associated with ribosome biogenesis-related factor levels in CRC, including ribosome proteins (RPs), eukaryotic translation initiation factors and RNA polymerase I/III. EXOSC8 silence decreases nucleolar protein and proliferation marker levels, as well as rRNA/DNA and global protein syntheses. Clinically, EXOSC8 is upregulated across human cancers, particularly CNV-driven upregulation in CRC was markedly associated with poor clinical outcomes. Mechanistically, EXOSC8 knockdown increased p53 levels in CRC, and the oncogenic proliferation phenotypes of EXOSC8 depended on p53 in vitro and in vivo. We discovered that EXOSC8 knockdown in CRC cells triggers ribosomal stress, nucleolar RPL5/11 being released into the nucleoplasm and "hijacking" Mdm2 to block its E3 ubiquitin ligase function, thus releasing and activating p53. Furthermore, our therapeutic experiments provided initial evidence that EXOSC8 might serve as a potential therapeutic target in CRC. Our findings revealed, for the first time, that the RNA exosome gene (EXOSC8) promotes CRC tumorigenesis by regulating cancer-related ribosome biogenesis in CRC. This study further extends our previous Pan-cancer study of the rRNA metabolism-related genes. The inhibition of EXOSC8 is a novel therapeutic strategy for the RPs-Mdm2-p53 ribosome biogenesis surveillance pathway in CRC.	[Cui, Kaisa; Zhang, Han; Chen, Ying; Gong, Zhicheng; Wang, Yuanben; Sun, Shengbai; Cao, Yulin; Huang, Zhaohui] Jiangnan Univ, Affiliated Hosp, Wuxi Canc Inst, Wuxi 214062, Jiangsu, Peoples R China; [Gong, Liang] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi 214122, Jiangsu, Peoples R China; [Liu, Bingxin] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Key Lab Modern Toxicol,Minist Educ, Nanjing 211166, Jiangsu, Peoples R China; [Li, Jiuming] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Minist Educ,Key Lab Environm Med & Engn, Nanjing 210009, Jiangsu, Peoples R China; [Li, Yajun] Henan Normal Univ, Outstanding Overseas Scientists Ctr Pulm Fibrosis, Coll Life Sci,Henan Int Joint Lab Pulm Fibrosis, Inst Biomed Sci,State Key Lab Cell Differentiat &, Xinxiang 453000, Henan, Peoples R China; [Zhang, Qiang] Sun Yat Sen Univ, Mol Canc Res Ctr, Sch Med, Dept Biochem, Shenzhen Campus, Shenzhen 518107, Guangdong, Peoples R China; [Li, Qilin] CALTECH, Dept Elect Engn, Comp Vis Lab, Pasadena, CA 91125 USA; [Fei, Bojian] Jiangnan Univ, Affiliated Hosp, Dept Surg Oncol, Wuxi 214122, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Nanjing Medical University; Southeast University - China; Henan Normal University; Sun Yat Sen University; California Institute of Technology; Jiangnan University	Cui, KS; Huang, ZH (corresponding author), Jiangnan Univ, Affiliated Hosp, Wuxi Canc Inst, Wuxi 214062, Jiangsu, Peoples R China.	ksxg@foxmail.com; zhaohuihuang@jiangnan.edu.cn		Cui, Kaisa/0000-0001-7255-2689	National Natural Science Foundation of China [82002550, 82173063]; Wuxi Medical Key Discipline [ZDXK2021002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuxi Medical Key Discipline	We acknowledge the TCGA, GEO, CCLE and CPTAC projects. We would like to thank developers of each dataset, method and package used in this study. We thank the Affiliated Hospital of Jiangnan University for providing the CRC samples. We also thank the platforms of Medical Research Center (Wuxi School of Medicine, Jiangnan University). This work was supported by grants from the National Natural Science Foundation of China (82002550 and 82173063) and Wuxi Medical Key Discipline (ZDXK2021002).	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Andreatta M, 2021, COMPUT STRUCT BIOTEC, V19, P3796, DOI 10.1016/j.csbj.2021.06.043; Bian ZH, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-02162-8; Boczonadi V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5287; Boutelle AM, 2021, TRENDS CELL BIOL, V31, P298, DOI 10.1016/j.tcb.2020.12.011; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao PB, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf4304; Chen XL, 2022, J CANCER, V13, P1456, DOI 10.7150/jca.69166; Cui KS, 2021, ONCOGENE, V40, P2130, DOI 10.1038/s41388-021-01677-w; Cui KS, 2020, ONCOGENE, V39, P786, DOI 10.1038/s41388-019-1026-9; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Ferdows BE, 2022, NANOSCALE, V14, P4448, DOI 10.1039/d1nr06991h; Gao RL, 2021, NAT BIOTECHNOL, V39, P599, DOI 10.1038/s41587-020-00795-2; GARDEN GA, 1995, MOL CELL NEUROSCI, V6, P293, DOI 10.1006/mcne.1995.1023; Gong L, 2021, SMALL, V17, DOI 10.1002/smll.202103463; Gong ZC, 2021, ADV SCI, V8, DOI 10.1002/advs.202004504; Hacot S, 2010, CURR PROTOC CELL BIO; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hein N, 2013, TRENDS MOL MED, V19, P643, DOI 10.1016/j.molmed.2013.07.005; Hong F, 2021, CANCER IMMUNOL RES, V9, P939, DOI 10.1158/2326-6066.CIR-20-1026; Jhan YY, 2020, INT J PHARMACEUT, V573, DOI 10.1016/j.ijpharm.2019.118802; Jiang TJ, 2002, P NATL ACAD SCI USA, V99, P5295, DOI 10.1073/pnas.072083699; Kang J, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00728-8; Lee HO, 2020, NAT GENET, V52, P594, DOI 10.1038/s41588-020-0636-z; Li D, 2020, CARBOHYD RES, V493, DOI 10.1016/j.carres.2020.108032; Li WJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0523-z; Li YJ, 2021, CELL DEATH DIFFER, V28, P2112, DOI 10.1038/s41418-021-00739-6; Liu QL, 2021, ELIFE, V10, DOI 10.7554/eLife.69454; Morral C, 2020, CELL STEM CELL, V26, P845, DOI 10.1016/j.stem.2020.04.012; Morton DJ, 2018, RNA, V24, P127, DOI 10.1261/rna.064626.117; Muller JS, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000678; Pan HD, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00643; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Prakash V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10100-8; Shen AL, 2019, CANCER RES, V79, P2257, DOI 10.1158/0008-5472.CAN-18-3238; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taniue K, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010496; van Eijndhoven MAJ, 2020, NAT BIOMED ENG, V4, P6, DOI 10.1038/s41551-019-0514-0; Yang BW, 2019, ADV MATER, V31, DOI 10.1002/adma.201802896; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; Zanchin NIT, 1999, NUCLEIC ACIDS RES, V27, P1283, DOI 10.1093/nar/27.5.1283; Zhang J, 2022, J BIOMED SCI, V29, DOI 10.1186/s12929-022-00789-z; Zhang Y, 2022, J NANOBIOTECHNOL, V20, DOI 10.1186/s12951-022-01472-z; Zheng R., 2022, J NATL CAN CENT, V2, P1, DOI [10.1016/j.jncc.2022.02.002, DOI 10.1016/J.JNCC.2022.02.002]; Zhu YH, 2022, HEPATOLOGY, DOI 10.1002/hep.32518; Zhu YH, 2020, MOL CELL, V77, P138, DOI 10.1016/j.molcel.2019.10.015	48	0	0	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene												10.1038/s41388-022-02530-4	http://dx.doi.org/10.1038/s41388-022-02530-4		NOV 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	6D2TY	36348012	Bronze			2022-12-26	WOS:000882550800002
J	Ebrahimian, S; Lee, C; Tran, Z; Sakowitz, S; Bakhtiyar, SS; Verma, A; Tillou, A; Benharash, P; Lee, H				Ebrahimian, Shayan; Lee, Cory; Tran, Zachary; Sakowitz, Sara; Bakhtiyar, Syed Shahyan; Verma, Arjun; Tillou, Areti; Benharash, Peyman; Lee, Hanjoo			Association of frailty with outcomes of resection for colonic volvulus: A national analysis	PLOS ONE			English	Article							OLDER-ADULTS; RISK-FACTORS; DELIRIUM; PREDICTOR; IMPACT; CARE; LAPAROSCOPY; MORTALITY; SURGERY	Background With limited national studies available, we characterized the association of frailty with outcomes of surgical resection for colonic volvulus. Methods Adults with sigmoid or cecal volvulus undergoing non-elective colectomy were identified in the 2010-2019 Nationwide Readmissions Database. Frailty was identified using the Johns Hopkins indicator which utilizes administrative codes. Multivariable models were developed to examine the association of frailty with in-hospital mortality, perioperative complications, stoma use, length of stay, hospitalization costs, non-home discharge, and 30-day non-elective readmissions. Results An estimated 66,767 patients underwent resection for colonic volvulus (Sigmoid: 39.6%; Cecal: 60.4%). Using the Johns Hopkins indicator, 30.3% of patients with sigmoid volvulus and 15.9% of those with cecal volvulus were considered frail. After adjustment, frail patients had higher risk of mortality compared to non-frail in both sigmoid (10.6% [95% CI 9.47-11.7] vs 5.7% [95% CI 5.2-6.2]) and cecal (10.4% [95% CI 9.2-11.6] vs 3.5% [95% CI 3.2-3.8]) volvulus cohorts. Frailty was associated with greater odds of acute venous thromboembolism occurrences (Sigmoid: AOR 1.50 [95% CI 1.18-1.94]; Cecal: AOR 2.0 [95% CI 1.50-2.72]), colostomy formation (Sigmoid: AOR 1.73 [95% CI 1.57-1.91]; Cecal: AOR 1.48 [95% CI 1.10-2.00]), non-home discharge (Sigmoid: AOR 1.97 [95% CI 1.77-2.20]; Cecal: AOR 2.56 [95% CI 2.27-2.89]), and 30-day readmission (Sigmoid: AOR 1.15 [95% CI 1.01-1.30]; Cecal: AOR 1.26 [95% CI 1.10-1.45]). Frailty was associated with incremental increase in length of stay (Sigmoid: +3.4 days [95% CI 2.8-3.9]; Cecal: +3.8 days [95% CI 3.3-4.4]) and costs (Sigmoid: +$7.5k [95% CI 5.9-9.1]; Cecal: +$12.1k [95% CI 10.1-14.1]). Conclusion Frailty, measured using a simplified administrative tool, is associated with significantly worse clinical and financial outcomes following non-elective resections for colonic volvulus. Standard assessment of frailty may aid risk-stratification, better inform shared-decision making, and guide healthcare teams in targeted resource allocation in this vulnerable patient population.	[Ebrahimian, Shayan; Lee, Cory; Tran, Zachary; Sakowitz, Sara; Bakhtiyar, Syed Shahyan; Verma, Arjun; Benharash, Peyman; Lee, Hanjoo] UCLA, David Geffen Sch Med, Div Cardiac Surg, Cardiovasc Outcomes Res Labs, Los Angeles, CA USA; [Tran, Zachary] Loma Linda Univ, Dept Surg, Med Ctr, Loma Linda, CA USA; [Bakhtiyar, Syed Shahyan] Univ Colorado, Dept Surg, Aurora, CO USA; [Tillou, Areti] UCLA, Dept Surg, David Geffen Sch Med, Los Angeles, CA USA; [Lee, Hanjoo] Harbor UCLA, Dept Surg, Med Ctr, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Loma Linda University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Lee, H (corresponding author), Harbor UCLA, Dept Surg, Med Ctr, Torrance, CA 90502 USA.	hleea16bc@dhs.lacounty.gov		Ebrahimian, Shayan/0000-0002-6819-4871				Agency for Healthcare Research and Quality, 2010, HCUP NAT READM DAT N; Berian JR, 2022, DIS COLON RECTUM, V65, P457, DOI 10.1097/DCR.0000000000002381; Cipriani G, 2016, AM J ALZHEIMERS DIS, V31, P706, DOI 10.1177/1533317516673155; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dobaria V, 2021, ANN THORAC SURG, V112, P108, DOI 10.1016/j.athoracsur.2020.08.028; Easterday A, 2020, J SURG RES, V245, P119, DOI 10.1016/j.jss.2019.07.038; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Farhat JS, 2012, J TRAUMA ACUTE CARE, V72, P1526, DOI 10.1097/TA.0b013e3182542fab; Franx BAA, 2017, DRUG AGING, V34, P425, DOI 10.1007/s40266-017-0462-x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gilbert T, 2018, LANCET, V391, P1775, DOI 10.1016/S0140-6736(18)30668-8; Gonzalez-Ayora S, 2016, INT J COLORECTAL DIS, V31, P1625, DOI 10.1007/s00384-016-2621-7; Hadaya J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255122; Hadaya J, 2021, AM SURGEON, V87, P1589, DOI 10.1177/00031348211024233; Halabi WJ, 2014, ANN SURG, V259, P293, DOI 10.1097/SLA.0b013e31828c88ac; Ho B, 2017, AM SURGEON, V83, P1179; Huang CH, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02466-6; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Iyengar A, 2020, ANN THORAC SURG, V109, P1120, DOI [10.1016/j.athoracsur.2016.10.087, 10.1016/j.athoracsur.2019.10.087]; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Juo YY, 2019, JAMA SURG, V154, P899, DOI 10.1001/jamasurg.2019.2141; Ko FC, 2019, CLIN THER, V41, P387, DOI 10.1016/j.clinthera.2019.01.014; Kothari P, 2019, UPDATES SURG, V71, P89, DOI 10.1007/s13304-018-0531-7; Lee C, 2022, SURGERY, V172, P506, DOI 10.1016/j.surg.2022.03.025; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Litaker D, 2001, GEN HOSP PSYCHIAT, V23, P84, DOI 10.1016/S0163-8343(01)00117-7; Madrigal J, 2022, J AM MED DIR ASSOC, V23, P684, DOI 10.1016/j.jamda.2022.02.004; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Mallick S, 2022, JAMA SURG, V157, P312, DOI 10.1001/jamasurg.2021.7126; McCusker J, 2001, CAN MED ASSOC J, V165, P575; McIsaac DI, 2020, ANESTH ANALG, V130, P1450, DOI 10.1213/ANE.0000000000004602; Mosquera C, 2016, WORLD J GASTROENTERO, V22, P9544, DOI 10.3748/wjg.v22.i43.9544; Nieman CL, 2018, LARYNGOSCOPE, V128, P102, DOI 10.1002/lary.26735; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raveenthiran V, 2010, COLORECTAL DIS, V12, pE1, DOI 10.1111/j.1463-1318.2010.02262.x; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Saur NM, 2022, DIS COLON RECTUM, V65, P473, DOI 10.1097/DCR.0000000000002410; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	40	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2022	17	11							e0276917	10.1371/journal.pone.0276917	http://dx.doi.org/10.1371/journal.pone.0276917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6U0HY	36346811	Green Published, gold			2022-12-26	WOS:000894053200013
